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The firs t part o f the thesis describes the characterization o f 19 kDa antigen 
from M . b o v is  BCG. The gene was expressed in E. co li and was detected using the 
monoclonal antibody CMA 134.1. I t  was shown to be inducible in E. c o li by 
performing Western blot analysis o f induced and non-induced lysogens. The 
complete nucleotide sequence o f the gene was determined and shown to be identical 
to that o f 19 kDa gene from M . tu b ercu lo s is . This gene has the potential to be used 
as a diagnostic tool for the early detection o f bovine tuberculosis.
The second part o f the thesis describes an attempt to clone, characterize and
sequence the two genes, dihydrofolate reductase (DHFR) and thymidylate
synthase (TS) from M . tu b ercu lo s is . Polymerase chain reaction technique was used
to amplify the coding DNA sequences and the amplified DNA product o f the reaction 
was used as the probe to screen the genomic library o f M . tu b e rc u lo s is . Putative 
genes for dihydrofolate reductase and thymidylate synthase were isolated from the 
genomic library. Both o f these putative genes failed to complement the E . co li 
deficient strains o f DHFR and TS genes. The complete nucleotide sequence o f both 
these genes was determined. CLUSTAL analysis o f both sequences showed only low 
homology w ith published Dihydrofolate reductase and Thymidylate synthase 
sequences.
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1) I N T R O D U C T I O N
Tuberculosis and leprosy are the only two major diseases of mankind which 
are known to be still persistent from 2000 B C  and 500 A D  respectively (Grange,
1989). These two diseases are caused by the members of the genus Mycobacterium. 
The causative agent of tuberculosis, M y c o b a c t e r i u m  t u b e r c u l o s i s , was discovered by 
Robert Koch in 1882, while Gerhard Henrik Armauer Hansen was successful in 
identifying leprosy bacillus, M y c o b a c t e r i u m  l e p r a e , in 1873. M y c o b a c t e r i u m  
t u b e r c u lo s i s  has one of the widest host ranges of all pathogenic bacteria and causes 
disease in many feral and domesticated animals. The disease tuberculosis was 
referred by the writers of the Hindu Upanishads (c. 1500 BC) as the king of diseases 
(Rogaraj) and the disease of kings (Rajayakshma). O n  the other hand M .  l e p r a e , has 
a very narrow range and natural disease is virtually restricted to man.
The generic name Mycobacterium was introduced by Lehman and N e u m a n  in 
the first edition of their "Atlas of Bacteriology" published in German in 1896. The 
name mycobacterium means fungus-like bacterium arising from the characteristic 
fungus-like pellicle produced by the tubercle bacilli when grown in liquid media. 
Today this genus consists of 41 different species as opposed to only two, M .  
t u b e r c u lo s i s  and M .  l e p r a e , at the time of Lehman and Neumann (Grange, 1988). 
Although the number of species in this genus has increased almost twenty times, the 
genus is still dominated by two original species with respect to the diseases in 
concern. With the increase in infection due to H u m a n  Immunodeficiency Virus 
(HIV), other mycobacterial species are n o w  becoming important due to opportunistic 
infections. Infection with the H I V  causes a progressive and ultimately profound
1.1) Mycobacteria:
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reduction in the cell-mediated immune response, thus setting the stage for a variety 
of opportunistic infections, mainly from organisms belonging to the group of M A I S  
complex. The relatively high incidence of M. a v i u m - i n t r a c e l l u l a r e - s c r o f u l a c e u m  in 
Acquired Imm u n e  Deficiency Syndrome (AIDS) patients have created interest in this 
species (Farhi e t  a l . ,  1985; Kiehn e t  a l . , 1985, Kiehn and Cammarata, 1986). M .  
k a n s a s i i had also been reported to cause disseminated infection in A I D S  patients 
(Sherer e t  a l . ,  1986). Thus the atypical mycobacteria are n o w  gaining importance 
and becoming clinically significant.
1.2) General Morphology:
Most species are whitish or cream-coloured, the slight colour being 
presumably due to cytochromes or other coloured constituents of the biochemical 
machinery of the cell. In some species, strains can be various shades ranging from 
yellow to deep red, the colour being due to carotenoid pigments (Tarnok and Tarnok, 
1970). Colonial morphology may be smooth or rough on solid media although 
colonial variation can occur (Collins e t  a l . ,  1985). e.g. virulent strains of the M .  
t u b e r c u lo s i s  and M .  a v i u m - i n t r a c e l l u l a r e  complexes are usually associated with rough 
colonies (Silva e t a l . ,  1985; Collins, 1988).
Mycobacteria are G r a m  positive bacilli with sizes ranging from 1 to 10 p m  
long and about 0.3 p m  to 1 p m  in width. M .  t u b e r c u lo s i s  usually, but not always , 
forms characteristic serpentine cords or rope like structures under the microscope, 
while M .  a v i u m  appears as short cocci-bacilli and M .  m i c r o t i as curved rods (Draper, 
1982).
The cord-like structures observed in M .  t u b e r c u lo s i s  are due to a component
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in the outer cell wall called the cord factor (CF). C F  is a glycolipid consisting of two 
mycolic acid molecules linked with trehalose (Noll e t  a l., 1956; Silva, 1985) and was 
shown to play an important role in host-parasite relationship. It was found to be 
associated with virulence, is involved in inhibiting leukocyte migration, confers 
hydrophobicity to the cell and acts as an immunostimulent (Silva e t  a l., 1985). Other 
mycobacteria also produce C F  but with variations in the number of carbon atoms in 
the mycolic acid molecules.
1.3) Acid Fastness:
All the bacteria from this genus are characterised by the property of acid 
fastness, i.e. resistance to decolorization by dilute mineral acids after staining with 
one of the arylmethane dyes such as basic fuchsin, crystal violet or auramine 
(Barksdale and Kim, 1977; Collins, e t  a l . ,  1985). The acid fastness, the most 
important characteristic property to a light-microscopist, was discovered by Ehrlich 
in 1882 and staining procedure used to identify mycobacteria is called the Ziehl- 
Neelsen staining method. The mechanism of the staining reaction has been much 
discussed (Barksdale and Kim, 1977; Goren et al., 1978) but still not understood in 
molecular terms. In general the acid fastness is thought to be due to the basic fuchsin 
or any other basic dye being trapped intracellularly by a barrier formed by mycolic 
acid-fuchsin complexes in the peptidoglycan layer of the outer cell wall. The 
property of acid fastness, although useful for distinguishing from others, is not unique 
to mycobacteria as bacterial spores and Nocardia are strongly acid fast and weakly 
acid fast respectively. Also young rapidly growing cultures of mycobacteria, 
especially of saprophytic species, may be only partially acid fast or even non-acid
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fast. According to Convit and Pinardi (1972, 1974) pyridine treatment of smears of 
mycobacteria before staining had no effect on any species except M .  l e p r a e , which 
it rendered non-acid fast; this is useful to distinguish M .  l e p r a e  from other 
mycobacteria.
1.4) Classification and Identification:
The traditional bacterial classification is based on variety of biochemical tests 
and cultural properties. Other than biochemical classification for taxonomic purposes, 
mycobacteria can be classified according to following criteria for the general studies:
A) Classification based on growth rate,
B) Classification based on pathogenicity,
C) Classification based on major antigens,
D) Classification based on genomic characteristics.
A) Classification based on growth rate: The genus Mycobacterium can be 
divided into two main groups - (1) Fast growers and (2) Slow growers. M .  
s m e g m a t is , M .  p h l e i ,  M .  f o r t u i t u m  are examples of fast growers. The colonies start 
becoming visible after 1 to 3 days of incubation on solid media. M .  t u b e r c u lo s i s ,  M .  
a v i u m ,  M .  x e n o p i are examples of slow growers and colonies start becoming visible 
after 10 days of incubation on solid media. Unfortunately M .  l e p r a e  can not be put 
in either of the class because there are no convincing reports of in vitro growth of the 
organism.
B) Classification based on pathogenicity: Mycobacteria can be simply 
classified into 3 groups as (1) Pathogenic species, e.g. M .  t u b e r c u lo s i s ,  M .  l e p r a e ,
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(2) Non-pathogenic species, e.g. M .  s m e g m a t is ,  M .  p h l e i, and (3) Opportunistic 
pathogens e.g M A I S  complex.
C) Classification based on major antigens: Stanford and Grange (1974) and 
Anderson e t  a l., (1986) compared species and strains using antigenic analysis of their 
soluble cytoplasmic antigens. This technique showed that mycobacterial antigens 
occur in four main groups (Table 1).
Table 1: The distribution of the four groups of antigens among mycobacteria:
Antigenic group
i ii iii iv
Slow growers +  + +  + Unique
M. l e p r a e  
M .  v a c c a e
+  + Unique
Fast growers +  4- +  + Unique
+  +  indicates the presence of antigenic group.
Fro m  table 1 it can be seen that antigenic group (iv) is very important because these 
antigens show species as well as group variations.
D) Classification based on genomic characteristics: Mycobacteria can be
classified depending on various genomic criteria. Relatedness among the 
mycobacteria have been determined by D N A - D N A  hybridizations (Clark-Curtiss,
1990). M .  t u b e r c u lo s i s  and B C G  strain variants can be easily identified (Hermans, 
e t  a l., 1990, Fomukong and Dale, personal communication). The technique of 
restriction fragment length polymorphism (RFLP) has also been used to classify
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organisms from M A I S  complex which are difficult to classify depending on classical 
biochemical tests (McFadden e t  a l . ,  1990). In conclusion the last method is the most 
discriminatory method for classification of mycobacteria.
1.5) Identification of Mycobacteria:
The most c o m m o n  mycobacterial diseases are leprosy and tuberculosis, 
however many non-tuberculous mycobacteria have been shown to be pathogenic to 
man. The identification of mycobacteria is routinely done from sputum samples in 
suspected cases of tuberculosis and from skin biopsies from cases of leprosy. 
Leprosy however is much rarer in developed countries and symptoms shown by 
leprosy are more easily identified. For identification of tuberculosis, the first and 
most important task is to identify the mycobacterium as either a tubercle or non­
tubercle mycobacteria. As in any other the diagnostic method the procedure involves:
(1) the direct observation of the organism (2) culturing of the organism and (3) final 
identification through various biochemical tests. If the mycobacterium is identified 
as M .  t u b e r c u lo s i s , the treating hospital is immediately notified and drug sensitivity 
tests are then performed and the variants are further identified.
Non-tubercle mycobacteria, after the first screening, are identified using a 
number of cultural and biochemical tests. The methods, media and routine 
procedures for diagnosis of tubercle and non-tubercle mycobacteria are very well 
standardised (Jenkins, e t  a l . , 1982; Marks, 1972; Marks, 1976; Zaher and Marks,
1977).
Clinical samples obtained for examination are usually contaminated with other 
microorganisms. Uncontaminated clinical specimens are restricted to exudates
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obtained by puncture such as pleural, peritoneal, articular and cerebrospinal fluids. 
These specimens can be directly used for the identification of organisms. Most 
specimens to be cultured for mycobacteria contain other microorganisms and pure 
cultures are obtained via the following methods: (1) direct plating, (2) selective 
destruction of contaminants in the material to be cultured, (3) culturing on selective 
media that support the growth of mycobacteria but suppress the proliferation of other 
micro-organisms.
Following the Ziehl-Neelsen procedure for acid fastness, samples are 
inoculated into Lowenstein-Jensen media containing glycerol (LJG) and tested for 
following:
(1) The growth rate at 37°C and at 25°C.
(2) Pigment production
(3) Growth on L J G  containing 500 mg/litre of p-nitrobenzoic acid (PNB).
The tubes are examined after 3,7 14 and 21 days of incubation. Tubercle bacilli do 
not grow at 25 °C and require about 10 days to give visible colonies on L J G  slopes 
incubated at 37°C. They do not produce pigment and do not grow in presence of 
PNB. At 21 days classical human and Asian strains of M .  t u b e r c u lo s i s  show 
characteristic, dry, cauliflower growth that is greyish white or buff in colour on LJG 
slopes at 37°C. Growth of the bovine or African variants is usually poor on L J G  but 
they grow better on LJP medium (Lowenstein-Jensen medium containing sodium 
pyruvate). These colonies are flatter and may not appear to be as rough as those of 
the human variant.
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S o m e  non-tubercle mycobacteria grow within three days and produce yellow, 
orange or pink pigmented colonies. They also grow at 25 °C and on P N B  medium 
or any combination of the above characteristics.
1.5.1) Identification of variants of M .  t u b e r c u lo s i s  and B CG:
Using the above set of tests organisms identified as tubercle bacilli are further 
characterised by following tests:
(1) Sensitivity to thiophen-2-carboxylic acid hydrazine (TCH): Initial studies 
showed that the human tubercle bacillus is resistant and the bovine tubercle bacillus 
is sensitive to this compound (Harrington and Karlson, 1966), but later studies by 
Yates and Collins (1979) found that many strains from Asian human type were also 
sensitive. Hence this test can not be used to identify only bovine strains.
(2) Nitratase production test
(3) Oxygen preference
(4) Pyrazinamide sensitivity
(5) Cycloserine sensitivity
Table 2 shows the reactions of the different variants and of B C G  for the above tests 
(Collins e t  a l., 1985). In practice all these tests are time consuming and with the 
advent of molecular biology techniques time and labour may be saved by using D N A  
probes for identification of correct strain. The use of D N A  probes for the detection 
is increasing rapidly and gives accurate differences at the D N A  level. The most 
commonly used technique, restriction fragment length polymorphism (RFLP), 
requires D N A  to be extracted and purified from the test organism. Using this 
technique, M  t u b e r c u lo s i s  and M .  b o v i s  were found to give similar but distinguishable
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genomic finger prints (Collins and de Lisle, 1984), however clear differences were 
observed between strains of either M .  t u b e r c u lo s i s  or M .  b o v i s  after use of the 
specific D N A  probe, namely IS986, the repetitive element (Zainudddin and Dale,
1989).
Table 2: Identification of species and variants of tubercle bacilli:
Species(a) Variants(b) T C H Nitra
tase
02
pref.
Py. C y
M .  tuberculosis Classical human R + A S s
Asian human S + A S s
M .  africanum African I s - M s s
African II s + M s s
M .  bovis Classical bovine s M R s
BCG(c) s - A R R
T C H  - Thiophen-2-carboxylic acid hydrazine, Py. - Pyrazinamide, Cy. - Cycloserine 
R  - Resistant 
S - Sensitive 
A  - Aerobic 
M  - Microaerophilic
(a) - Species according to Skerman e t  a l . , 1980
(b) - Variants of M .  tuberculosis according to Collins e t  a l . , 1982
(c) - Not recognized as a species.
Polymerase chain reaction (PCR) has also been used recently by number of 
researchers to distinguish between variants of M .  t u b e r c u lo s i s  and B C G  (Fomulcong 
e t  a l., 1991; Fries e t  a l . ,  1990). This method is more useful for the detection of
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mycobacteria from the sample rather than for the identification of the species or strain 
variants (Brisson-Noel e t  a l . , 1989; Eisenach e t  a l . , 1988; Hartskeerl e t  a l . , 1989). 
The technique is extremely sensitive and hence proper positive and negative controls 
play a very important role. Though the technique is very useful, because of the 
limitations, at present it can not be applied routinely in all bacteriological 
laboratories.
1.5.2) Identification of non-tubercle mycobacteria:
Non-tubercle mycobacteria are usually identified using the scheme of Pattyn 
and Portaels (1972). The scheme first identifies between rapid or slow growing 
mycobacteria. All rapidly growing species, except M .  m a r i n u m , produce abundant 
growth on peptone agar within 4 to 5 days. To identify further following tests are 
performed:
(1) Growth at different temperatures
(2) Pigment production
(3) Sensitivity to thiacetazone (TZ)
(4) Nitrate reduction
(5) Arylsulphatase production
(6) Catalase production
(7) Tween hydrolysis
(8) Tellurite reduction
(9) Citrate and Benzoate utilization
These are few tests commonly used to identify rapidly growing non-tubercle 
mycobacteria. For the slow growers more tests are necessary namely - Niacin
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production, Urease production, Nicotinamidase and pyrazinamidase activity, etc. 
(Jenkins et al., 1982).
D N A  probes have been used to distinguish various M . a v i u m  strains by 
McFadden e t  a l . (1987a). They were also able to separate different serotypes of 
M A I S  complex using a repetitive element as a probe (McFadden e t  a l., 1987b).
1.5.3) Identification of leprosy bacilli:
Although leprosy is usually readily recognizable in the late stages, diagnostic 
difficulties often arise in the early stages, when clinical manifestations are developing. 
One of the cardinal signs of leprosy is finding non-cultivable acid-fast bacilli in the 
lesions. The early diagnosis of leprosy is important but should be based on non- 
cultivable acid-fast bacilli in skin lesions along with clinical and histological 
examination.
1.6) Drug sensitivity tests:
Once the identification of the micro-organism is complete, it is subjected to 
drug sensitivity testing. This is very important for the treatment of the mycobacterial 
diseases. In sensitivity testing a high degree of accuracy is required since the 
following factors often affect sensitivity test results:
(1) Variations in the activity of different batches of the same drug and storage 
of culture media containing drugs,
(2) The range of concentrations of the drugs used and the size of inoculum,
(3) The relation between the i n  v i t r o  and i n  v i v o  activity of the drug,
(4) Slow growth of the organism and possible reduction in effective 
concentration of the antibiotic during prolonged incubation, and
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There are at least five methods of drug sensitivity tests used routinely 
throughout the world:
A) The absolute concentration method:
This method was introduced by Meissner (1964) and is popular in some parts 
of Europe. The method essentially determines the minimum inhibitory concentration 
(MIC) of each drug for the test organism. The most c o m m o n  solid medium is 
Middlebroolc’s 7H10. Usually solid media are used which gives cleaner end-points. 
The medium is melted and the appropriate amount of drug is added and petri plates 
or tubes are poured. Plates or tubes are inoculated with test the organism and 
incubated at 37°C for 18-21 days. Each strain is tested at least in duplicate.
B) The proportion method:
This method is popular in the U S A  and also used in Europe (Canetti e t  a l., 
1969; Vestal, 1975). As the name suggests this procedure compares the number of 
colonies growing on drug-containing medium with the number on drug-free medium. 
The criterion for resistance is that the number of colonies on the drug-containing 
medium is 1 %  or more of the number on the drug-free medium.
C) The resistance ratio method:
This method is used in the U K  and those countries that are influenced by 
British bacteriologists (Leat and Marks, 1970; Collins and Lyne, 1984). The M I C  
of the test strain is compared with the modal average results of several control strains 
using the same batch of medium. Therefore, the exact amount of drug in the medium 
is not so important as that of the absolute concentration method. The resistance ratio
(5) The proper controls in the testing experiments.
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of each test strain to each drug is calculated by dividing the M I C  of the test strain by 
the Modal MIC, which is the average M I C  of the control strains. Strains giving a 
resistance ratio of 1 or 2 are reported as sensitive and ratios higher than this are 
considered as resistant.
D) The Disc method:
This method was introduced by Collins (1955, 1956), modified by W a y n e  and 
Kransnow (1966) and was found to be useful for field work by Griffith e t  a l , (1971). 
One paper disc containing the test drug is placed in each quadrant of a Felsen plate 
and 7H11 agar medium is poured and allowed to set. The quadrants are inoculated 
with the test and control organisms and incubated till the zones of inhibition are 
visible. The zones of inhibition of test strains are compared with that of control 
strains.
E) The Radiometric method:
This method is the most recent procedure which measures the metabolic 
activity of mycobacteria in the presence of antituberculosis drugs (Vincke e t  a l . ,  
1982). A  commercial instrument ( B A C T E C  - Johnston Laboratories) has been 
developed to give rapid and fairly reliable results. Sputum or other sample is 
inoculated into Middlebrook broth medium containing antibiotic and 14C-labelled 
palmitic acid. If the test organism grows in presence of a drug, the 14C-labelled 
palmitic acid is broken down and the air from the system is checked for 14C 0 2 
evolved. Though the method gives very rapid results, the materials and equipments 
used are too expensive for routine diagnostic use in most laboratories (Body e t  a l . ,
1990). The other disadvantage of the system is the handling and disposal of
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radioactive material. N o w  this problem has been solved by the use of non-radioactive 
material in the system.
Mycobacterial diseases:
1.7) Leprosy:
Leprosy is a chronic infectious disease caused by M y c o b a c t e r i u m  l e p r a e . It 
is one of the oldest disease of mankind. Most probably, the disease was originated 
in India and the first authentic description of different types of leprosy was found in 
"Sushruta Samhita" written in India in 600 BC. The disease was probably brought 
to the Mediterranean region by the soldiers of Alexander the Great returning from 
their Indian Campaign in 327-326 BC. At the beginning of the 13th century, leprosy 
was rampant in Europe, from Iceland to Italy and started decreasing in Europe from 
the 15th century. Today the disease is still endemic at a low level in Portugal, Spain, 
Italy, Greece, Turkey, Cyprus and Southern Russia (Thangaraj and Yawalkar, 1986).
Leprosy, also known as Hansen’s disease, is most prevalent in tropical 
countries. This is not due to the climate, since the disease exists in cold countries but 
because of the overcrowding which leads to more frequent close contact with the 
source of infection. At present about 11 million sufferers of the disease are present 
throughout the world as estimated by the World Health Organization (W.H.O., 1985).
Leprosy bacillus was first discovered in 1873 by Hansen at Bergen in Norway. 
Hansen’s discovery was accepted six years later by Albert Neisser of Germany who 
in 1879, stained the organism with fuchsin and gentian violet. M .  l e p r a e  is an obligate 
intracellular acid fast bacillus multiplying mainly inside the macrophages of the skin 
(histocytes) and of the nerves (Schwann cells). The bacillus, M .  l e p r a e , closely
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resembles M .  t u b e r c u l o s i s , however it is less acid-fast than M .  t u b e r c u lo s i s . Leprosy 
bacilli are pleomorphic, straight or curved, rod-lilce Gram-positive bacteria. Although 
the discovery of leprosy bacilli was reported in 1873, they have not yet been grown 
in artificial media. Shepard in 1960 first reported the growth of leprosy bacilli in the 
mouse footpad and the generation time in mouse footpad is 12 to 13 days during the 
phase of logarithmic growth, while its overall mean generation time ranges from 18 
to 42 days. Kirchheimer and Storrs (1971) reported a disseminated experimental M .  
l e p r a e  infection in the nine banded armadillo. The infected armadillo’s liver may 
contain as many as 109 bacilli per gram of tissue and since the infection can be 
transmitted to the seven and eight-banded armadillo, large quantities of M .  l e p r a e  can 
be obtained from infected armadillo’s for genetical and immunological studies.
The infection of M .  l e p r a e  is virtually restricted to the human being and 
armadillo’s (with exception of some reports of infection in monkeys), the infected 
human being is considered to be the only source of infection. The infective capacity 
of multibacillary leprosy cases is 4-11 times greater than paucibacillary leprosy, 
untreated patients of multibacillary leprosy thus constitute the main source of 
infection. In general, as leprosy is feebly infectious, prolonged and close contact is 
usually considered to be necessary for its transmission. However, in a susceptible 
person casual or short contact may cause the disease. The contact need not be "skin 
to skin" contact, because the nose is the main portal of exit of bacilli from patients 
with multibacillary leprosy. Untreated lepromatous patients may discharge as many 
as 108 leprosy bacilli from their nasal secretions every day (Waters, 1989). Leprosy 
bacilli may remain alive outside the human body in droplets of nasal secretions for
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several days and thus the inhalations of bacilli-laden droplets contribute to the major 
source of infection.
1.7.1) Pathogenesis and immune response:
It is generally accepted that Schwann cells are the target for M .  l e p r a e  
although the reasons for this are unknown. The organisms remain unrecognised for 
a long period in the Schwann cells and multiply gradually, depending upon host 
resistance, i.e. cell-mediated immunity determined by T  lymphocytes. Table 3 shows 
the relationship between the host resistance and the type of infection. Once the cells 
recognise the presence of M .  l e p r a e  in the Schwann cells, host-parasite interaction 
takes place, further the growth is checked and the disease resolves to a subclinical 
level in most cases. Susceptible individuals are unable to mount an effective immune 
response and cannot overcome infection at subclinical levels. They may present with 
various types of leprosy depending upon the levels of cell-mediated immunity that 
they exhibit (Table 3). In the area where the prevalence of leprosy is 10 per 1000 
of the population, it may be concluded that only 1%  of the population is susceptible 
and the rest are immune (Ganapati and Revankar, 1989).
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Table 3: Range of clinical manifestations depending on the infected individual’s 
resistance to leprosy bacilli:
Host’s resistance Clinical manifestation of leprosy
Excellent N o  infection
Good - Sub-clinical infection showing
spontaneous regression
- Intermediate leprosy showing
spontaneous regression
Fair - Indeterminate leprosy (I)
- Primary polyneuritic leprosy(PP)
- Tuberculoid leprosy (TT)
- Borderline-tuberculoid 
leprosy (BT)
All above types are of Paucibacillary (PB) leprosy.
Poor - Mid-borderline leprosy (BB)
- Borderline-lepromatous
leprosy (BL)
Very poor/none - Lepromatous leprosy (LL)
Above three types are known as Multibacillary (MB) leprosy.
1.7.2) Diagnosis:
Although leprosy is usually readily recognizable in the late stages, diagnostic 
difficulties often arise in the early stages, when clinical manifestations are developing.
The three cardinal signs of leprosy are: (1) Sensory impairment in the affected 
area, (2) Enlargement plus tenderness of the peripheral nerves associated with signs 
of peripheral nerve damage, such as paralysis, sensory loss or sudomotor dysfunction 
and (3) Finding non-cultivable acid-fast bacilli in the lesions.
Tuberculoid leprosy is the most well established type of leprosy both clinically
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and immunologically. A  patient may have from one to three lesions (either macular 
{flat} or infiltrated {raised}) with well defined margins, hypopigmented or mildly 
erythematous and with definite anaesthesia. Usually one nerve trunk or a cutaneous 
nerve supplying the area containing a skin lesion may be thickened and tender. The 
well established patch may be dry, hairless and show loss of modalities of sensation, 
i.e. temperature, pain and touch. Skin smears are always negative for acid-fast bacilli 
and so tuberculoid leprosy is considered to be non-infectious. Clinically tuberculoid 
leprosy is characterised by strong lepromin positivity. Histopathology shows a well- 
defined lymphocytic granuloma infiltrating the nerve and characterised by epitheloid 
cells with giant cells and the architecture of the nerve may be completely disrupted 
by the invading granulomas.
Differential diagnosis in case of leprosy patients is very important as a variety 
of entirely unrelated diseases may show macular (flat), infiltrated (raised) and nodular 
lesions. Macular lesions developed in Vitiligo, Occupational leucoderma, Tinea 
versicolour or Pityriasis versicolour, Onchocerciasis,etc., Infiltrated lesions developed 
in Lupus vulgaris, Lupus erythematosis, Sarcoidosis, Psoriasis, etc. and Nodular 
lesions developed in Post-Kala-Azar dermal leishmaniasis, Cutaneous leishmaniasis, 
Syphilis, Onchocerciasis, etc. may be mistaken as leprosy on superficial 
observations.
Polymerase chain reaction has been shown successful in early detection of 
leprosy and though with some difficulties of contamination, has the potential to be 
very useful tool for routine diagnosis.
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For a very long time control of the disease consisted merely of isolating the 
patients from rest of the population. This is a reflection of outdated and inappropriate 
stigma of the disease which still persists in most cultures and societies. There is no 
other disease (possible exception of AIDS) whose sufferers are subjected to so much 
stigma and rejection, which are much more damaging than the disease itself.
Nowadays chemotherapy can prevent leprosy more effectively and in a much 
better way than segregation did in the past. Detection of all leprosy sufferers, 
preferably in the early stages, through surveys or other means and putting them onto 
the current anti-leprosy treatment is n o w  established as the method of choice for the 
cure, prevention and control of the disease.
Chemoprophylaxis has been tried with dapsone which afforded 5 0 %  protection 
among child contacts of leprosy patients (Noordeen and Neelan, 1978). However, 
in view of widespread dapsone-resistant strains of M .  l e p r a e , in general there is doubt 
regarding the prophylactic use of dapsone.
F rom the immunoprophylactic point of view, various efforts are being made 
to develop a vaccine against leprosy with high efficacy, acceptability and cost- 
effectiveness. B C G  was the first vaccine to be considered against leprosy following 
the reports by Fernandez in 1939 on over 9 0 %  lepromin conversion among lepromin- 
negative healthy children, following B C G  vaccination (cited by Thangaraj and 
Yawallcar,1986). In 1960s various field trials were conducted to ascertain the value 
of B C G  vaccination and the overall protective effect attributable to B C G  was found 
to be 8 0 %  in Uganda (Stanley e t  a l., 1981), 4 6 %  in Papua N e w  Guinea, 2 8 %  in
1.7.3) Control and Therapy:
19
Since the advent of the armadillo-derived M . l e p r a e  bacilli, several vaccine 
trials, sponsored by the U N D P / W o r l d  B a n k / W H O  Special programme for Research 
and Training in Tropical Diseases, have been undertaken. The vaccine known as 
I M M L E P ,  consists of heat-killed, gamma-irradiated whole M .  l e p r a e  cells. The 
vaccination programme has two objectives, immunoprophylaxis or the protection of 
the uninfected population and immunotherapy or stimulation of cell-mediated immune 
responsiveness of infected patients. Since lepromatous leprosy patients exhibit high 
antibody titre but no cellular immunity, the I M M L E P  vaccine would only serve the 
first function in protecting the uninfected population by priming the immune system 
to specific M .  l e p r a e  antigens. The rationale is that this latent state of cell-mediated 
immunity would be boosted upon infection by the leprosy bacillus, thus placing the 
patient at the tuberculoid end of the spectrum, resulting in the self-healing 
mechanism, or resulting in subclinical leprosy. Convit e t  a l . (1982) demonstrated 
that a vaccine consisting of a mixture of killed M .  l e p r a e  plus B C G  was capable of 
upgrading the immune status of patients with lepromatous and borderline leprosy, and 
suggested that it would be capable of doing the same in susceptible but healthy 
contacts. This led to the use of a combined I M M L E P / B C G  vaccine in two major 
trials in Venezuela (Zuniga and Convit, 1985) and Malawi (Williams, 1985) which 
are still in progress. Deo e t  a l . (1981) reported that a killed, cultivable 
mycobacterium, known as I C R C  bacillus and related to M A I S  complex, resulted in 
significant skin-test conversion, not only in lepromin negative, healthy individuals but 
also in borderline and borderline lepromatous leprosy patients. Emmrich and
India (Tripathy, 1984) and 20% in Burma (Lwin et ah ,  1985).
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Kaufmann (1986) demonstrated that the I C R C  bacillus caused elevated T-cell 
stimulation as compared to stimulation with B C G ,  indicating the usefulness of the 
I C R C  bacillus as a vaccine candidate. Chaudhuri e t  a l . , (1983) reported significant 
skin-test conversion rates in healthy individuals and lepromatous leprosy patients 
when using a strain known as M y c o b a c t e r i u m  W ,  also belonging to the M A I S  
complex. Trials of vaccines derived from both these mycobacteria as well as the 
I M M L E P  vaccine are currently being carried out in India (Deo, 1984).
Chemotherapy of leprosy dates back to the 1940’s when the sulphone-derived 
antibiotic Promin was first used by Faget e t  a l . ,  (1943). Shortly after the 
introduction of Promin, a new antibiotic, dapsone (4,4’-diaminodiphenyl sulphone, 
D D S )  was tried by various researchers in Malaysia (Molesworth e t  a l . ,  1949), India 
(Muir, 1950) and in Nigeria (Lowe, 1950) and was found to be very effective. This 
drug is as cheap as aspirin, stable and relatively non-toxic and hence made it a very 
useful drug (Bloom and Godal, 1983). Soon oral dapsone in became standard in 
many parts of the world for a number of decades. However, rather than facilitating 
the eradication of leprosy, dapsone-monotherapy has failed in the control of the 
disease. Firstly, the emergence of secondary drug resistance, i.e. resistance arising 
during treatment, was found in patients at the lepromatous or multibacillary end of 
the disease spectrum and primary drug resistance, that is detection of M .  l e p r a e  
strains in untreated patients, was reported by Pearson e t .  a l . ,  (1977). This led 
the W H O  Scientific Working Group on the Chemotherapy of Leprosy to recommend 
a multiple-drug therapy for both paucibacillary and multibacillary leprosy cases. For 
patients at the lepromatous end of the spectrum a triple-drug regimen, consisting of
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dapsone, rifampicin and clofazimine was suggested. Rifampicin was not only found 
to be more effective than dapsone in killing M .  l e p r a e  cells (Rees e t  a l., 1970) but 
was also effective against bacilli resistant to dapsone. The emergence of both 
dapsone and rifampicin resistant strains is prevented by the inclusion of the third 
antibiotic, clofazimine. This however, is associated with a side-effect resulting in 
abnormal skin pigmentation, particularly in Caucasian patients. For this purpose, 
ethionamide is often used as the third component of the regimen, being administered 
for a minimum of two years, until skin smears are negative. Patients at the 
tuberculoid end of the spectrum are treated for up to six months with dapsone and 
rifampicin only. Table 4 summarises the dosage and time of each antibiotic 
administered in this multiple-drug regimen.
Table 4: W H O  multiple-drug regimen for adult leprosy patients (1982)
Type of Leprosy Paucibacillary 
Leprosy (I,TT,BT)
Multibacillary 
Leprosy (BB,BL,LL)
BI according to 
the Ridley scale
Less than two at 
all sites
T w o  or more at 
any site
Regimen Dapsone 100 m g  
Daily
Dapsone 100 m g  
Clofazimine 50 m g  
Daily
Rifampicin 600 m g  
Once a month
Rifampicin 600mg 
Clofazimine 300 m g  
Once a month
Duration of 
Treatment
Six months At least two years, 
preferably until 
negative skin 
smears are obtained
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As multidrug therapy ( M D T )  is a very important weapon in the fight against 
leprosy, it is absolutely imperative that adequate in-depth planning is made before the 
M D T  programme is introduced in any area. Parallel programme of health education 
must be run to improve the chances of early diagnosis and treatment which will help 
for the eradication of leprosy.
1.8) Tuberculosis
Tuberculosis is the most c o m m o n  disease in the world from which m a x i m u m  
number of people suffer. Although the causative agent of tuberculosis was first 
shown to be the pathogen in 1885, still after more than 100 years it remains the most 
c o m m o n  disease in the third world. The importance of the disease in industrially 
developed countries has diminished considerably due to improvements in public 
health, sanitation and better nutrition.
It is estimated that almost one third of the world’s population has been infected 
with M .  t u b e r c u lo s i s  i.e. 1722 million people had been infected with tuberculosis 
bacilli at the end of 1990 (Kochi, 1991). According to a W.H.O. survey in 1990 
alone there were 8 million new cases of tuberculosis throughout the world and the 
death toll in 1990 was about 3 million. It is significant that 9 5 %  of the new cases 
were from third world countries as opposed to only 5 %  from the developed world. 
Thus in developing countries there are 100-150 smear-positive cases, and 50-75 new 
smear-positive cases annually for every 100000 of the population (Holm, 1984).
Unfortunately, the acquired immune deficiency syndrome (AIDS) has added 
a new dimension to the worldwide problem of tuberculosis (Goldman, 1988). It has 
been estimated that the risk of acquiring tuberculosis is considerably greater in those
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with A I D S  than in the general population. Clearly, the actual risk of acquiring 
tuberculosis will depend on the prevalence of that disease in a given community, but 
in the U.S.A., a low-prevalence area, there was, for the first time in 33 years, an 
increase (of 2.3%) in notified cases of tuberculosis in 1986 (Grange, 1988). One of 
the first conducted case-controlled studies showed that in the younger age group (20- 
to 39-yr old) of Haiti 3 1 %  of tuberculosis was attributable to H I V  infection ( Long 
e t  a l., 1991). The impact of A I D S  on the incidence of tuberculosis in developing 
nations remains to be determined completely, but the prospects give cause for serious 
concern unless the spread of AID S  can be limited or halted.
Infection with M .  t u b e r c u lo s i s  occurs most frequently via the lung, less 
frequently via the oropharynx, intestine and skin, as the small cough droplets 
containing a few bacilli are the major factor for the spread of the disease. Pulmonary 
tuberculosis is the major concern for mortality, although other sites such as the lymph 
nodes, bone, kidneys, the reproductive systems, intestines, skin, central nervous 
system can also be infected. H o w  the bacilli actually invade the epithelial tissues is 
not clear.
1.8.1) Pathogenesis and Immune Response:
The events that follow the initial infection vary enormously from patient to 
patient. According to Wallgren (1948) the general temporal pattern of disease can 
be observed in four stages. During the first stage of 3 to 8 weeks after infection, the 
primary complex is formed and tuberculin test appears as positive. The primary 
complex is formed by the Ghon focus and the enlarged regional nodes in which 
additional bacillary multiplication may occur. Tuberculin test may appear positive
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due to sensitization by environmental mycobacteria and care must be taken to 
distinguish it from the infection by M .  t u b e r c u lo s i s . This is superseded by the second 
stage which may last up to three months, during which serious forms of the disease, 
such as meningitis and miliary tuberculosis, may develop as a result of 
haematogenous dissemination. Stage 3 is characterised by the development of 
tuberculous pleurisy. This is either due to haematogenous dissemination or the 
necrotic local lung lesion discharges bacilli or antigen into the pleural spaces and a 
hypersensitivity reaction causes the effusion. This stage may persists for 3 to 4 
months. During the fourth and final stage, the primary complex heals completely, 
but the earlier haematogenous spread of bacilli into bones, joints and kidney may 
progress instead of resolving, causing destructive caseous lesions. This stage lasts 
for 5 years or more in untreated but non-progressive cases.
The outcome in an individual is unpredictable, group experiences show the 
following pattern:
a) The majority will overcome the infection and will develop hypersensitivity 
without the occurrence of overt disease or symptoms.
b) S ome will develop clinically or radiologically evident primary disease but 
never suffer from significant symptoms or complications.
c) Others will develop symptomatic disease either primary or, after an 
interval, adult type disease but will overcome this without clinical illness or 
treatment.
d) A  few unfortunate will develop disease, more often in the lungs than 
elsewhere, which is preventable by chemoprophylaxis. Any stage of the disease can
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The immune response by an individual against tuberculosis is, like in any 
other infection, a triple R  response - involving recognition, response and reaction. 
Since mycobacteria are predominantly intracellular parasites, infecting mainly 
macrophages, their destruction within macrophages is mediated by lysosomal enzymes 
and oxygen radicals. Thus the successful inhibition of mycobacteria depends on the 
activation of macrophages. The protection afforded against tuberculosis is a cell- 
mediated immune (CMI) response, involving T-lymphocytes, which helps to enhance 
the ability of the macrophages to inhibit and destroy the invading tubercle bacilli.
be effectively arrested by appropriate chemotherapy.
Table 5: Tuberculosis and immunological response:
Disease spectrum Infectious response I mmune response
1. N o  infection 
N o  disease
Innate immunity 
N o  colonization 
N o  primary infection
N o  tuberculin
2. Infection 
N o  disease
Mucosal colonization 
Alveolar infection 
Primary tubercle 
N o  spread beyond 
draining lymph node
Tuberculin 
conversion 
Cell mediated 
immunity(CMI)
3. Infection 
Chronic disease
Primary tubercle 
Hilar lymph nodes 
spleen and liver 
Caseation &  cavitation 
Eventual death
Tuberculin
conversion
C M I
Antibody
production
4. Infection 
Miliary disease
Primary tubercle 
Rapid spread to spleen 
liver, bone 
Diffuse granuloma 
formation
Tuberculin 
anergy, N o  CMI, 
Excessive 
antibody 
production
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Antibody production, involving B-lymphocytes and mediated by the humoral immune 
response, is also involved but is not thought to play a vital role (Grange, 1988). 
Lenzini e t  a l . , (1977) described a spectrum for tuberculosis which is made up of four 
different forms of the disease, characterised by their immune response (Table 5). As 
with leprosy, the position of a patient within this spectrum depends on the degree of 
cellular immunity expressed upon infection. A  detailed description of the cell- 
mediated immune response involved in tuberculosis is given by Grange (1988). As 
the T-helper lymphocytes and macrophages play a central role in mounting the 
immune response against tuberculosis and the infections with the H I V  viruses are 
cytotoxic to T-helper cells, the likelihood of getting mycobacterial infection in A I D S  
patients is much more than in the general population.
1.8.2) Control and Therapy :
Tuberculosis may be controlled by the dual action of raising the degree of 
resistance of the healthy uninfected part of the population and by reducing the number 
of infectious persons within a population who may spread the disease. The former 
may be achieved either through a vaccination programme or through 
chemoprophylaxis, whilst the latter may be brought about through a strict 
chemotherapy regimen. Also, environmental improvements e.g. better housing may 
be useful in controlling tuberculosis.
B C G  and Vaccination:
B C G  (Bacilli Calmette-Guerin) is an attenuated strain of M .  b o v i s  produced 
by repeated passage (213 passages) between the years 1908 and 1918 in France. 
B C G  vaccines were used first against human tuberculosis in 1921, in France and since
27
then over 3 billion doses have been administered over the past four decades, and 
more than 7 0 %  of the world’s children now receive B C G  (Fine, 1988). Over last 
four decades B C G  strains have been maintained by different methods in several 
laboratories around the world. Different laboratories have their specific strains, 
showing variations, which are not due to different growth conditions and media but 
are strain dependent (Fomukong e t  a h , 1991; Abou-zeid, e t  a l . , 1986; Osborn, 1983; 
Miura e t  a l., 1983) . Lind (1960) showed that some strains contained an antigen 
called factor c which was absent in others. Another antigen, antigen 15, was also 
missing in some B C G  strains (Stavri e t  a l, 1981). Minnikin e t  a l (1984) discovered 
that strains of Brazil and Sweden produced mycolic acids which are not found in 
others. The amount of secreted protein mpb70 differs from strains from Brazil, 
Sweden and U S S R  as compared to others (Abou-Zeid e t  a l , 1987). Recently 
Fomukong e t  a l . (1991) have found an extra copy of an insertion element IS986 in 
strains from Brazil, Japan and U S S R  and have suggested the regulation of mpb70 
protein by this element. All these variations from the original strain of B C G  have 
laid scepticism about efficacy of B C G  vaccines.
The current B C G  preparations, though cheap, stable, safe and widely used, 
are less than ideal because of the unpredictable nature of their protective efficacy in 
different populations. A  number of trials have been carried out in different parts of 
the world to determine the effectiveness of the B C G  vaccine in protection against 
tuberculosis. Table 6 shows the results of these trials.
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Table 6 : Efficacy o f BCG vaccination against tuberculosis
Trial Percentage
protection
Tuberculosis in 
control group per 1000 per year
1. N. American Indian (1935-38) ~ 80 15.6
2. Chicago infants (1937-38) ~ 75 2.2
3. British school children (1950-52) ~ 78 1.3
4. South Indian rural (1950-55)' 60 0.86
population, Mandenapalle
5. Puerto Rican 31 0.43
school children (1949-51)'
6. Alabama, Georgia population(1950)~ 14 0.13
7. Georgian school children (1947)' nil 0.118. South Indian, Madras (1986)* nil 38.3
~  Fro m  Sutherland, 1971.
* Tuberculosis Prevention Trial - 1979a, 1979b and 1980.
The above table shows an extraordinary range of results, from nil as observed 
in trials in the southern United States and in South India, to approximately 80%, as 
observed in the British M R C  trial.
Various possible explanations have been debated for last 30 years, but still 
there is no widely accepted reason/s for the variations observed in the efficacy of 
B C G  vaccination. A m o n g  the most popular explanations is that it reflects differences 
between B C G  strains. According to ten D a m  e t  a l (1976) a low potency strain of 
B C G  was used in the trials in Puerto Rico and the two trials in Georgia, all of which 
showed low protection efficacy. The strain called Tice strain (produced by Tice 
Laboratories, Chicago) showed low protection in animal models. However, this 
explanation does not explain the very different efficacies in the trials in South India 
and British trials where the same strain of B C G  was used.
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The second most popular explanation for the observed differences in B C G ’s 
efficacy has been that it reflects regional differences in the prevalence of infections 
with "environmental" mycobacteria. Numerous species of mycobacteria are found 
in soil and water (e.g. M .  x e n o p i and M .  k a n s a s i i are found in tapwater in the UK), 
and many human beings are sensitised to these bacteria. W o r k  in animal models 
(guinea pigs) has shown that infections with some species of environmental 
mycobacteria can induce as much protection against the tubercle bacillus as can B C G  
(Palmer and Long, 1966). This hypothesis was also supported by the results of a 
study by Shield (1983) on the Madras trial where it was found that a high proportion 
(> 90%) of the population were infected and sensitised to M .  a v i u m . It has thus been 
argued that B C G  can contribute little in populations where natural infections with 
certain environmental mycobacteria have already induced a high prevalence of 
heterologous protection against tuberculosis and leprosy. There is evidence from 
some B C G  trials that the protection afforded by B C G  decreases with age of the 
vaccinee and time after vaccination, both of which trends may reflect an increasing 
prevalence of environmental mycobacterial infections in the trial populations over 
time (Fine and Rodrigues, 1990). To contradict this opinion, no differences in 
protection were observed in the Puerto Rico trial between individuals with moderate 
tuberculin sensitivity (attributed to infections with environmental mycobacteria) and 
those regarded as tuberculin negative (Comstock e t  a l , 1974). The large number and 
variety of environmental mycobacterial species, and the possibility that immunological 
responses which they induce may interact in complex ways, make evaluation of these 
hypotheses difficult.
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Another explanation is based on the hypothesis that different immunological 
mechanisms act against different stages of mycobacterial infection and disease, and 
that B C G  affects some of these more than others. Yet other explanations for B C G ’s 
inconsistent behaviour include hypotheses that genetic or physiological differences 
between the trial populations, or geographic differences in M .  t u b e r c u l o s i s . 
According to Fine and Rodrigues (1990) rather than a single mechanism, several 
factors have conspired together, like differences in B C G  strains and regional 
differences in mycobacterial ecology, in addition to differences in trial methods and 
have all contributed to the observed variation in B C G ’s efficacy. But the fact remains 
that B C G  vaccines are being used routinely in many populations with little evidence 
of their effectiveness in protecting against disease. Recently, various attempts are 
being made to develop recombinant B C G  as a multivaccine vehicle (Jacobs e t  a l . , 
1988; Snapper e t  a l . , 1990).
Chemotherapy of tuberculosis:
The aim of chemotherapy is the complete elimination of the infectious tubercle 
bacilli from the patient, thus not only curing the patient but also rendering them non- 
infectious. The complete elimination of tubercle bacilli by a single drug is very 
difficult because of two major biological characteristics of M .  t u b e r c u lo s i s .
The first one is the major differences in the metabolic rates of tubercle bacilli 
in the lesions of patients, e.g. bacilli in well-oxygenated lesions, such as open 
pulmonary cavities are likely to be metabolizing actively, the second group of bacilli 
are intracellular which are moderately active metabolically and the third group of 
bacilli can be found in both environments but show only sporadic bursts of activity.
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Thus different drugs must be used which will be active in the different environments 
and effective against he variety of physiological states of the cells in a host.
The second characteristic factor, does not only belong to M .  t u b e r c u lo s i s ,  
namely drug resistance which emerges by mutation, so that even wild strains of bacilli 
- those which have never been exposed to antituberculosis drugs, contain resistant 
mutants. Accordingly, if a patient is given single drug treatment, there is a risk that 
the drug-sensitive bacilli will be killed or suppressed and that drug-resistant mutants 
will overgrow them and become the dominant organisms.
During the development of highly effective regimens of antituberculosis 
chemotherapy the following points are taken into considerations: (1) Curing patients 
rapidly without interfering unnecessarily with their daily life and work (2) Minimising 
therapeutic failure caused by poor compliance in treatment (3) Treating patients with 
initially drug-resistant strains of bacilli effectively (4) Avoiding adverse reactions, 
particularly serious toxicity and (5) Providing regimens which are appropriate and 
safe in a wide variety of patient populations and clinical situations throughout the 
world.
The main treatment regimen against tuberculosis consists of a combination of 
streptomycin, isoniazid, rifampicin, pyrazinamide, ethambutol and para-amino 
salicylic acid. These drugs which constitute the first line of defence in 
antituberculosis chemotherapy are considered enough to kill the different populations 
of tubercle bacilli according to Mitchison’s hypothesis (1980). Mitchison identified 
four sub-populations of tubercle bacilli depending on their metabolic activities. The 
largest group consists of 107 to 109 extracellular bacilli in a metabolically active state.
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Streptomycin, isoniazid and rifampicin are all effective against this group of bacilli 
(Dickinson and Mitchison, 1976; McClatchy, 1980). The second group consists of 
104 to 105 intracellular and only moderately active bacilli. Pyrazinamide is the most 
effective drug for this group of bacilli, since it can only work at low p H  (Collins e t  
a l, 1985). Isoniazid is also effective against this group but streptomycin is 
ineffective, since it is inactivated by low pH. The third group consists of 104 to 105, 
both intracellular and extracellular bacilli with only sporadic metabolic activity. 
Again rifampicin and isoniazid are effective against this group of bacilli. The fourth 
and last group of bacilli consists of dormant bacilli exhibiting no metabolic activity. 
These bacilli are unlikely to be killed by any drugs, and indeed it is well known that 
small numbers of viable bacilli can lie dormant in quiescent lesions for many years 
even after good chemotherapy (Girling, 1989).
In addition to the above drugs, kanamycin, cycloserine, viomycin, 
capreomycin, thiacetazone and ethionamide are also used in the chemotherapy. The 
British Thoracic and Tuberculosis Association (1976) recommended a 9 month 
regimen in which isoniazid and rifampicin are given daily with the addition of 
ethambutol for the first two months. The modern standard short-course regimens 
consists of isoniazid, rifampicin and pyrazinamide for the first two months followed 
by isoniazid and rifampicin for the next four months. Other variants of standard 6- 
month regimen have been recommended by I U T A L D  (Committee on treatment of the 
I U T A L D ,  1988).
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One of the aim of molecular studies of mycobacteria is to establish an easy, 
highly reproducible, specific and cheap system for the early diagnosis of the disease.
Tuberculosis detection at the earlier stage is very important and if detected at 
the earlier stage, can be cured completely with the help of multidrug therapy 
recommended by World Health Organization. In the third world countries where 
prevalence of tuberculosis is high, because of the lack of good medical infrastructure 
tuberculosis is detected at very late stage, which results into high mortality rates. 
With the help of newer molecular biology techniques, new detection system ldts can 
be developed which will aid in early diagnosis of tuberculosis even by non-medically 
qualified persons.
Presently, the early diagnosis of primary tuberculosis is based on (i) a history 
of contact with active tuberculosis, tuberculin testing and clinical features with 
radiological support. In most parts of the world tuberculin tests, which are 
unequivocally positive with small doses of tuberculin derived from M y c o b a c t e r i u m ,  
t u b e r c u l o s i s , are very strong presumptive evidence of the nature of a primary 
disorder.
Tuberculin is a mixture of proteins derived from culture filtrates of 
M y c o b a c t e r i u m  t u b e r c u lo s i s  and is also known as purified protein derivative (PPD). 
P P D  prepared from M .  b o v i s  is used for the diagnosis of M .  b o v i s  infection in both 
cattle and deer. However, screening by skin-test reactions may not always be 
accurate as P P D  is a heterogenous preparation. The shared epitopes between 
mycobacteria and other organisms may give considerable cross reactions and hence
1.9) Early diagnosis o f mycobacterial diseases:
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there is a need for improvement of immunodiagnostic screening for M .  b o v is  
infection, which essentially relies on the identification and purification of antigens 
exhibiting a high degree of specificity. Previous work from our laboratory had shown 
the monoclonal antibody C M A  134.1 is specific to M .  b o v is ,  M .  t u b e r c u lo s i s  and M .  
k a n s a s i i . This monoclonal antibody reacts with the 19 lcDa antigen of M .  b o v i s  a n d  
M .  t u b e r c u lo s i s .
One of the aims of the present study (Chapter 3) is to characterize and 
sequence the gene for the 19 k D a  antigen from M .  b o v is  which is similar to that of 
19 k D a  antigen from M .  t u b e r c u lo s i s  (Ashbridge e t  a l . ; 1989). Characterization of 
this gene may be useful for the early detection of tuberculosis.
1.10) Problems of present chemotherapy of tuberculosis and leprosy:
The first and foremost striking feature of these two mycobacterial diseases is 
the slow metabolic rate of M .  t u b e r c u lo s i s  and M .  le p r a e . This is obviously reflected 
in the long duration of treatments for tuberculosis and leprosy. For both diseases, 
the minimum period for completely successful treatment is at least six months. 
Because of the introduction of multidrug therapy ( M D T )  in these two diseases, the 
treatment period has been reduced from number of years to six months.
T w o  biological characteristics of M .  t u b e r c u lo s i s  are of particular relevance 
to the chemotherapy of tuberculosis. First, as referred to earlier, there are likely to 
be major differences in the metabolic rates of bacilli in the lesions of untreated 
patients: bacilli in well-oxygenated lesions, such as open pulmonary cavities, are 
likely to be metabolizing actively, but M .  t u b e r c u lo s i s  can remain dormant or in semi- 
dormant state when its metabolism is inhibited by, for example, phagocytosis, low
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oxygen tension or low pH. Secondly, drug resistance emerges by mutation, so that 
even wild strains of bacilli contain resistant mutants.
The present multidrug therapy for tuberculosis can overcome the above stated 
problems, because of the combination of number of drugs which are active in 
different environments and acquired drug resistance can be prevented by giving drug 
combinations.
The major problem of all antituberculosis regimens is the capability of causing 
adverse reactions. They are usually minor, but are occasionally serious and rarely, 
even life-threatening (Girling, 1982). All the antituberculosis drugs can cause 
cutaneous and generalized hypersensitivity reactions. The most commonly responsible 
drugs are streptomycin, P A S  and its salts, and thiacetazone. The reactions vary 
greatly in severity from mild and transient rash and fever, to rare exfoliative 
dermatitis. Anaphylactic shock may occur rarely if a large dose of a drug is given 
after a previous hypersensitivity reaction. Minor hypersensitivity reactions may occur 
within the first four weeks of treatment which are self limiting, requiring only 
symptomatic treatment.
All the antituberculosis drugs, with the possible exception of streptomycin, can 
cause hepatitis. In 16 controlled clinical trials conducted in more than 20 countries 
in Africa, Asia and Europe, the risk of hepatitis ranged from 0 to 5 %  (Girling,
1978). The risk increases with age and the cumulative risk rises during the first 16 
weeks of treatment, but changes little thereafter (Riska, 1976).
Reactions to individual drugs may vary from drug to drug. For example, 
isoniazid may cause neurological problems by competitively inhibiting the coenzymes
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produced from pyridoxine which is an important cofactor in the synthesis of synaptic 
transmitters. Also it may cause pellagra, haemolytic anaemia and arthralgia. 
Rifampicin is hepatotoxic while pyrazinamide quite frequently causes flushing and 
m a y  rarely cause photosensitization, in addition to hypersensitivity reactions and 
arthralgia. Streptomycin causes giddiness, numbness around the mouth, headache and 
lassitude. Ethambutol causes dose-related retrobulbar neuritis while para- 
aminosalicylic acid causes gastric discomfort, anorexia, nausea, vomiting and 
diarrhoea.
In addition to the above problems the duration of multidrug therapy is very 
long and requires supervision throughout the treatment. Also, some of the drugs are 
expensive which are not affordable to patients from poor countries.
Problems associated with antileprosy drugs are more or less similar to that of 
antituberculosis drugs. Monotherapy with dapsone was done for decades, which 
initially thought to be giving good results. Because of (1) poor compliance, (2) 
primary drug resistance and (3) secondary drug resistance to dapsone, this 
monotherapy for leprosy failed.
Antibiotic resistance in mycobacteria is mainly of two types, as listed above 
(Gangadharam, 1984; Suwanogool e t  a l., 1984) and a third category is also 
sometimes recognised, called as initial drug resistance where the patient denies and 
has no recorded history of chemotherapy. The role of plasmids and mobile genetic 
elements in antibiotic resistance in case of mycobacteria is still not proven 
conclusively (Crawford e t  a l . ,  1990; Franzblau e t  a l . ,  1986; Gangadharam e t  a l ,  
1989; Martin e t  a l . ,  1990).
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The phenomenon of drug resistance in mycobacteria has serious consequences 
for the success of chemotherapy especially in the light of increasing number of 
patients suffering from the disease in the less developed countries and the infections 
caused by mycobacteria in A I D S  patients.
World Health Organization Study Group recommended multidrug therapy for 
leprosy in 1982. Rifampicin was decided as the main drug to achieve bacterial killing 
in addition to dapsone and clofazimine. According to Waters (1989) there are five 
main problems in applying W H O  multidrug regimens: (a) Distinguishing between 
paucibacillary and multibacillary leprosy patients, (b) Difficulties in distinguishing 
reversal reactions from relapse, (c) Diagnosis of relapse, (d) Geographical problems 
and (e) Medical problems.
1.11) Need for new drugs and aim of the present work:
Though the antituberculosis and antileprosy multidrug therapy seem to be 
successful there is a continuous need for new drugs. A  rational approach to 
chemotherapy essentially relies on identifying enzymes or metabolic pathways which 
can be inhibited. These activities should be characteristic of the microbe so that 
agents which act against it should be highly selective. Once a suitable target is 
identified, agents would be designed and improved to increase their inhibitory effect 
on the target. It is without doubt that the development of suitable i n  v i t r o  systems, 
increased knowledge in molecular biology and the application of modern 
computerized techniques for the analysis of quantitative structure-activity relationships 
can serve to reach this aim. The major problem in the application of these techniques 
is the complexity of the biological system and the steps involved in drug action. For
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example a dose of a drug is administered to a biological system from which it gets 
absorbed to a certain extent, is distributed, metabolized, bound to serum- and tissue 
constituents and eliminated. These complex pharmacokinetic events determine the 
amount of drug which reaches the target in the biophase. Once the drug is in the 
environment of the bacilli, bacterial defence mechanisms come into picture, such as 
permeability through the cell wall, increased or altered production of the target 
enzyme/site, synthesis of new compounds to inactivate the drug, etc.
N e w  drug development and testing in case of M .  t u b e r c u lo s i s  and M .  l e p r a e  
was hampered because of the slow growth rate of M .  t u b e r c u lo s i s  and inability to 
grow M .  l e p r a e  i n  v i t r o . Developments in molecular biology techniques enable 
researchers to construct genomic libraries of M .  t u b e r c u lo s i s  and M .  l e p r a e  and study 
and express the genes of particular interest (Clark-Curtiss e t  a l . ,  1985; H o p w o o d  e t  
a l . ,  1988; Khandekar e t  a l . ,  1986; Kieser e t  a l . ,  1986).
Para-aminosalicylic acid (PAS) and dapsone are thought to act by inhibiting 
the dihydropterate synthetase of M .  t u b e r c u lo s i s  and M .  l e p r a e  respectively. Folic 
acid biosynthesis is an important step involved in bacterial metabolism. The question 
is if a further increase in inhibitory activity can be achieved by using another inhibitor 
in the folic acid biosynthetic pathway.
Dihydrofolate reductase (DHFR) and thymidylate synthase (TS) are two 
further enzymes involved in folic acid metabolism and play a central role in D N A  
synthesis in both prokaryotic and eukaryotic organisms. Thus it would seem 
advantageous for cells to regulate co-ordinately the expression of these two enzymes. 
Figure 1 shows the relationship between D H F R  and TS in the folic acid metabolism.
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Figure 1: Relationship between DHFR and TS involved in folic acid metabolism
TS
d T M P -------- dUMPF A H 2 ----------------------- CH2- FAH4 *------- ► ch - f a h 4 -----* cho-fah4
NADPH \  /^Gly \  /
DHFR X. \  /
> SerNADPH^ F A H 4 Purines
CH - FAH 4 — • 5) xo - Methenyl tetrahydrofolate
CHO - FAH4 —  40 - formyl tetrahydrofolate 
5 10CH^ - FAH4 —  N ,N - Methylene tetrahydrofolate
FAH 2 —  Dihydrofolate
F A H 4 —  Tetrahydrofolte
dUMP —  2 - deoxyuridylate
dTMP —  Thymidylate
SHMT —  Serine hydroxymethyltransferase
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D H F R  is the final enzyme involved in the biosynthesis of tetrahydrofolic acid. W h e n  
the enzymatic pathway, structures and enzymes involved in biosynthesis of 
tetrahydrofolic acid became known a search was made for antagonists among 
structural analogues of folic acid itself. Trimethoprim is a structural analogue of folic 
acid and has good antibacterial activity. The major effects of blockage of 
tetrahydrofolate are on several stages of the biosynthesis of purines and pyrimidines, 
since it is involved as one carbon donor. The synthesis of thymine is particularly 
sensitive to inhibitors of D H F R  because of the requirement for tetrahydrofolate in the 
transformation of d U M P  to d T M P .  Also, the biosynthesis of methionine, glycine and 
the formyl group of fmet-tRNA is affected by the limitation of tetrahydrofolate.
Trimethoprim can be used in combination with sulphonamides. Unfortunately 
trimethoprim is not effective in mycobacterial chemotherapy. Seydel and co workers 
studied the action of dihydrofolate reductase inhibitors such as trimethoprim and 
related compounds (Benzylpyrimidines) against cell-free and whole cell systems of 
various mycobacteria. Table 7 clearly indicates poor inhibitory activity against 
mycobacteria, however, relatively strong inhibitory activity against the isolated target 
enzyme (Seydel e t  a l., 1988). According to these researchers, this result indicates 
limited permeability of the drug into the bacterial cell. Al-Rubeai and Dale (1986) 
had purified and characterized D H F R  from M y c o b a c t e r i u m ,  p h l e i and shown that it 
is competitively inhibited by both methotrexate and trimethoprim, although the 
affinity is less than other bacterial dihydrofolate reductases. Similar results were 
found with the dihydrofolate reductase from M y c o b a c t e r i u m  s m e g m a t is  (Sirawaraporn 
e t a l , 1991).
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Table 7: Observed biological activities of marketed and newly synthesised dihydrofolate 
reductase inhibitors against cell-free and whole cell systems of mycobacteria
Compound M. 1 ufu 
growth 
kinetics
150(/uM)
cell-free
enzyme
M .lufu
MIC (/tiM) 
M. tuberculosis 
H37Rv
Trimethoprim 95 0.07 >110 >110
Brodimoprim 45 0.06 26.5 94
Tetroxoprim 213 0.33 - 71
GH305 - 0.16 25.3 51
GH306 - 0.17 - 97
K137 - 0.04 1.9 2.8
K 138 - 0.08 3.8 7.7
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N e w  derivatives of trimethoprim have been synthesised but there are many 
limitations in conducting proper studies on the enzyme dihydrofolate reductase from 
M .  t u b e r c u lo s i s  or from M .  l e p r a e .
The main aim of the present work is to isolate the genes for dihydrofolate 
reductase and thymidylate synthase from M .  t u b e r c u lo s i s  and to express these genes 
in E .  c o l i .
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2) M A T E R I A L S  A N D  M E T H O D S
2.1) Reagents and kit suppliers:
Amersham International Pic.:
H y b o n d - N ™  Nylon membranes, Radioactive nucleotides, Multiprime D N A  
labelling system 
Applied Biosvstems:
All solvents, columns and reagents for oligonucleotide synthesis 
B D H  Chemicals:
All laboratory chemicals, unless otherwise stated 
Biogenesis Ltd:
The RNAzol kit 
Boehringer Corpo. Ltd.:
Calf intestinal alkaline phosphatase (CIAP), I P T G  (isopropyl B-D 
thiogalactopyranoside) , Lysozyme, P A G E  (38:2) solution, Proteinase K, X- 
Gal (5-bromo-4-chloro-3-indolyl B-D-galactopyranoside)
Cambridge Bioscience:
Sequenase™ (version 2.0) kit 
Difco Laboratories:
Bacterial culture media 
Fuji Photo Film Co. Ltd.:
R X  X-ray film, Polaroid films - Type 665 (positive/negative) and Type 667 
(positive only)
Part A) MATERIALS:
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Saran-wrap™
Gibco-BRL:
Agarose (ultra-pure), D N A  and R N A  molecular weight markers for 
electrophoresis, E .  c o l i DH5-ce m a x i m u m  efficiency competent cells, 
Formamide, Klenow polymerase, Phenol (Ultra-pure), Restriction enzymes 
along with 10 X  react buffers, Ribonuclease A, Taq D N A  polymerase, T4 
D N A  ligase,
M a y  and Baker Ltd.:
All solvents were of A R  grade: Chloroform, Ethanol, Glacial acetic acid, 
Hydrochloric acid, Methanol, Sodium hydroxide 
Pharmacia:
IEF Phast-system gels (pH 3-9), Protein colour markers for S D S - P A G E  gel, 
Protein molecular weight markers for S D S - P A G E  gel, Ribonuclease A  (DNase 
free)
Sigma Chemicals Co. Ltd.:
Ampicillin, Bovine serum albumin (BSA), Caesium chloride (Ultra-pure), 
Chloramphenicol,DNA from Herring testis (type XIV), N,N- 
Dimethylformamide (DMF), DL-Dithiothreithol (DTT), Ethidium bromide, 
Ethylenediaminotetracetic acid (EDTA), Ficoll, Folic acid, 8- 
Hydroxyquinoline, 2-mercaptoethanol, (3-[N-morpholino])propane sulphonic 
acid (MOPS), 3-(4,5-dimethyl thiazolyl-2)-2,5-diphenyl tetrazolium bromide 
(MTT), N A D P H ,  Polyethylene glycol (PEG) 6000, Poly vinyl pyrollidone
Genetic Research Instruments:
(PVP), Methacryloxypropyl-trimethoxy silane, Dimethyl dichloro silane, 
Sodium dodecyl sulphate (SDS), Spermidine, T E M E D ,  Tween 80, Trizma 
base, Urea (Ultra-pure)
Stratech Scientific Ltd.:
Geneclean™ kit 
Whatman Laboratories Ltd.:
Whatman 3 m m  filter paper
2.2) Bacteria. Bacteriophages and. Plasmids:
2.2.1) Bacterial strains:
Table 8: E s c h e r i c h i a  c o l i strains (only relevant characteristics are listed)
Strain Genotype Reference
JM101 A  ( l a c - p r o  A B ) , s u p E ,  t h i / F ’ 
t r a D 3 6 , p r o A B , /#ciQZ(QM15
Messing e t  a l .  
(1981)
DH5ce F", l a c Z C ) M l 5 ,  e n d A l ,  r e c A l ,  
s u p E 4 4 ,  r e lAl
Hanahan(1985)
LE392 R, h s d R 5 \ 4 ,  s u p E A 4 ,  l a c l Y l ,  
g a l K 2 , Lambda'
Murrey, e t  a l .  
(1977)
Y1089 l a c E  1 6 9 ,  p r o A + , < 3 I o n ,  
s t r A ,  h flA
Young &  Davis 
(1983)
JD317 E .  c o l i 114, T h y Dr. Dale (personal 
collection)
JD417 E .  c o l i SK383 pAGlOl 
p U C 8 with 1.1 kbp E .  c o l i  
D H F R  insert
Howell e t  a l . , 
(1988)
JD418 E .  c o l i LH18(NM522, t h y  A ,  
f o l w  kan
Howell e t  a l . , 
(1988)
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2.2.2) Bacteriophages:
M13mpl8, M13mpl9, E M B L 4 - M .  t u b e r c u lo s i s  library (Zainuddin, 1988).
2.2.3) Plasmids:
pUC18, pUC19, pAG l O l  (Howell e t  a l ,  1988)
2.3) Culture Media:
All media were sterilized by autoclaving at 121 °C (15 P.S.I.) for 15 min or by 
filtration through a 0.2 p M  flowpore D-filter. For the preparation of all media and 
buffer solutions Milli-Q water was used and referred as water through out the 
thesis.
i) Luria-Bertani (LB) broth:
Bacto-tryptone - 10 g, Bacto-yeast extract - 5 g, NaCl - 5 g, water to 1 lit.
ii) L B  Agar:
L B  broth containing 1.2% agar (Technical grade type 3)
iii) Minimal medium:
SS D S
ic2h p o 4 7 g 14 g
k h 2p o 4 3 g 6g
N a3Citrate.2H20 0.47 g 0.97 g
M g S 0 4.7H20 0.1 g 0.2 g
( N H4)2S 04 1 g 2g
water up to 1 lit 1 lit
Double strength (DS) medium and D S  agar autoclaved separately, mixed together and 
filter sterilized vitamin B1 (1 mg/ml) and 0.7ml of 4 0 %  glucose/100 ml medium
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added before pouring of the plates. Cofactors and antibiotics were added separately 
wherever required.
iv) S O C  medium:
Bacto-tryptone - 2 %  (w/v), bacto-yeast extract - 0.5% (w/v), NaCl - 10 m M ,  
KC1 - 25 m M ,  M g C l2 - 10 m M ,  M g S 0 4 - 10 m M ,  glucose - 20 m M ,  p H  -7.0. 
S O C  was prepared in the absence of the magnesium salts and glucose and 
sterilized by autoclaving. Filter sterilized magnesium salts and glucose were 
added prior to use.
v) T-Top agar:
Bacto-tryptone - 15 g, NaCl - 5 g, M g S 04.7H20  - 2.46 g, Bacto-agar 
(technical no. 3) - 8 g, water to 1 lit.
vi) 2 X  T Y  medium:
Bacto-tryptone - 16 g, Bacto-yeast extract - 10 g, NaCl - 5 g, water to 1 lit.
vii) 7 H 9  broth:
0.47 g powder was dissolved in 90 ml of water containing 0.05 g Tween 80 
and autoclaved. Ten ml of Middlebrook oleic acid-albumin-dextrose- catalase 
( O A D C )  enrichment solution was added to 90 ml of sterilized broth.
viii) Antibiotics:
All antibiotic stock solutions were prepared with sterile water and filter 
sterilized except chloramphenicol which was prepared in ethanol.
2.4) General Buffers and Solutions:
i) E D T A :  E D T A  - 0.5 M ,  Prepared in water and p H  was adjusted to 8.0 with
N a O H  pellets and final volume was made up with water. Autoclaved.
48
ii) Chloroform:iso-amyl alcohol:
This solution was prepared by mixing chloroform and iso-amyl alcohol as 24:1 
(v/v).
iii) Phenol:
Phenol was melted by placing the container in 55°C waterbath, saturated with 
0.1 M  Tris-HCl, p H  8.0 and stored in the presence of antioxidant 8- 
hydroxyquinoline (0.1%  w/v) in brown coloured bottle.
iv) Phenol: Chloroform:
Phenol: chloroform was prepared as a 1:1 (v/v) mixture, saturated with 0.1 M  
Tris-HCl (pH 8.0) and stored in the presence of antioxidant 8- 
hydroxyquinoline (0.1%  w/v).
v) Sodium acetate solution:
3 M  N a  acetate, p H  5.2 with glacial acetic acid. Autoclaved.
vi) Sodium chloride solution:
5 M  sodium chloride was prepared in water and autoclaved.
vii) S M  buffer:
NaCl - 0.2 M ,  M g S 0 4.7H20  - 0.001 M ,  Tris-HCl, pH7.5 - 0.05 M ,  gelatin - 
0.01%. Autoclaved.
viii) S T E  buffer:
NaCl - 0.1 M ,  Trizma base - .01 M ,  E D T A  - 0.001 M ,  p H  to 7.5 with H C 1  
and autoclaved.
ix) T E  buffer:
Trizma base - 0.01 M ,  E D T A  - 0.001 M ,  p H  to 8.0 with H C 1  and autoclaved.
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Trizma base - 2.0 M ,  p H  adjusted to appropriate p H  with concentrated HC1 
and final volume was made up with water and autoclaved.
2.5) Enzyme buffers:
i) 10 X  C I A P  buffer:
Tris-HCl (pH 8.0) - 0.5 M ,  M g C l2 - 0.01 M ,  ZnCl2 - 0.001 M  
Usually 10 X  React 3 restriction enzyme buffer was used for phosphatase 
treatment, since removal of zinc chloride is difficult and may inhibit further 
manipulations.
ii) 10 X  Kinase buffer:
Tris-HCl (pH 7.5) - 0.7 M ,  M g C l2 - 0.1 M ,  KC1 - 0.001 M ,  D T T  - 0.05 M ,  
spermidine - 0.001 M ,  E D T A  - 0.001 M .  Prepared in sterile water.
iii) 10 X  Restriction enzyme buffers:
All restriction enzymes buffers used were supplied with enzyme by enzyme 
manufacturers.
iv) 5 X  Ligase buffer:
Tris-HCl, p H  7.6 - 0.25 M ,  M g C l2 - 0.05 M, A T P  - 0.005 M ,  D T T  - 0.005 
M ,  P E G  8000 - 25 %  (w/v). 5 X  ligase buffer was supplied with T4 D N A  
ligase enzyme by BRL.
2.6) Solutions for Agarose gel electrophoresis:
i) 1 x T A E  (Tris-acetate) buffer:
Trizma base - 0.04 M ,  E D T A  - 0.001 M ,  p H  to 8.0 with glacial acetic acid 
and autoclaved.
x) Tris.HCl:
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ii) 1 X  T B E  (Tris-borate) buffer:
Trizma base - 0.089 M ,  boric acid - 0.089 M ,  E D T A  - 0.002 M. Autoclaved.
iii) D N A  loading buffer:
bromophenol blue - 0.25% (w/v), xylene cyanol - 0.25% (w/v), sucrose - 
4 0 %  (w/v). Prepared in sterile water.
2.7) Solutions for D N A  and R N A  blotting and hybridizations:
i) Alkali transfer solution:
N a O H  - 0.25 M ,  NaCl - 1.5 M
ii) Denaturing solution:
NaCl - 1.5 M ,  N a O H  - 0.5 M
iii) Depurination solution:
0.25 M  HC1
iv) Neutralizing solution:
NaCl - 1.5 M ,  Tris.Hcl, p H  7.2 - 1.0 M ,  E D T A  - 0.001 M
v) 20 X  SSC:
NaCl - 3 M ,  N a 3citrate - 0.3 M
vi) 50 X  Denhardt’s solution:
B S A  - 1 %  (w/v), ficoll - 1 %  (w/v), P V P  - 1 %  (w/v)
vii) D N A  Prehybridization/hybridization buffer:
Denhardt’s solution - 5 X, Denatured Herring testis D N A  - 20 jug/ml, 
E D T A  - 0.005 M ,  S D S  - 0.1% (w/v), SSC - 6 X
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a) N a O H  - 0.4 M
b) S S C  - 0.1 X, S D S  - 0.1 %  (w/v), Tris-HCl(pH7.5) 0.2M
2.8) Solutions for small scale plasmid D N A  extraction from bacteria:
i) Solution 1/ Glucose lysozyme solution: Prepared freshly at the time of 
extraction as follows:
glucose - 0.05 M ,  E D T A ,  p H  8.0 - 0.01 M ,  Tris.HCl, p H  8.0 - 0.025 M ,  
lysozyme - 5 mg/ml
ii) Solution II/ Alkaline lysis solution: Prepared freshly at the time of extraction 
and chilled:
N a O H  - 0.2 M ,  S D S  - 1 %  (w/v)
iii) Solution III:
60.0 ml 5 M  potassium acetate
11.5 ml glacial acetic acid
28.5 ml water and autoclaved.
2.9) Solutions for large scale plasmid D N A  extraction from bacteria:
i) Brij/Doc solution:
Brij 58 - 1 %, sodium deoxycholate - 0.4%, prepared in T E  buffer (2.4-ix) and 
autoclaved.
ii) Isopropanol saturated with CsCl:
CsCl was dissolved in S T E  buffer (refer to 2.4 - viii for S T E  buffer) and 
saturated with isopropanol.
iii) Lysozyme solution: lysozyme - 2 mg/ml, prepared freshly in sterile water.
viii) Probe removing solution:
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2.10) Solutions for mycobacterial genomic D N A  extraction:
i) Glycine:
Glycine - 2 0 %  (w/v) prepared in deionised water and autoclaved.
ii) SDS:
S D S  - 10% (w/v) prepared in deionised water and autoclaved.
iii) RNase A  solution:
RNase A  - 10 mg/ml, prepared in 0.01 M  Tris.HCl (pH 7.5) and 0.015 M  
NaCl. The solution was heated at 100°C  for 15 min and allowed to cool 
slowly to room temperature, dispensed into aliquots and stored at -20°C.
2.11) Solutions for bacteriophage D N A  extraction: 
i) PEG/Salt/SM solution:
P E G  6000 - 20%, NaCl - 2.5 M  in S M  buffer ( S M  buffer refer to 2.4-vii) and 
autoclaved.
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2.12) Maintenance of cultures and libraries:
All the E .  c o l i strains used in this study were stored in two sets. The first, 
working stock cultures were streaked out on L-agar plates containing appropriate 
antibiotic or on minimal medium supplemented with other supplements and 
subcultured after every four weeks. For long term storage of strains the cultures 
were grown overnight in 2 X  strength medium and sterile glycerol was added to the 
final concentration of 0.15%. The mixes were frozen and stored in -70 °C freezer.
The mycobacterial working stocks were maintained on Lowen stein-Jen sen 
slopes and stored at room temperature in the dark in the case of slow growers or at 
4°C in the case of fast growers.
E M B L 4 - M .  t u b e r c u lo s i s  library was also maintained as working stock and 
long term storage stock. The working stock was maintained as high titre amplified 
stock (109-1010 pfu/ml) in S M  buffer containing chloroform at 4°C. For long term 
storage the amplified stock was frozen in 7 %  D M S O  and stored at -70°C freezer.
2.13) Ethanol precipitation of D N A :
D N A  precipitation was carried out
a) using 0.15 M  NaCl or
b) using 0.1 Vol. 3 M  sodium acetate, p H  5.2 or
c) using 0.15 M  NaCl -\-  I  p \  glycogen (20 jug/ml), for lower amounts of 
D N A
After addition of sodium salts, two volumes of chilled ethanol was added, mixed well 
and left at -20°C overnight or at -70°C in liquid nitrogen bath for 10 min.
Part B) METHODS:
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Precipitated D N A  was collected by centrifugation at 14000 R P M  (10000 x g) at 4°C 
for 20 min. The D N A  pellet was washed in 8 0 %  ethanol by briefly resuspending and 
centrifuging it at 14000 R P M  for 10 min. The D N A  pellet was dried in vacuum 
desiccator and resuspended in appropriate volume of T E  buffer.
2.14) Quantitation of D N A  samples:
2.14.1) Spectrophotometric method (Maniatis e t  a l . , 1982):
The principle of this method is the absorption of U V  light by the bases of 
nucleic acids. This method is useful for the high amounts of D N A  samples, however 
the major disadvantage of the method is the failure of distinguishing between 
degraded D N A ,  R N A  and undegraded D N A .
The D N A  solution was diluted 10 to 20 fold in autoclaved water and placed in a 
quartz cuvette. The absorbance at 230, 260, 280 and 310 n m  wavelengths were 
measured using a Pye Unicon model PU8820 UV/VIS spectrophotometer. The ratio 
of the readings 260/280 provides an estimate of the purity of the D N A  preparation. 
A  ratio of >1.7 indicates D N A  solution of high purity with little protein 
contamination. A n  absorbance of 1.0 at 260 n m  is equivalent to a D N A  concentration 
of 50 jug/ml for double stranded D N A .  Therefore the D N A  concentration of the 
preparation can be calculated from the following formula:
D N A  concentration -  (O.D. at 260 n m  X  50 X  Dilution
factor)^g/ml
2.14.2) Comparative intensity method:
This method was used when not enough D N A  sample (total quantities of less 
than 500 ng) was available for quantitation using procedure 2.14.1.
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A  known volume of the D N A  sample of interest was electrophoresed on an 
agarose gel with a known amount of lambda D N A  digested with Hind III as 
molecular weight markers. The gel was stained with ethidium bromide (2 p g / m l )  and 
photographed under U V  light. The intensity of fluorescence of D N A  is directly 
proportional to the total mass of the D N A  (Maniatis, e t  a l , 1982). Therefore, by 
comparing the intensity of the D N A  of interest to that of the lambda fragments, a 
marker fragment of similar intensity can be chosen and an estimation of the amount 
of D N A  in the sample can be calculated as follows:
a) The ratio of the size of the marker fragment to total size of marker D N A  was first 
calculated:
X  =  size of chosen fragment (kb)/Total size of marker D N A  (kb)
b) The amount of D N A  in the sample volume can then be calculated:
The amount of D N A  in the chosen marker fragment =  X  x Y  ng =  Estimated 
amount of D N A  in the sample in ng, where X  =  see (a) above and Y  =  total amount 
of marker D N A  in ng.
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Procedure:
Single restriction digests: Typical restriction enzyme digests with one enzyme were
set up in an eppendorf tube as shown below:
10 p i D N A  (up to 1 p g  of D N A )
2 p i 10 X  Restriction buffer
7 p i Deionised distilled water
1 p i Restriction enzyme (1 to 10 units)
For digestion of genomic D N A ,  B S A  (10 m M  final concentration) and 
spermidine (4 m M  final concentration) were added to carry out complete digestion 
and the digestions were done in 100 p i of total reaction volume. The reaction 
mixture was then centrifuged briefly and incubated at the required temperature for 60 
min; usually 37°C. Digestion was stopped by heating to 65°C for 10 min if the 
enzyme is heat labile. For heat stable enzymes, the reaction mix was extracted with 
1 volume of phenol chloroform saturated with T E  buffer followed by ethanol 
precipitation and resuspension in T E  buffer. If the digested D N A  was to be used for 
work other then Southern blot hybridization, it was extracted as above regardless of 
the nature of the enzyme.
Each restriction enzyme has a particular type of buffer composition which 
gives 100% digestion reaction. Enzymes were bought from BRL, unless stated, 
which were supplied along with 10 X  reaction buffers. The buffers were used as 
recommended by the manufacturers. Table 9 shows some of the restriction enzymes, 
buffers and optimum incubation temperature for the reaction used in this work.
2.15) Restriction endonuclease digestion o f DNA:
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Table 9: Restriction enzymes and buffers
Enzyme 10 X  REact buffer Incubation temperature
B a m  HI 3 37°C
Eco Rl 3 37°C
Hind III 2 37°C
PstI 2 37°C
Pvu I 7 37°C
Pvu II 6 37°C
Sail 10 37°C
S m a  I 4 30°C
Sau 3 A 2 37°C
Double restriction digests: The D N A  was digested with both the enzymes at 
the same time if the recommended buffers were identical for both. However care was 
taken to maintain the volume of enzymes to less than the 1/10 of the total reaction 
volume. Depending on the situation the total reaction volume was increased up to 
100 ix 1. In some cases, the activity of one enzyme in a selected buffer is less than 
100%. The two digestions were still carried out at the same time if this activity is 
greater than 50%. The incubation time however was increased to 2 hours. If the 
activity is less than 5 0 %  or star activity of one enzyme occurred in the chosen buffer, 
digestion with low salt buffer enzyme was done first and enzyme was inactivated. 
The salt concentration was increased up to optimum for the second enzyme and 
digestion was started by adding the enzyme. In some cases D N A  was precipitated 
after the first reaction and the new reaction mixture was set up using the other buffer.
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2.16) Dephosphorvlation of D N A :
Restriction enzyme digestion results in the exposure of 5 ’ phosphate groups. 
These groups can be removed i.e. D N A  ends are dephosphorylated, by the action of 
two enzymes: a) Bacterial alkaline phosphatase (BAP), 
b) Calf intestinal alkaline phosphatase (CIAP).
In cloning procedure vector D N A  can be treated by one of the enzymes to prevent 
self-religation and thus maximising the formation of recombinant molecules. C I A P  
was usually used as it can be inactivated easily as compared to BAP.
Procedure:
Following restriction endonuclease digestion and enzyme inactivation by 
phenol chloroform extraction and ethanol precipitation, D N A  was resuspended in 1 
X  C I A P  buffer or 1 X  REact 3 buffer and 0.1 unit of C I A P  was added per 
microgram of D N A .  REact 3 buffer was usually used as C I A P  was active in the 
buffer. Also C I A P  buffer contains ZnCl2, which if not removed completely after 
reaction interferes with ligation. The reaction mix was then incubated at 37°C for 
30 min. The reaction was terminated by heating to 70°C for 30 min followed by 
phenol chloroform extraction. The D N A  was then ethanol precipitated and 
centrifuged. The D N A  pellet was dried and resuspended in T E  buffer.
2.17) End filling of recessed 3 ’ termini:
Recessed 3 ’ termini created by the digestion of D N A  by some restriction 
enzymes can be filled in by using the large fragment of D N A  Polymerase I (known 
as Klenow fragment). The klenow fragment retains the 5 ’->3’ polymerase and 3’->5’ 
exonuclease activities of D N A  Polymerase I but lacks the 5 ’->3’ exonuclease activity.
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Thus the klenow fragment has a variety of uses including the creation of blunt ends 
for blunt end ligations and end labelling of D N A  with radiolabelled nucleotides by 
filling in recessed 3’ termini.
Procedure:
The typical reaction was set up as follows:
digested D N A  (up to 1 p g )  10 p i
2 m M  d A T P  in water 1 p i
2 m M  d C T P  in water 1 p i
2 m M  d G T P  in water 1 p i
2 m M  d T T P  in water 1 p i
10 X  end labelling buffer 2 p i
deionised water 3 p i
Klenow fragment (1 u f p i )  1 p i
The reaction mix was incubated at room temperature (20°C) for 30 min. The 
reaction was terminated by extraction with phenol chloroform and the D N A  was 
recovered from aqueous phase by ethanol precipitation and centrifugation. The D N A  
was resuspended in T E  buffer and used for ligation or stored at 4°C.
2.18) D N A  ligation:
The D N A  molecules to be ligated were first digested with the appropriate 
restriction enzymes. D N A  modifications such as blunt ending, dephosphorylation etc. 
were done if required. The D N A  molecules to be ligated were then resuspended in 
1 X  ligase buffer such that the concentrations of the D N A  and the ratio of the 
different D N A  molecules would result in m a x i m u m  recombinant molecule generation. 
Usually the ratio of 2:1 of insert:vector in terms of ends of the molecules was used.
60
Typical ligation reaction mixtures were set up as shown below:
D N A
5 X  ligation buffer 
water
T4 D N A  ligase
10 f d
4 f d
5 f d
1 f d  (1-5 units)
The mixture was incubated at 13-15°C overnight for staggered end ligations 
and at 8-9°C overnight for blunt end ligations. For blunt end ligations, usually up 
to 5 units of T4 D N A  ligase was used. The T4 D N A  ligase and 5 X  ligation buffer 
used were purchased from BRL.
2.19) Transformation:
2.19.1) Preparation of competent cells for transformation using Tris-CaCL method 
(Maniatis e t  a l., 1982) :
CaCl2 - 0.05 M  in 0.05 M  Tris.HCl p H  8.0
A n  overnight culture of the host strain was grown at 37°C. 1 ml inoculum 
was used to inoculate 50 ml of pre-warmed L B  broth in a 250 ml conical flask. The 
culture was grown at 37°C rotary shaker until the optical density at 650 n m  was 0.5. 
The culture was cooled on ice for 15 minutes and the cells were harvested by 
centrifugation at 5000 R P M  for 10 min at 4°C in Beckman centrifuge. The 
supernatant was discarded and pellet was resuspended in 15 ml of ice cold 0.05 M  
CaCl2 prepared in 0.05 M  Tris.HCl (pH 8.0) and placed on ice for 30 min. The cells 
were harvested as described above and the pellet was resuspended in 2 ml of the same 
solution and the cells were stored on ice until required.
Reagent:
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2.19.2) Preparation of competent cells for transformation using electroporation:
Reagents:
deionised sterile ice cold water
glycerol - 10%  in deionised water, autoclaved.
A n  overnight culture of the host strain was prepared and 2 ml was used to 
inoculate 100 ml pre-warmed L B  broth. The culture was incubated, at 37°C with 
shaking, until the O.D. at 650 n m  was 0.8. The cells were harvested by 
centrifugation at 5000 R P M  for 10 min at 4°C. The supernatant was decanted and 
the cells were washed with 100 ml of ice cold sterile water. The cells were again 
harvested by centrifugation as previously described. The cells were rewashed with 
80 ml of ice cold water and 40 ml of 10% ice cold glycerol solution. Finally the 
pellet was resuspended in 500 p i of 10% glycerol, dispensed into aliquot of 80 p i and 
stored on ice until required or stored at -70 °C for further use.
2.19.3) Transformation procedure:
2.19.3.1) Transformation using cells prepared as in 2.19.1 and E .  c o l i DFT5o! 
competent cells:
E .  c o l i DH5o: competent cells were bought from B R L  and used for 
transformation. Competent cells were removed from -70°C freezer and thawed on 
ice. For each transformation 25 p i of D H 5 a  cells or 100 p i of competent cells from 
2.19.1 were dispensed into sterile eppendorf tubes. To each aliquot 5-10 p i of D N A  
solution containing no more than 10 ng of D N A ,  for D H 5 a  cells, and up to 40 ng 
D N A  for prepared competent cells was added and kept on ice for 30 min. The DH5o: 
cells were heat shocked for 45 seconds at 42 °C without shaking and placed on ice for
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2 min. The other competent cells (prepared as in 2.19.1) were heat shocked for 2 
min at 42°C without shaking and kept on ice for 15 min. 0.9 ml of pre-warmed 
S.O.C. solution was added to each tube and the cells were incubated at 37°C for 60 
min. The neat culture of 100 p i each was then plated out on selective agar plates.
2.19.3.2) Transformation using electroporation:
This transformation method is very rapid and gives high transformation 
efficiencies.
The cells were removed from the freezer and thawed on ice. The cells were 
distributed (40 p i each) into pre-cooled sterile eppendorf tubes and maintained on ice. 
D N A  solution up to 3 p i in volume and no more than 50 ng in amount was added to 
each aliquot and kept on ice for 1 min. The cells containing D N A  were then 
transferred to pre-chilled 0.2 c m  electrode gene pulser cuvette. The electroporator 
was set at 25 ^FD, 200 and 2.5 K V  and pulse was given. The cells were 
recovered quickly and cuvette was washed with 1 ml of S.O.C. solution. The cells 
were in a shaking incubator incubated at 37 °C for 60 min at a speed of 225 R P M .  
Following the incubation the neat culture and diluted samples were plated on selective 
agar plates.
2.19.4) Selection of transformants:
Transformants were selected on LB-agar plates containing the appropriate 
antibiotics and other supplements if required. Table 10 shows the commonly used 
antibiotics and other supplements used in this study.
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Table 10: Antibiotics/Supplements used
Antibiotic/S upplement Concentration
Ampicillin 25, 50 jug/ml
Chloramphenicol 10,20,30 i x g /ml up to 2mg/ml
Kanamycin 25 p g/ml
X-Gal 20 fxg/ml
I P T G 50 ixM
Adenine 20 jug/ml
Glycine 50 [ x g /ml
Methionine 50 f x g / m l
Pantothenate 2 jug/ml
Thymine 200 jug/ml
2.20) Nucleic acid extraction methods from bacteria:
2.20.1) Isolation of M .  b o v is  B C G  chromosomal D N A  (Zainuddin and Dale, 1989):
Reagents:
7 H 9  broth 
glycine solution 
lysozyme solution 
S D S  
phenol
phenol: chloroform
chloroform:iso-amyl alcohol
NaCl
ethanol
RNase A
T E  buffer
M .  b o v is  B C G  culture (Glaxo strain) was inoculated into 10 ml of 7 H 9  broth 
and grown at 37 °C in a shaking incubator. After 10 days of, growth 5 ml inoculum 
was used to inoculate 100 ml of 7 H 9  broth and incubated at 37 °C in a shaking 
incubator. Following three weeks glycine was added to a final concentration of 2 %
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and incubation was continued for 24 hr. The culture was centrifuged at 3000 R P M  
for 15 min at 4°C and the pellet was resuspended in 5 ml of lysozyme solution (10 
mg/ml) and incubated at 37 °C for 16-18 hr. S D S  was added to the final 
concentration of 1 %  and mixed well by vortexing. T w o  phenol, two 
phenol:chloroform and two chloroform:iso-amyl alcohol extractions were performed. 
These extractions were performed by adding equal volumes of either saturated phenol 
or phenol:chloroform or chloroform:iso-amyl alcohol to the aqueous phase, mixing 
well by vortexing and centrifuging at 5000 R P M  for 10 min at room temperature. 
Each time the aqueous phase was collected carefully and used for next set of 
extraction. To the final aqueous phase NaCl was added to a final concentration of 
0.15 M  and D N A  was precipitated by adding two volumes of chilled ethanol.
The D N A  pellet was recovered by centrifugation, dried and resuspended in 
400 p i of T E  buffer. DNase free RNase A  was added to a final concentration of 50 
p g !ml and incubated at 37°C for 1 hr. Following the incubation, one phenol, one 
phenol:chloroform and one chloroform:iso-amyl alcohol extractions were performed. 
The aqueous phase was collected and D N A  was precipitated using NaCl (0.15 M  final 
concentration) and two volumes of ethanol. D N A  was collected by centrifugation, 
the pellet was dried and resuspended in 400 p i T E  buffer.
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Reagents:
LB-broth containing appropriate antibiotic 
Solution I (2.8-i)
Solution II (2.8-ii)
Solution III (2.8-iii) 
phenol
phenol: chloroform 
RNase A  
ethanol 
T E  buffer
The method described by Birnboim and Doly (1979) was adapted after slight 
modification for the extraction of plasmid D N A  from E .  c o l i cultures. The culture 
was inoculated in 10 ml of selective media and incubated at 37 °C in a shaking 
incubator at 250 R P M  for 18-20 hr. Following the heavy growth, the culture was 
transferred in a plastic universal and centrifuged at 3000 R P M  for 10 min at 4°C in 
a table top Beckman centrifuge. Supernatant was decanted and the pellet was 
resuspended in 200 p i of glucose/lysozyme solution (2.8 - i) and left at room 
temperature for 5 min. 400 p i of alkaline lysis solution (2.8 - ii) was added and 
mixed well by gently inverting the tube and left on ice for 10 min. Following the 
incubation 300 p i of solution III (2.8 -iii) was added and mixed well by gently 
inverting the tube and incubated on ice for 10 min. The contents were centrifuged 
in an eppendorf microfuge in cold room (4°C) for 10 min at 14000 R P M .  The 
supernatant was collected and used for further extractions. T w o  phenol, two 
phenol:chloroform and one chloroform:iso-amyl alcohol extractions were carried out 
and final aqueous phase was precipitated using NaCl (0.15 M )  and two volumes of 
chilled ethanol. D N A  was collected as described in 2.13 and resuspended in 100 p i
2.20.2) Small scale plasmid extraction from E. coir.
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T E  buffer. RNase A  was added to a final concentration of 50 /xg/ml and incubated 
at 37°C for 1 hr. One phenol:chloroform and one chloroform:iso-amyl alcohol 
extractions were performed and D N A  was precipitated (2.13) and pellet was 
resuspended in 100 fx 1 T E  buffer.
2.20.3) Large scale plasmid extraction from E .  c o l i (Maniatis e t  a l 1982): 
Reagents:
LB-broth
2 mg/ml lysozyme solution, freshly prepared
Brij/Doc solution
chloramphenicol
20 mg/ml ethidium bromide solution
caesium chloride
isopropanol
isopropanol saturated with caesium chloride 
8 0 %  ethanol 
T E  buffer
E .  c o l i culture (single colony) containing amplifiable plasmid was inoculated 
into L B  broth containing appropriate antibiotic and incubated at 37 °C for overnight. 
O n  the following day 3 ml inoculum was used to inoculate pre-warmed 150 ml L B  
broth containing appropriate antibiotic and incubated at 37 °C with vigorous shaking 
till the O.D. of 0.6-0.8 at 600 n m  was obtained. Chloramphenicol (170 jug/ml) was 
used to amplify the plasmid and incubation was continued for 18-20 hr at 37°C on 
a rotary shaker.
The cells were harvested by centrifuging the culture at 5000 R P M  for 10 min 
at 4°C in a Beckman centrifuge. Supernatant was decanted and pellet was 
resuspended in 6 ml of freshly prepared lysozyme solution and kept on ice for 15 to 
30 min. 4 ml of Brij-Doc solution was added and mixed by pipetting up and down
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with a 10 ml pipette. The solution was left on ice for 20 to 30 min to ensure 
complete lysis. Following this incubation cell debris and most of the chromosomal 
D N A  was removed by centrifugation at 17000 R P M  for 45 min at 4°C.
The supernatant also known as the cleared lysate was recovered by decanting 
carefully into a fresh tube. The volume was measured and caesium chloride was 
added to a final concentration of 0.95 g/ml. Ethidium bromide was then added to the 
final concentration of 500 jug/ml.
The above suspension was then put into a Beckman Quick Seal polyallomer 
ultracentrifuge tube, balanced with the opposite tube and sealed. The tubes were 
loaded onto a Beckman Ti 70.1 or Ti 75.1 rotor and centrifuged for 48 hours at 
40000 R P M  in a Beckman L5 ultracentrifuge.
The plasmid band was visualised using U V  illumination (hand monitor) and 
recovered by puncturing the side of the tube, just below the band, with a 19 G  
disposable needle and drawing it into a 1 ml syringe.
A n  equal volume of isopropanol saturated with caesium chloride was added 
and mixed thoroughly. This was allowed to stand for a few minutes until two phases 
were obtained. The top, isopropanol, phase was removed and this process was 
repeated until all the ethidium bromide had been removed.
To each 200 p i of extract, 250 p i of distilled deionised wafer was added 
followed by 50 p i 3 M  sodium acetate and 500 p i isopropanol. This was kept on ice 
for 30 minutes and the D N A  recovered by centrifuging for 15 min at 4°C. The 
supernatant was removed and the pellet was washed with 8 0 %  ethanol. The pellet 
was then dried in a vacuum desiccator and resuspended in T E  buffer.
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Reagents:
D E P C  treated sterile water
lysis buffer (1% SDS, 0.2 M  Tris.Cl pH7.5, 0.2 M  NaCl, 0.04 M  E D T A )
phenol (Tris saturated)
ethanol
All solutions were prepared in D E P C  treated water and containers. All 
plasticware was treated with D E P C  by soaking in 0.1 %  D E P C  solution overnight and 
rinsed with D E P C  treated sterile water and autoclaved.
Procedure:
0.5 ml of overnight culture was used to inoculate 50 ml of LB-broth. The 
flask was incubated at 37°C with vigorous shaking (300 R P M )  till the O.D. of culture 
reached to 0.6-0.8 at 600 nm. After attaining the desired optical density/ growth the 
culture was chilled rapidly and centrifuged at 5000 R P M  for 10 min at 4°C, in D E P C  
treated centrifuge tubes. Supernatant was decanted and cells were resuspended in 2 
ml of D E P C  treated autoclaved deionised water. To this cell suspension, 2 ml of hot 
lysis buffer was added from the tube sitting in a boiling water bath. After 1-2 min, 
2 ml of preheated (to 64 °C) buffered phenol was added and vortexed for 2-3 min. 
The tube was revortexed, chilled rapidly and centrifuged at 8000 R P M  for 10 min at 
4°C. The aqueous phase was collected and re-extracted with cold phenol. To the 
resulting aqueous phase 2 vol. of chilled ethanol was added and stored at -20°C for 
18-20 hr for precipitation of R N A .  R N A  was sedimented by centrifuging the tube 
at 10000 R P M  at 4°C for 20 min. The pellet was washed in 7 0 %  ethanol, dried in 
vacuum and resuspended in 50 p \ of D E P C  treated deionised sterile water.
2.20.4) Bacterial RNA isolation using hot phenol extraction:
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extraction:
Reagents:
RNAzol Solution (from kit) 
sodium acetate, pH4.0 - 2 M  
phenol - water saturated 
chloroform 
isopropanol
D E P C  treated deionised sterile water
All solutions were prepared in D E P C  treated water and containers. All 
plasticware were treated with D E P C  by soaking them in 0.1% D E P C  solution 
overnight and rinsed with D E P C  treated sterile water and autoclaved.
Procedure:
L B  broth was inoculated with 1 %  of overnight grown culture. Cells were 
grown at 37 °C in a rotary shaker (300) R P M  till the optical density at 600 n m  
reached to 0.6. The culture was chilled rapidly and cells were harvested by 
centrifugation at 5000 R P M  for 10 min at 4°C. The supernatant was decanted and 2 
ml of RNAzol solution was added to 10 x 106 cells and transferred to a 4 ml 
polypropylene tube. Subsequently 0.2 ml of 2 M  sodium acetate p H  4.0, 0.2 ml of 
chloroform was added to the homogenate. The final suspension was shaken 
vigorously for 10 sec and cooled on ice for 15 min. The suspension was centrifuged 
at 10000 g for 20 min at 4°C and aqueous phase was transferred carefully to a fresh 
tube. R N A  was precipitated by adding 2 volumes of isopropanol and incubated at 
-20°C for 2 hr. Sedimentation of R N A  was done by centrifuging the tube at lOOOOg 
at 4°C for 20 min and the resulting R N A  pellet was resuspended in 0.3 ml of
2.20.5) Bacterial RNA isolation by acid guanidium thiocvanate phenol chloroform
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tube and R N A  was precipitated with 1 vol of isopropanol at -20 °C for 2 hr.
Following centrifugation for 10 min at 4°C, the R N A  pellet was dried and
resuspended in 50 p i of D E P C  treated deionised sterile water.
2.20.6) Extraction of D N A  from Lambda phage (Maniatis e t  a l., 1982):
Reagents:
L-broth, L-agar, T-top agarose
chloroform
PEG-6000
NaCl
S M  buffer
DNase
RNase
S D S
E D T A
phenol, phenol: chloroform 
chloroform:iso-amyl alcohol 
ethanol
1 mM EDTA. This resuspended RNA was then transferred into a 1.5 ml eppendorf
For the extraction of lambda phage D N A  from single plaque forming unit, the 
phage was first amplified to obtain high titre phage stock. A  single isolated phage 
plaque was resuspended in 100 p i S M  buffer and kept at 4°C for at-least 6-8 hr to 
elute the phage. 50 p i of this phage solution was used to infect 105 E .  c o l i LE392 
cells grown overnight in L-broth containing 0.01 M  M g S 0 4, 0.2 %  maltose.
D N A  extraction from Lambda phage can be divided into three basic steps: (A) 
Preparation of plating cells, (B) Preparation of lambda phage from solid or liquid 
media and (C) Extraction of lambda D N A .
A) Preparation of plating cells:
A  single colony of E .  c o l i LE392 was inoculated into 10 ml L-broth
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containing 0.01 M  M g S 0 4 and 0.2% maltose and incubated overnight at 37°C with 
shaking. The cells were harvested by centrifugation at 3000 R P M  for 10 min at 4°C 
and the pellet was resuspended in 2 to 4 ml of 0.01 M  M g S 0 4. These cells were 
used immediately for the infection of phage in the ratio of 100:1 of cells:phage.
B. 1) Preparation of lambda phage from solid media:
The plating cells prepared as above (c.200 p i i.e 107 cells) were mixed with 
diluted phage stock of 20 p i (105 pfu) and incubated at 37°C for 15 to 20 minutes. 
This allows adsorption of the phage to the cells. The infected cells, after incubation, 
were mixed with 3 ml of molten T-top agarose and overlaid onto L-agar petri plates 
of 90 m m  size. The top agarose was allowed to set and plates were incubated at 
37°C from 8 hr to overnight.
The plates showing confluent lysis were further used for the collection of the 
phage as follows: The plates were flooded with 5 ml of S M  buffer and kept at 4°C 
for 2 to 3 hr. The buffer along with T-top agarose was recovered into 10 ml 
polypropylene tube and centrifuged at 5000 R P M  for 10 min at 4°C. The supernatant 
was collected and used for the extraction of the phage D N A  as described below. 
B.2) Preparation of lambda phage from liquid media:
This method gives better yield of the phage in shorter time. Lambda phage 
stock was diluted to give 106 pfu in a 20 to 100 p \ volume of S M  buffer. 
Alternatively, a single isolated plaque was picked up using a sterile tip or Pasteur 
pipette and added directly to the 108 plating cells in 200 to 400 p i volume. This 
mixture was then incubated at 37 °C for 15 to 20 minutes for the adsorption of the 
phage. The mixture was added to the pre-warmed (37 °C) 10 ml L-broth and
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incubated with shaking (250 to 300 R P M )  at 37 °C until the cells began to lyse. This 
usually takes 3 to 4 hr depending on the cells:phage ratio. Once the cell debris 
started appearing 1 ml of chloroform was added and lysate was shaken for 5 minutes. 
The lysate was then centrifuged at 3000 R P M  for 10 min at 4°C and the supernatant 
was collected and used for the extraction of the phage D N A .
C) Extraction of lambda D N A :
The phage lysate prepared as above from B.l or B.2 was treated with DNase 
and RNase A  at concentrations of 5 jug/ml and 50 p g / m l respectively at 37 °C for 1 
hr. These treatments removed most of the host chromosomal D N A  and R N A .  After 
the treatment, solid PEG-6000 was added to the lysate to a final concentration of 10% 
followed by the addition of solid NaCl to a final concentration of 6%. PEG-6000 and 
NaCl were dissolved completely and the mixture was incubated on ice for 1 hr. The 
mixture was centrifuged at 5000 R P M  for 10 min at 4°C. The supernatant was 
decanted and the side of the tube was wiped with tissue to remove all traces of PEG. 
The phage pellet was resuspended in 0.5 to 1 ml of S M  buffer. DNase (10 p g /ml) 
and RNase A  (50 p g /ml) was added and incubated at 37 °C for 1 hr for the complete 
removal of host chromosomal D N A  and R N A .  Subsequently enzymes were 
inactivated by adding E D T A  pH8.0 to the final concentration of 0.01 M. S D S  was 
added to the final concentration of 0.5% and the phage D N A  was released by heating 
at 65°C for 10 min. A n  equal volume of equilibrated phenol was added, mixed well 
and centrifuged at 10000 R P M  for 3 to 4 min in microfuge. The aqueous phase was 
collected carefully and subjected to one more phenol extraction. T w o  extractions with 
phenol:chloroform and two extractions with chloroform:IAA were performed. The
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M  and D N A  was precipitated by adding two volumes of chilled 100% ethanol. D n a
precipitation was carried out at -20°C overnight or at -70°C for 10 min. The D N A
was collected by centrifugation at 10000 R P M  for 20 min at 4°C. The D N A  pellet
was washed with 8 0 %  ethanol, dried and resuspended in 100 - 200 p \ of T E  buffer
depeding on size of the pellet.
2.21) Agarose gel electrophoresis:
Reagents:
agarose (ultrapure, BRL)
1 X  Tris acetate buffer (TAE)
1 X  Tris borate buffer (TBE) 
ethidium bromide - 10 mg/ml
In this study various types of gel electrophoresis kits were used:
Horizontal Mini gels: B R L  Model H 6, Pharmacia-Gel electrophoresis apparatus G N A
100
Horizontal gels: B R L  Model H 5  and BioRad sub cell gel electrophoresis system 
The equipment was set up as recommended by the manufacturers. Either Tris acetate 
(TAE) or Tris borate (TBE) buffer was used depending on the experimental 
requirements, in the preparation and running of the gel. Various gel concentrations 
ranging from 0.8 to 2.2% were used depending on the requirements. Gels were 
prepared by boiling the agarose powder in the 1 X  buffer until molten and cooled to 
55°C before pouring to cast a gel. Once the gel was set, the comb was removed and 
the gel was pre-electrophoresed for 10-15 min. Samples were loaded in the wells with 
loading buffer and electrophoresed for various lengths of time depending on the
aqueous phase was collected, 5 M  NaCl was added to the final concentration of0.15
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Typical electrophoresis conditions are shown below, when T A E  buffer was
used.
Type of gel Voltage Running time
Minigel ( B R L H6) 100 40 min
Horizontal gel (BRLH5) 100 2.5 hrs
These conditions usually allow the marker dye to travel to about 2 to 3 c m
from the end of the gel.
The gel was stained with ethidium bromide (2 pig/ml) for 15-20 min. The
D N A  bands were visualised using long wave U V  illumination and photographed via
orange filter (23A) using Polaroid 665 or 667 film.
2.22) Recovery of D N A  from agarose gels:
The Geneclean method:
The D N A  from gel was recovered using the commercial kit, called
G E N E C L E A N 1M, developed by BIO 101. The principle is based on the affinity of
D N A  molecules to a silica matrix. The kit contains a specially formulated silica
matrix called "Glassmillk" that binds single and double stranded D N A  without
binding contaminating material. The process is rapid (20-25 min) and recovers
approximately 8 0 %  of D N A  without other contaminants.
Reagents: All reagents were supplied with the ldt.
sodium iodide (Nal) solution - 6 M  
"Glassmilk" - silica matrix suspension
N E W  concentrate buffer - NaCl, ethanol, water; The exact composition not 
known)
T B E  modifier - For recovery of D N A  from T B E  agarose gels 
T E  buffer - Not supplied with the kit
requirements.
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The D N A  sample was electrophoresed through agarose gel, stained with 
ethidium bromide and the gel slice containing the D N A  fragment(s) of interest was 
excised from the gel and the weight was determined. 3 volumes of Nal stock solution 
was added and incubated at 55 °C for 5 min to dissolve agarose. If the gels were 
electrophoresed in T B E  buffer, T B E  modifier (1/2 vol of T B E  modifier and 4.5 vol 
of Nal solution) was added to aid the melting of agarose gel in Nal and neutralize the 
inhibitory effects of T B E  buffers on the binding of D N A  to glassmilk. 5 p i (per 5 
p g  of D N A )  of "Glassmilk" suspension was added, mixed thoroughly, and placed on 
ice for 10-15 min to allow binding of the D N A  to the silica matrix. The silica matrix 
was pelleted by centrifuging for 5 sec. The supernatant was discarded and 500 p i of 
ice cold N E W  buffer was added. The pellet was resuspended well by pipetting back 
and forth while digging into the pellet with the pipet tip. After complete 
resuspension, it was centrifuged for 5 sec and supernatant was discarded. The wash 
with the N E W  buffer was repeated twice and after the last wash supernatant was 
removed completely to avoid diluting the elute.
The washed pellet was resuspended in 10 p i of T E  buffer and incubated at 
55 °C for 2-3 min. The D N A  was collected by centrifuging the tube for 30 sec and 
collecting the supernatant in clean eppendorf tube. The pellet was washed twice with 
equal volumes of T E  buffer to collect m a x i m u m  amount of D N A  from silica matrix. 
The D N A  from supernatant was either used directly or precipitated using NaCl and 
ethanol. The typical recovery of D N A  was between 70-90% depending on the size 
of the D N A .
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There are many practical variations to the technique and the method described below 
was the one commonly used throughout this thesis.
The method can be divided into 5 stages:
2.23.1) Immobilization of the D N A  to be analyzed to a
solid support
2.23.2) Preparation of the probe
2.23.3) Hybridization
2.23.4) Washing
2.23.5) Autoradiography
2.23.1) Immobilization of the D N A :
Nylon membrane (Hybond-N) supplied by Amersham was used as the solid 
support to bind the D N A  of interest.
Three methods of transferring D N A  to the filter membranes were commonly used:
2.23.1.1) Southern blotting (Southern, 1975):
Reagents:
agarose
1 X  T A E  or T B E  buffer 
depurination solution (refer to 2.7) 
denaturing solution (refer to 2.7) 
alkali transfer buffer (refer to 2.7) 
neutralizing solution (refer to 2.7)
Procedure:
The D N A  to be analyzed was first digested with restriction enzymes, if 
necessary, loaded onto an agarose gel and electrophoresed as described earlier. The
2.23) Hybridization Techniques:
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If the D N A  fragments, to be transferred, were larger than 10 kb in size, the 
gel was placed in depurination buffer until the dyes had changed colour and left in 
fresh depurination solution for additional 10 min. This step was performed when 
undigested D N A  samples were used for Southern blotting, since it helps in nicking 
of undigested closed covalently circular D N A  molecules, which often do not transfer 
efficiently to the membrane.
The gel was rinsed in distilled water and was then placed in denaturation 
buffer for 30 min. with constant shaking. Care was taken to soak the gel completely.
The denatured gel was then used to set a capillary blot using alkali transfer 
method. The gel was placed on a piece of 3 M M  Whatman paper, supported by a 
glass plate, with both ends of the paper dipping into a reservoir of alkali transfer 
buffer. This 3 M M  paper acts as a wick for the transfer. Care was taken to remove 
all air bubbles trapped between the glass, paper and gel. All the sides of the gel were 
covered with parafilm to prevent the blotting buffer being absorbed directly into the 
paper towels above.
A  piece of Hybond-N membrane filter, cut just bigger than the gel was then 
placed on the gel. Air bubbles, if any, were then removed by rolling a 10 ml pipette 
on the filter gently. Three pieces of 3 M M  paper of the size of nylon membrane 
were saturated with alkali transfer buffer and were placed on top of the Hybond-N 
membrane. This was followed by 2-3 dry pieces of 3 M M  paper and then by a stack 
of blotting paper or tissues cut to the exact size. A  glass plate was then placed on top 
of the assembly followed by a weight of at least 500 g. The blotting was allowed for
gel was then stained and photographed.
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After blotting the apparatus was dismantled carefully and before removing 
from the gel, the membrane was marked with a pencil to allow later identification of 
tracks. The membrane was neutralized in neutralization solution for 30 min and 
washed briefly and carefully in 2 X  S S C  solution to remove any adhering agarose. 
The membrane was air dried for 15 min and baked in an oven at 80°C  for 1 hr. 
Alternatively after air drying, the D N A  was fixed by U V  light by placing the 
membrane ( D N A  side down) on a U V  transilluminator for 3-5 min. The membrane 
was either used immediately for prehybridization or stored wrapped in 3 M M  paper 
at room temperature until required.
2.23.1.2) Colony blotting:
Procedure:
Cells (usually E .  c o l i) were grown on LB-agar plates containing appropriate 
antibiotic to form individual colonies. Normally a tooth pick method was used to 
give 25 to 50 individual separated colonies on each plate depending on the 
experimental requirement. A  second replica plate was made and stored at 4°C for 
further selection of colonies. A  marked circular nylon membrane, Hybond-N 82 m m  
in diameter from Amersham, was placed on the agar plate containing colonies. After 
1 min the filter was carefully removed and placed, colony side up, on a 3 M M  paper 
soaked in denaturing solution for 7 min. The filter was removed and placed on a 3 
M M  paper saturated with neutralizing solution for 5 min. The filter was finally 
rinsed in 2 X  S S C  solution, air dried and then baked at 80°C for 1 hr or bound to 
nylon membrane by U V  cross linking as described earlier. The filter was then used
overnight usually 16 to 18 hr.
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2.23.1.3) Plaque lift/blotting (Benton and Davis; 1977):
Procedure:
Plaques were grown using the method described in Section 2.20.6-B.l. 
Usually for plaque blotting, instead of 90 m m  petri dishes, large Bio-assay plates 
were used. The plates were kept at 4°C for 1 hr to cool the soft agar and to allow 
good transfer of plaques without lifting up of soft agar.
The procedure used for plaque blotting was identical to that of the colony lift 
as described above. W h e n  large bioassay plates were used to screen the library, the 
proper size Hybond-N membranes were used and plaque lifts were done in duplicates 
with a second membrane placed on the plate for 2 min instead of 1 min.
2.23.2) Preparation of probe:
2.23.2.1) Preparation of double stranded probe:
Reagents:
D N A  to be labelled
Multiprime labelling kit
o:-32P labelled d C T P  (10 p C H p l )
Procedure:
The principle of the method is based on the random hybridization of the 
primer sequences from the kit to the single stranded D N A  and synthesis of double 
stranded D N A  with the incorporation of a-32P  labelled dCTP. The primer in the kit 
consisted of random hexanucleotide sequences which hybridized to the denatured 
D N A  at numerous points.
for hybridization experiment or stored at room temperature until required.
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The D N A  to be labelled (25 ng to 50 ng) was denatured by boiling for 2 min 
and chilling on ice for 2 min and used for the labelling reaction as recommended by 
the manufacturers (Amersham). The newly synthesised labelled strand was separated 
from the template by heating in a boiling water bath for 2 min followed by cooling 
on ice.
2.23.2.2) Preparation of single stranded probe:
Reagents:
single-stranded D N A  to be labelled
M 1 3  Universal primer or other specific primer
32p d C T P  (3000 ci/mMol)
d N T P  solutions - 10 m M  each
Klenow fragment of D N A  polymerase
agarose
Geneclean kit
D T T  - 0.1 M ,  M g C l2 - 1 M ,  N a O H  - 1 M , 2 M  Tris.Cl p H  7.5, 1 M  Tris.Cl 
p H  4.6, distilled sterile water
Procedure:
The principle used to prepare single-stranded D N A  probes was to prepare the 
second strand of D N A  using the single-stranded template annealed to the specific 
primer. The second strand was synthesised using a32P d C T P  to obtain radiolabelling 
through the strand. Once the synthesis was complete, the two strands were denatured 
and separated by agarose gel electrophoresis. Autoradiography was done on agarose 
gel and the area showing a band on the film was cut out from the gel. The labelled 
single-stranded D N A  was then isolated using Geneclean kit. This labelled D N A  was 
used for the Northern blot hybridisation experiment.
The single stranded D N A  to be labelled was isolated from recombinant M 1 3  
bacteriophage vector as described in 2.24-B. T w o  p g  of D N A  was used for the
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The first step of annealing was done as follows:
SS D N A  - 4.0 p i (2 p g )
M l 3 Universal primer - 2.0 p i (10 ng)
2 M  Tris.Cl p H  7.5 - 2.4 p i
0.1 M  D T T -  4.8 p i
1 M  M g C l2 - 2.9 p i
Distilled water 228.0 p i
Total volume - 244.1 p i
This mixture was heated to 90 °C for 3 min and cooled slowly to 30 °C and 
then transferred to ice. To this tube 2.4 p i 10 m M  solutions of dATP, d G T P  and 
d T T P  were added and mixed well. From this 5 p i annealed template was used for 
further reactions and remaining mixture was frozen at -70 °C for further use.
preparation of the probe.
annealed template - 5 p i
32p d C T P  (30yuci) - 3 p i
Klenow fragment (1 Unit) - 1 p i
distilled water - 1 p i
10 p i
All the additions were done on ice and the reaction was started by addition of 
Klenow fragment and transferring the tube to 18°C waterbath for 20 min. The 
reaction was continued by addition of 1 p i cold solution of 10 m M  d C T P  for a further 
20 min at the same temperature. The mixture was heated at 65 °C for 15 min to stop 
the reaction by inactivating the Klenow fragment and cooled to 4°C rapidly. The 
reaction often synthesised M 1 3  D N A  from the other end of the insert. To cut out this 
M l 3 labelled D N A  restriction enzyme digestion was done with the enzyme which was 
used for a cloning of the insert into M l 3 vector. The digestion reaction was carried
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out in 20 p i volume and with 10 to 20 units of appropriate restriction enzyme at 37 °C 
for 30 min. The two strands were separated by the addition of N a O H  to the final 
concentration of 0.2 M  and the incubation was done at 37°C for 10 to 15 min. The 
SS D N A  was neutralised by adding 15 p i of Tris.Cl p H  4.6 and immediately 
electrophoresed on 1.2 %  agarose gel. The gel was stained using ethidium bromide 
and photographed. Since the gel contained very high counts of radioactivity, 
electrophoresis and all further manipulations were also done in controlled area. Gel 
autoradiography was done for 2 to 4 min and film was developed. The area on the 
gel corresponding to the band on the film was cut out and the D N A  purified using 
Geneclean kit. Before using this probe for the Northern blot hybridisation it was 
again denatured and then added to the prehybridized filters.
2.23.3) Hybridization:
Reagents:
hybridization buffer
labelled probe
Procedure:
Hybridization consists of two steps. First, the prehybrization of the membranes 
and secondly the addition of the labelled probe to the prehybridized membranes.
Hybridization was performed either (i) in heat sealable plastic bags attached 
with luer ports through which buffers and solutions were introduced or removed and 
the bags were incubated in waterbath at required temperature, or (ii) in Hybaid bottles 
and Hybaid hybridization oven.
The filter to be hybridized was placed between the two pieces o f gauze
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supports soaked with 2 X  SSC, rolled carefully and placed in a Hybaid bottle 
containing 2 X  SSC. The gauze supports were unrolled carefully so that the 
membrane was in between two support pieces and stuck to the sides of the bottle. 
The 2 X  S S C  solution was replaced by 10 - 15 ml preheated (68°C) hybridization 
solution and incubated in 68°C Hybaid oven for 1.5 - 2 hr.
After the prehybridization, the probe was added to the same solution mixed 
well and bottle was capped tightly. To avoid any leaking of the radioactive probe the 
cap was covered by a plastic bag and incubated in Hybaid hybridization rotary oven 
at 68 °C overnight.
2.23.4) Filter washing:
Reagents:
3 X  SSC, 0.1 %  S D S
1 X  SSC, 0.1 %  S D S
0.1 X  SSC, 0.1 %  S D S
2 X  SSC
Procedure:
All the above solutions were pre-warmed to 68°C. The hybridization solution 
containing radioactive probe was removed from the bottle. 50 ml of 2 X  S S C  was 
then added to the bottle and the filter was rinsed briefly for 2-3 min. The buffer was 
replaced by 30 ml 3 X  SSC, 0.1 %  S D S  and incubated at 68°C for 20 min. This 
wash was repeated once again and the filter was monitored by Geiger counter. 
Depending on the stringency required the filter was then washed with 1 X  SSC, 0.1 
%  S D S  at 68°C for 20 min twice followed by 2 washes with 0.1 X  SSC, 0.1 %  S D S  
at 68°C.
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The filter was then removed from the bottle, placed on a glass plate and 
covered with Saran wrap. The X-ray cassette was cleaned, checked with counter and 
the filter was then put into the cassette for autoradiography.
2.23.5) Autoradiography:
A  piece of R X  X-ray film (Fuji) was placed on the filter and cassette was then 
put in -70 °C freezer or autoradiography was allowed to proceed at room temperature 
for the length of time depending on the requirement. The film was developed after 
the exposure of 2 hr to days depending on the signal intensity.
2.23.6) Removal of probe and re-use of blots:
Depending on the requirement of the blot for re-use, the probe was removed 
after the autoradiography by the following method:
The filter was incubated at 45 °C for 30-45 min in 0.4 M  N a O H  followed by 
incubation in 0.1 X  SSC, 0.1 %  SDS, 0.2 M  Tris-HCl p H  7.5 for 30 min at 45°C.
The filter was autoradiographed for 24 hr to check complete removal of probe. 
The filter was then covered in Saran wrap and stored at room temperature until 
required.
2.24) D N A  sequencing:
D N A  sequencing was carried out using two different methods as far as 
templates are concerned: (1) Single stranded D N A  sequencing using cloning into M 1 3  
bacteriophage vectors and (2) Double stranded D N A  sequencing using plasmid clones. 
In both the methods the principle of sequencing based on that was described by 
Sanger et al., (1977). The method is also known as dideoxy chain-termination 
sequencing and basically consists of three steps:
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The annealing is the first step and consists of annealing of primer to the 
template D N A .  For good sequencing reaction the mole ratio of primer:template is 
important and was maintained as 1:1. This stoichiometry was maintained when using 
larger or smaller templates.
The second step is known as labelling reaction or D N A  synthesis reaction. 
In this step, using labelled and unlabelled d N T P ’s and modified D N A  polymerase 
(Sequenase - modification of T7 D N A  polymerase) the labelled D N A  was synthesised 
in vitro using the template D N A  and annealed primer from step 1. The ratio of 
unlabelled d N T P ’s was varied to give longer labelling reactions according to 
manufacturer’s instructions.
The third and final step in the reaction is known as termination reaction. In 
this step, the concentration of all the d N T P ’s was increased and a dideoxy d N T P  was 
added to each reaction. D N A  synthesis occurred until all growing chains were 
terminated by a dideoxy nucleotide. The concentration of d N T P ’s and d d N T P  can be 
varied to give longer chains and hence more bases can be read on the autoradiograph. 
The reactions were terminated by the addition of E D T A  and formamide, denatured 
by heating and electrophoresed on 5 %  polyacrylamide gels containing 7 M  urea. 
Electrophoresis was performed using B R L  gel kit and at 65 to 70 Watts till the desire 
length of time. Gels were fixed in 10% acetic acid, 10% methanol, washed 
thoroughly in cold water for 5 to 7 minutes and dried at 80°C for 1 hr. Gels were 
exposed to X-ray film for autoradiography. Film was developed and the sequence 
was read and entered into the computer using "Staden-plus" software for further D N A  
analysis.
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Various primers of 17 to 21 bases in length were synthesised on an 
oligonucleotide synthesizer and eluted from columns according to the manufacturer’s 
instructions. These primers were used in sequencing reactions for the annealing of 
template D N A  and thus to overcome the problem of overlapping clones.
M 1 3  D N A  sequencing protocol:
The sequencing of D N A  using M l 3 recombinant clones involves the following
steps:
A) Cloning of D N A  into M 1 3  bacteriophage vector
B) Preparation of single-stranded M l 3 template
C) Preparation of plates and pouring of Urea-Polyacrylamide gel
D) D N A  sequencing reactions
E) Autoradiography and reading of sequence
A) Cloning of D N A  into M l 3 bacteriophage vector:
M 1 3  bacteriophage cloning vectors were constructed by Messing (1983) 
specifically for the sequencing reactions. Cloning into M 1 3  vectors is a convenient 
method of producing single-stranded copies of cloned D N A  which can be used for 
chain termination sequencing reactions.
In this project, M 1 3 m p l 8  and M 1 3 m p l 9  bacteriophage vectors were used for 
cloning. Both the vectors are similar in their D N A  content. The only difference is 
the opposite orientation of the multiple cloning site. This feature is useful for 
obtaining clones of each strand and hence sequencing reactions can be performed on 
both strands of the D N A .
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M 1 3 m p l 8  and M 1 3 m p l 9  replicative form D N A s  were digested with one 
restriction enzyme separately. The ends were dephosphatased using CIAP. The 
D N A  to be cloned was digested with similar enzyme and ligation was carried out as 
described in 2.18. Transformation was performed using E .  c o l i JM101 competent 
cells and white transformants were selected as the recombinant clones (2.19.4).
B) Preparation of single-stranded M l 3 template:
100 p i of overnight grown culture of E .  c o l i JM101 in 2 X  T Y  broth was 
added to 10 ml of pre-warmed 2 X  T Y  broth and dispensed into aliquot of 1.5 ml in 
sterile bijoux. White coloured recombinant M l 3 plaques from transformation plates 
or 5-10 p i of a previously plaque purified M l  3 phage lysate was added to each bijoux 
separately and were shaken vigorously at 37 °C for 5-7 hr. Cultures were transferred 
into sterile eppendorf tubes and centrifuged in microfuge at room temperature for 5 
min. The supernatants were decanted into fresh tubes and recentrifuged for 5 min. 
To each 1 ml of supernatant 250 p i of 20 %  P E G  6000 in 2.5 M  NaCl was added and 
incubated on ice for 15 to 20 min. P E G  precipitated phage was collected by 
centrifugation at 4°C for 15 min. Supernatant was decanted and the tube was 
recentrifuged for 5 sec. All the supernatant was removed using a drawn out pasteur 
pipette. The pellet was resuspended in 100 p i of T E  buffer. 100 p i of 
phenol:chloroform was added, vortexed and left at room temperature for 10 min 
before revortexing and spinning in a microfuge at room temperature for 5 min. The 
aqueous layer was collected carefully and the D N A  was precipitated using 10 p i of 
3 M  N a  acetate p H  5 and 250 p i of chilled ethanol. The mixture was left on ice for 
30 min before centrifuging at 4°C for 20 min in a microfuge. Supernatant was
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decanted and the pellet was resuspended in 100 p i of T E  buffer. Proteinase K  
solution was added to the final concentration of 5 p g / m l and incubated at 37 °C for 
30 min. T w o  phenol:chloroform extractions were performed and the final aqueous 
layer was used for the precipitation of D N A .  To the 100 p i of aqueous layer 10 p i  
of 3 M  N a  acetate p H  5 and 250 p i of chilled ethanol were added and left at -20 °C 
overnight. The D N A  was pelleted on the following morning by centrifuging at 4°C 
for 15 to 20 min in a microfuge. The pellet was washed with 80 %  ethanol, dried 
and resuspended in 25 p i of T E  buffer. The D N A  quality and quantity was estimated 
by electrophoresing 2 p i of D N A  along with standard molecular weight D N A  on a 
1 %  agarose gel and staining with ethidium bromide.
C) Preparation of plates and pouring the gel for D N A  sequencing:
The plates were scrubbed thoroughly with detergent and hot water and rinsed 
with distilled water. The inner sides of the plates were swabbed with 100 %  ethanol 
and allowed to dry in a fumehood. The inner side of the back plate was swabbed all 
over with a solution comprising 10 ml ethanol, 30 p i methacryloxypropyl-trimethoxy 
silane, 150 p i 10 %  acetic acid and allowed to dry in fumehood. Using fresh tissues 
the inner side of the front plate was coated with 10 ml of dimethyl dichlorosilane 
solution and allowed to dry in fumehood. Both the plates were wiped with ethanol 
to remove excess solutions and the plastic spacers were placed on the back plate. The 
front plate was lowered into position on back plate taking care that the coated sides 
were faced to each other. Sides, bottom and corners of the assembled plates were 
sealed with sealing tape and bulldog clips were placed on each side.
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The 5 % Urea-polyacrylamide gel was prepared as follows:
urea -
bis-acrylamide solution (2:38) - 
10 X  T B E  buffer
distilled sterile water - up to
31.5 g 
9.3 ml
7.5 ml 
75 ml
Urea was dissolved completely at 37° C  using minimum stirring to avoid 
aeration and just before pouring of the plates 75 p i T E M E D  and 420 p i 10 %  
a m m o n i u m  persulphate was added, mixed well and drawn into 75 ml plastic syringe. 
Bis-acrylamide solution was purchased from Boehringer corpo. ltd. The assembled 
plates were lifted and tilted to one end and the solution was poured from the same 
end from the top. The plates were lowered slowly as the solution reached to the top. 
Care was taken to avoid trapping of any air bubbles. The combs were inserted and 
the gel was allowed to set for 45 to 60 min.
D) D N A  sequencing reactions:
The D N A  sequencing was carried out using Sequenase version 2.0 kit from 
U S B  Corporation and the reactions were performed according to the manufacturer’s 
instructions. The sequencing reactions were usually carried out during the time of 
gel polymerisation. Most of the times reactions and gel electrophoresis was 
performed on the same day, if not the reactions were stopped and stored at -70°C for 
overnight and electrophoresis was done on the following day.
D.l) D N A  sequencing using double-stranded plasmid D N A :  D o u b l e
stranded plasmid sequencing was performed following the denaturation and
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neutralization of the plasmid DNA. Typical reaction consists of
D N A
2 N  N a O H  
10 m M  E D T A  
dist. water
5 p i (3 p g )
2  p i (0.2 N  final concentration)
2 /xl (0.2 m M  final concentation) 
12 p i
20 p i
The reaction was incubated at 37°C for 30 min. for the denaturation of double 
stranded D N A  and subsequently neutralised and precipitated immediately by addition 
of 3 M  sodium acetate (pH 4.8, 2 p i )  and 3 volumes of chilled ethanol by incubating 
in dry ice, ethanol bath for 15 min. The D N A  pellet was collected by centrifugation 
at 10000 R P M  for 20 min at 4°C. Supernatant was decanted and the pellet was 
washed with 7 0 %  ethanol, before drying and resuspending in 7 p i of autoclaved 
water.
Following this, the sequencing reactions were carried out as recommended by 
the kit manufacturer (Sequenase version 2).
E) Autoradiography and reading of the sequence:
After the electrophoresis, the front plate was separated and the gel was fixed 
in 10%  methanol and 10%  glacial acetic acid solution for 20 minutes, washed with 
cold running water for 5 minutes and dried onto the back glass plate at 80 °C for 1 
hour. Autoradiography was done at room temperature and the X-ray film was 
developed after one or two days of exposure. The sequence was read from the 
bottom and entered in the computer either manually or using digitizer. The data was 
assembled and analyzed using "Staden-plus" and "Micro-genie" software.
91
2.25) Preparation of crude protein extract from bacterial cells and isolation of
inclusion bodies for SDS-polyacrylamide gel electrophoresis:
For the analysis of the crude protein extracts on SDS-PAGE, the cells were 
grown overnight in 5 ml of L B  containing appropriate antibiotic and with I P T G  as 
inducer or without IPTG, as per the case. The cells were harvested by centrifugation 
at 3000 R P M  for 15 min at 4°C. Supernatant was decanted and the pellet was 
resuspended in 300 p i of 50 m M  Tris.HCl (pH 8.0) and stored at -70°C until 
required.
Before loading the samples on pre-electrophoresed SDS-Polyacrylamide gels 
40 p i of sample was mixed with an equal volume of 2 X  S D S - P A G E  dye and boiled 
for 5 min. Electrophoresis was performed at 150 volts and 50-60 m A M P  for 4-5 hr 
and the gel was stained with comassie brilliant blue for 1 hr at room temperature. 
The destaining was done overnight in destaining solution at room temperature, before 
drying the gel.
For the isolation of inclusion bodies, the cells were grown overnight in 15 ml 
medium and harvested by centrifugation at 3000 R P M  for 15 min at 4°C. The pellet 
was resuspended in 1 ml solution of 100 m M  NaCl, 1 m M  E D T A  (pH 8.0) and 50 
m M  Tris.HCl (pH 8.0). To this suspension, lysozyme was added to the final 
concentration of 1 mg/ml. Following the incubation at room temperature for 20 
min., the suspension was microfuged at 10000 R P M  for 5 min at 4°C. Supernatant 
was removed and the pellet was resuspended in 1 ml ice-cold solution of 0.1%  
sodium deoxycholate on ice for 10 min with intermittent mixing by vortexing. 
Magnesium chloride and DNase I were added to the final concentrations of 8 m M  and
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10 /xg/ml respectively and incubated at 4°C with mixing until viscosity disappeared. 
The suspension was centrifuged at 2000 R P M  in microfuge, supernatant was decanted 
and the pellet was resuspended in 1 ml of 0.1 %  sodium deoxycholate containing 1 %  
NP-40. The suspension was again centrifuged and the pellet was washed in 0.1% 
sodium deoxycholate, before resuspending in 150 p \ of 0.1 %  sodium deoxycholate. 
This was either stored at -70°C or used immediately for SDS-PAGE.
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3) CHARACTERIZATION AND SEQUENCING OF THE GENE FOR THE 
19 kDA ANTIGEN OF M Y C O B A C T E R IU M  B O V IS
Identification and characterization of protein antigens of different mycobacteria 
has been recently providing us with a better understanding of mycobacterial diseases 
including the molecular mechanisms involved in the immune response to mycobacteria 
and possibility of finding key antigens which can be used to raise specific monoclonal 
antibodies for immunodiagnostic tests. Detailed characterization of prominent protein 
antigens and their genes with the help of molecular biology techniques can possibly 
lead to production of specific D N A  probes for diagnostic use and for use of subunit 
vaccines. Production of monoclonal antibodies has accelerated progress in research 
on the antigens of mycobacterium and it can be divided from the perspective of 
monoclonal antibodies in four broad areas:(1) identification of antigenic molecules,
(2) detailed analysis of antigenic determinants, (3) analysis of human T  cell responses 
to defined antigens, and (4) tests for detection of antibodies and antigens in clinical 
samples.
Bovine tuberculosis is caused by M .  b o v is  and still persists at a significant 
level in certain areas of south-west England as a result of the reservoir of M .  b o v is  
infection present in the badger population (Wilesmith &  Williams, 1987). Disease 
caused by infection with M .  b o v is  is also recognized as a problem in farmed deer 
(Stuart e t  a l . ,  1988). Diagnosis of M .  b o v i s  infection in both cattle and deer relies 
on isolation of organisms from tissues of suspect animals. This can be a time 
consuming process. These animals must be identified as potentially infected by 
screening skin-test reactions to the crude M .  b o v is  antigen preparation known as 
purified protein derivative (PPD). However, P P D  is a heterogeneous preparation and
3.1) Introduction:
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considerable cross-reactions occur with other non-pathogenic organisms (Thorns &  
Morris, 1986; Chaparas e t  a l., 1970). Thus there is a need for identification and 
characterization of highly specific antigens from M .  b o v is . Previous work in this 
laboratory had established a genomic library of M .  b o v i s  D N A  in a lambda gtll 
vector and screened this library for clones expressing a 19 kDa protein antigen using 
monoclonal antibody CMA 1 3 4 . 1  (Collins, e t  a l , 1990). This monoclonal antibody 
reacts specifically with antigens from M .  b o v i s ,  M y c o b a c t e r i u m  t u b e r c u lo s i s  and 
M y c o b a c t e r i u m  k a n s a s i i . Recently Ashbridge e t  a l . ( 1989) have determined the 
sequence of the M .  t u b e r c u lo s i s  gene coding for a 19 kDa antigen, which is identical 
to the sequence of M .  b o v is  gene described in this chapter.
In order to understand the expression and regulation of the M .  b o v i s  19 kDa  
antigen gene w e  decided to subclone this gene, sequence it completely and study its 
expression at molecular level.
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In order to examine the expression of the 19 k D a  gene by recombinant lambda gtll 
clones, it was necessary to produce lysogens. This was done using the host strain E .  
c o l i Y1089 (Young and Davis, 1983), which contains a mutation that enhances the 
frequency of phage lysogeny (hflA150); the l a c  I gene product (the lac repressor) 
which prevents l a c  Z  directed gene expression (i.e. prevents expression of the beta- 
galactosidase gene and production of beta-galactosidase fusion proteins), until 
derepressed by the addition of I PTG to the cell culture and a deficiency in the Ion 
protease which increases the stability of expressed recombinant fusion proteins.
For preparing lysogens, 10 ml L-broth ( supplemented with 0.2% maltose) 
was inoculated with E .  c o l i Y1089 cells and incubated at 30°C overnight. Aliquot 
of this culture (c.104 cells) was mixed with phage from an amplified, plaque purified 
stock, at a multiplicity of 100 phage/cell as follows:
100 p i  E .  c o l i Y1089 cells (c.104 cells) +  880 p i L-broth (+0.2% Maltose) +  10 
m M  M g C l2 +  1 x 106 phage.
This infection mixture was then incubated at 30°C for 20 minutes, to allow 
adsorption of the phage to the cells to occur and then aliquot were plated out onto L- 
Agar plates (at a density of c.200 cells per plate) which were then incubated at 30°C 
overnight.
Colonies grown on the plates were subsequently tested for lysogenization as 
follows. With the aid of tooth picks, those colonies which grew at 30°C were 
stabbed onto two sets of L-agar plates; one set of plates was incubated at 30°C
3.2) Methods:
3.2.1) The production of recombinant lambda g tll lysogens:
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overnight and the second set of plates was incubated at 42 °C overnight. The lambda 
gtll vector produces a temperature-sensitive phage repressor (cI857) which is 
functional at 30°C but inactive at 42°C, resulting in the growth of lysogenic colonies 
at 30°C and not at 42°C.
3.2.2) Preparation of crude protein extracts from induced lvsogens:
T o  prepare crude protein lysate from the lysogenic colonies, a 2 ml L-broth 
culture of each lysogen was prepared by growing overnight at 30°C. Aliquot (300 
p \ )  of these overnight cultures were used to inoculate 30 ml volumes of L-broth. 
Cultures were grown at 30°C for 3 hours, until the optical density of the culture was 
0.5 at 600 nm. The cultures were incubated at 42°C for 20 minutes, to inactivate the 
temperature-sensitive phage repressor (cl 857) and to induce the lysogens. To 
derepress the l a c  promoter and thus stimulate l a c  Z  directed gene expression, leading 
to the production of recombinant antigen, I P T G  was added to the final concentration 
of 10 m M .  Following the addition of IPTG, the cultures were incubated at 37°C for 
30 minutes, to allow the expression and accumulation of large quantities of the phage 
products within the cells. If incubation at 37°C is prolonged then the lysogens do 
undergo lysis because of the ’leakiness’ of the S 100 mutation in the gtll vector. 
Thus, following the incubation of the cultures at 37°C for 30 minutes and prior to 
onset of lysis, the cells were harvested by centrifugation at 8000 rpm for 5 minutes 
at 37°C and the pellets were then resuspended in 1ml volumes of 50 m M  Tris-HCl, 
p H  8.0. The cell suspensions were then frozen in liquid nitrogen for 1 hour and then 
thawed, to cause complete lysis of the induced lysogens and the released of the 
recombinant antigens. These concentrated crude protein lysate samples were then
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This procedure can be divided into three distinct steps: (a) the separation of 
the proteins of different molecular weights by electrophoresis through SDS- 
Polyacrylamide (SDS-PAGE) gel (Laemmli, 1970); (b) the electrophoretic transfer 
of the separated proteins, from the S D S - P A G E  gel to a nylon membrane, by Western 
blotting (Towbin e t  a l , 1979) and (c) detection of proteins/antigens on the Western 
blot by specific primary antibody and subsequent development of the blot using 
secondary antibody and appropriate colour development solution.
(a) SDS-Polyacrylamide Gel Electrophoresis:
Reagents:
1) Acrylamide solution: 3 0 %  acrylamide; 0.8% bis-acrylamide
2) 4 X  Stacking gel buffer: 60.5 g/litre Tris base, adjusted to p H  6.7; 0.4% S D S
3) 4 X  Separating gel buffer: 181.6 g/litre Tris base, adjusted to p H  8.8; 0.4% 
S D S
4) T E M E D
5) 10% A m m o n i u m  persulphate
6) 5 X  S D S - P A G E  running buffer: 60.5 g/litre Tris base; 37.5 g/litre glycine; 
0.5% S D S
7) PBS: 8 g/litre NaCl; 0.2 g/litre KC1; 0.2 g/litre K H 2P 0 4; 1.15 g/litre 
N a2H P 0 4 p H  7.3
8) 2 X  S D S - P A G E  loading buffer: 75 m M  Tris.Cl, p H 6.8, 5 %  2- 
mercaptoethanol, 2 %  SDS, 0.002% bromophenol blue
stored at -70°C until required.
3.2.3) Detection of proteins on SDS-polyacrvlamide gels with antibodies:
S D S - P A G E  gels were prepared using a B R L  Vertical kit (model V I 6-2). Most of the 
gels used in these experiments consisted of two parts: a lower separating gel and an 
upper stacking gel. Stacking gel was always prepared using 5 %  acrylamide. The 
percentage of acrylamide in the separating gel was determined by the size of the 
protein molecules to be separated: (1) a 3-5 %  separating gel gives optimum separation
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of protein molecules larger than 100 kDa; (2) a 5-12% separating gel optimises the 
separation of protein molecules of 30 kDa-150 kDa; (3) a 10-15% separating gel will 
optimise the separation of protein molecules of 10 kDa -80 k D a  and (4) a 15% 
separating gel (or larger) will optimise the separation of proteins smaller than 15 kDa. 
Table 11 describes the production of the separating and stacking gels, commonly used 
in this project.
The two glass plates were washed with cleaning powder, rinsed thoroughly in 
distilled water and ethanol and spacers of 1.5 m m  thickness were inserted between 
them and held in place by bulldog clips, to form the sides and bottom of the gel. A  
40 ml volume of the appropriate percentage separating gel was prepared and 
immediately poured between the glass plates, leaving upto 4cm space from the top. 
To form a sharp edge to the separating gel 500 p i of water-saturated butan-l-ol was 
overlayed and the gel was left to polymerise for 30 minutes. W h e n  the gel had set 
the butan-l-ol layer was taken off and after washing the traces of butan-l-ol, 5%  
stacking gel was poured. A  20 well comb was inserted immediately and the gel was 
allowed to set for 20 minutes. W h e n  the gel had set the comb, bottom spacer and 
bulldog clips were removed and the glass plates with gel were placed into the B R L  
Vertical ldt tank apparatus and held in place by bulldog clips. 1 X  S D S - P A G E  
running buffer was added to both the upper and lower reservoirs.
Samples of recombinant plasmid clones were initially grown as 2 ml L-broth 
overnight cultures and then 1 ml aliquot of these overnight cultures were pelleted by 
centrifuging in an eppendorf tubes at 14,000 rpm at 4°C for 2-3 minutes. The pellets 
were resuspended in 500 p i volumes of PBS. Samples were repelleted in 100 p i
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Table 11: Recipes for SDS-PAGE gels
5%
Stacking
Gel
Percentage of Separating Gels
7.5 % 10% 12% 15 % 20%
30% Acrylamide 5.0 ml 10.0 ml 13.0 ml 16.0 ml 20.0 ml 26.0 ml
4 X Stacking 
Gel Buffer 7.5 ml - - - - -
4 X Separating 
Gel Buffer - 10.0 ml 10.0ml 10.0 ml 10.0ml 10.0ml
distilled
water 17.0 ml 19.5 ml 16.5 ml 13.5 ml 9.5 ml 3.5 ml
TEMED 30.0 Ail 30.0 Ail 30.0/ul 30.0/ul 30.0jul 30.0/11
10% Ammonium 
persulphate
300/11 400 jul 400 jul 400 ;ul 400Ail 400/11
TOTAL VOLUME 30 ml 40 ml 40 ml 40 ml 40 ml 40 ml
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volumes of 1 X  S D S - P A G E  loading buffer, boiled for 5 minutes and loaded on the 
gel. Crude protein lysate samples of recombinant gtl 1 clones were simply mixed 
with an equal volumes of 2 X  S D S - P A G E  loading buffer and boiled for 5 minutes 
prior to loading. For comparison of molecular weights, an aliquot of a standard 
protein marker mixture (Table 12) was loaded in all the gels.
Electrophoresis was carried out at 80 V  for 2 hours through the stacking gel 
and then at 160 V  for 2 hours through the separating gel, i.e. until the tracking dye 
was within 1 c m  from the bottom of the edge of the gel.
(b) Western Blotting of SDS-Polyacrylamide Gels:
Reagents:
1 X  Electroblotting buffer: 3.03 g/litre Tris base; 14.4 g/litre glycine; 2 0 %  (v/v)
methanol
Procedure:
Following electrophoresis, the S D S - P A G E  gel was removed from the 
electrophoresis tank and incubated in a 500 ml volume of 1 X  electroblotting buffer, 
for 30 minutes. T w o  sheets of Whatman No.l filter paper and a nylon membrane 
(Hybond N  from Amersham) were cut to the size of the S D S - P A G E  gel and were 
incubated in electroblotting buffer. For the transfer of proteins from the S D S - P A G E  
gel to the nylon membrane, the gel filter papers and nylon membrane were placed in 
an electroblot gel holder (Bio-rad Trans-blot cell) in the following order: filter pad 
saturated with an electroblotting buffer; a sheet of buffer saturated filter paper; the
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Table No. 12 : Standard Protein Marker Mixtures:
Marker Mixture Proteins Molecular Weight
High molecular weight Myosin (rabbit muscle) 205000
standard protein B-galactosidase ( E .  c o l i) 116000
mixture (Sigma) phosphorylase b (rabbit
muscle) 97400
albumin (bovine) 66000
albumin (egg) 45000
carbonic anhydrase 
(bovine erythrocytes) 29000
L o w  molecular weight albumin (bovine) 66000
standard protein albumin (egg) 45000
mixture (Sigma) glyceraldehyde-3-phosphate
dehydrogenase 
(rabbit muscle) 36000
carbonic anhydrase 
(bovine 29000
erythrocytes) 
trypsinogen 
(bovine pancreas) 24000
trypsin inhibitor 
(soyabean) 20100
ce-lactalbumin 
(bovine milk) 14200
Coloured Markers:
Mid range Colour M . W .
Myosin blue 200000
phosphorylase b brown 92500
bovine serum albumin red 69000
ovalbumin yellow 46000
carbonic anhydrase orange 30000
trypsin inhibitor green 21500
lysozyme magenta 14300
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buffer saturated S D S - P A G E  gel; buffer saturated nylon membrane; a second buffer 
saturated filter paper followed by a second buffer saturated filter pad. The electroblot 
gel holder was then closed and placed within the electroblotting tank with the SDS- 
P A G E  gel facing the cathode. The tank was filled with 1 X  electroblotting buffer 
(approximately 3 litres) and blotting was carried out at 30 V  overnight at 4°C, 
followed by 60 V  for 1 hour at 4°C. Subsequently the nylon membrane was used for 
the detection of proteins of interest with the use of monoclonal antibodies.
(c) Screening Western Blots with Monoclonal Antibodies:
Reagents:
(1) TBS: 50 m M  Tris-HCl, p H  7.5; 150 m M  NaCl
(2) TBST: 50 m M  Tris-HCl, p H  7.5; 150 m M  NaCl; 0.05% Tween 20
(3) BSA: Bovine serum albumin
(4) Primary antibody: Monoclonal antibody - C M A  134.1
(5) Secondary antibodies: Biotin conjugated-secondary antibody
(6) Colour development solution: Horseradish peroxidase
20 ml methanol +  60 m g  4-chloro-l-naphthol, dissolved completely 
and added to 100 ml of T B S  containing 15 p i H 20 2.
Procedure:
Following blotting the nylon membrane was removed from the blotting 
apparatus and incubated for 60 minutes in a solution of T B S T  containing 3 %  BSA, 
to saturate the non-specific protein biding sites on the filter. The filter was then 
removed from the blocking solution and incubated for 1 hour in a solution of T B S T  
with 3 %  B S A  and an appropriate dilution of the primary antibodies to be used. After 
1 hour incubation with primary antibodies the filter was washed twice with T B S T  for 
5 minutes each and then incubated in T B S T  containing the secondary antibodies. 
Following incubation in T B S  for 1 hour (to remove unbound secondary antibodies),
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the filter was incubated in the appropriate colour development solution and antigenic 
proteins were detected as coloured bands on the filter.
The protein marker bands can be located by staining the S D S - P A G E  gel, 
which was not used for blotting. If coloured protein markers were used then they 
automatically transferred on the nylon membrane and were cut out separately before 
using the membrane for the protein detection using antibodies.
(d) Protein Staining of SDS-Polyacrylamide Gels:
Reagents:
P A G E  Blue 83 Stain: 0.2% P A G E  Blue 83 prepared in 9 5 %  ethanol.
Destain solution: 4 5 %  methanol; 10% acetic acid.
Procedure:
The SDS-Polyacrylamide gels, if not Western blotted, were stained with 
P A G E  Blue 83 dye in order to visualise the separated protein bands from sample or 
from protein marker bands. Immediately prior to use, the P A G E  Blue 83 stain is 
mixed with an equal volume of 2 0 %  acetic acid and the S D S - P A G E  gel is then 
incubated in this solution for 3 hours. The stained gel is then incubated in the destain 
solution until no further dye is removed from the gel (usually overnight on shaker) 
and the protein bands can be visualised.
3.2.4) Gel electrophoresis of R N A :
Three methods frequently used to separate small molecular weight R N A s  
under denaturing conditions are formaldehyde gel electrophoresis, glyoxal gel 
electrophoresis and urea/polyacrylamide gel electrophoresis. In this chapter 
formaldehyde gel electrophoresis method (Miller, 1988) was used to separate R N A
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molecules which were then transferred on to nylon membrane (Northern blotting) and 
fragments of interests were detected using single stranded D N A  probes.
Buffers:
(1) 10 X  M O P S / E D T A  (pH 7.0): 0.5 M  M O P S ;  0.01 M  N a2E D T A ,  adjust to 
pH7.0 with N a O H
(2) Buffer A: 2 9 V  10 X  M O P S / E D T A  (pH 7.0); 706 p i H 20
(3) formaldehyde/formamide: 89 p i formaldehyde (37%, 12.3 M); 250 p i  
formamide
(4) Dyes: 322 p i Buffer A; 5 m g  xylene cyanol; 5 m g  bromocresol green; 400 m g  
sucrose
(5) Gel loading buffer: 2 p i formaldehyde (37%, 12.3 M); 5 p i formamide; 7 p i  
dyes
(6) Electrophoresis buffer: 1 X  M O P S / E D T A  (pH 7.0)
(a) Sample preparation:
The R N A  samples were ethanol precipitated, as described in section 2.20.4, 
and resuspended in 1 p i volume of DEPC-treated autoclaved distilled water. To each 
of the sample 4.4 p i of buffer A, 11.6 p i of formaldehyde/formamide solution were 
added. Tubes were heated at 70°C for 10 minutes and chilled immediately on ice to 
denature R N A .  Following the addition of 1.5 p i of gel loading buffer to each tube, 
samples were mixed and loaded on formaldehyde agarose gel for electrophoresis.
(b) Gel preparation and electrophoresis:
Electrophoresis was performed on an 11 x 14 c m  horizontal submarine gel 
(BRL Model No.H5). 1.5% agarose/formaldehyde gel was prepared by dissolving 
0.75 g agarose in 36 ml of DEPC-treated water and cooled to 70°C. Five ml of 10 
X  M O P S / E D T A  (pH 7.0) and 9 ml of 3 7 %  formaldehyde (final concentration of 2.2 
M )  were added to molten agarose gel and the gel was cast in a fume hood and 
allowed to set for at least 1 hour at room temperature. Gel was pre-electrophoresed
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in 1 X  electrophoresis buffer at 60V for 3 minutes before loading the samples. 
Samples were electrophoresed at 100V until the bromocresol green dye had migrated 
8cm. Electrophoresis buffer was mixed and redistributed after every 45 minutes.
(c) Staining, Destaining and Photography:
After electrophoresis the gel was stained for 10 minutes in 0.5 jug/ml ethidium 
bromide in DEPC-treated water. Destaining in D E P C  treated water was done in the 
dark at 4°C for overnight and the gel was then photographed on a shortwave U V  
transilluminator using an orange photographic filter and polaroid film and camera.
(d) Northern Blotting:
As the staining and destaining of electrophoresed R N A  inhibits complete and 
effective transfer of R N A  from gel on to the nylon membrane, two sets of R N A  
samples were loaded; one set was used for staining and photography and the second 
set was used for Northern blotting without staining.
Reagents/Buffers:
(1) 20 X  SSC: 3 M  NaCl; 0.3 M  N a 3citrate
(2) 50 X  Denhardt’s solution: 1 %  (w/v) BSA; 1 %  (w/v) ficoll; 1 %  (w/v)
polyvinylpyrollidon
(3) Prehybridization/Hybridization Buffer: 5 %  formamide; 5 X  SSC; 25 m M
NaPhosphate buffer (pH 6.8), 5 X  Denhardf s solution
Setting up a capillary blot (Maniatis e t  a l . ,  1982):
The tray which was filled with blotting buffer (20 X  SSC) contained a 
platform covered with a wick made from two sheets of Whatman 3 M M  filter paper, 
saturated with blotting buffer. Following the electrophoresis of R N A ,  the gel was 
inverted and placed on the wick. Care was taken to avoid trapping air bubbles
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beneath it. The gel was surrounded with parafilm to prevent the blotting buffer being 
absorbed directly into the paper towels above. A  sheet of Hybond-N nylon 
membrane was cut to the exact size of the gel, prewetted with blotting buffer and 
placed on top of the gel, again avoiding any air bubbles by rolling a glass rod on the 
membrane. Three sheets of Whatman 3 M M  paper cut to exact size were prewetted 
with blotting buffer and placed on top of the nylon membrane. A  stack of absorbent 
paper towels (approximately 5 c m  high) was placed on top of the 3 M M  paper. A  
glass plate was put on the top of paper towels followed by c. 1 K g  weight. Transfer 
of R N A  from the gel on to the nylon membrane was allowed to proceed for 12-16 
hours (usually overnight). After blotting, the apparatus was dismantled carefully. 
Before removing the membrane from the gel, it was marked with pencil to allow later 
identification of tracks. The membrane was washed briefly in 2 X  S S C  solution and 
air dried. The R N A  was fixed on the membrane by exposing the membrane to U V  
light for 3 minutes and then baking at 80°C  for 1 hour.
(e) Procedure for filter hybridization:
Single stranded end labelled D N A  probes were prepared as described in 
section 2.23.2.2 and used for detecting specific R N A  transcripts on the Northern blot. 
The blot was prehybridized with 5-7 ml of prehybridization solution at 65 °C for 2 
hours to block the binding of probe at nonspecific sites. Single stranded D N A  probe 
was added to the prehybridized membrane and hybridization was carried out at 65 °C 
for 12-16 hours. Following hybridization, the probe was removed and the membrane 
was washed twice with 3 X  S S C  containing 0.1% S D S  at 55°C for 10 minutes each. 
For a medium stringency wash the membrane was washed twice with 1 X  SSC
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containing 0.1% S D S  at 55°C for 30 minutes each. Finally the membrane was rinsed 
with 3 X  SSC, drip dried and covered with saran wrap before exposing it to X-ray 
film for autoradiography. The film was developed after overnight exposure at -70°C, 
fixed and dried according to the manufacturers instructions.
3.2.5) Sequence analysis:
D N A  sequencing of M 1 3  subclones was carried out using the dideoxy 
procedure as described in section 2.24 and the data were assembled and analysed with 
the ’Staden-plus’ software (Amersham).
S
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The lambda gtll library of M .  b o v is  was constructed by Collins, M.E. and 
Wall,S. The procedure used was based on that described by Huynh e t  a l . (1985). 
D N A  was extracted from M .  b o v i s  as described by Zainuddin and Dale (1989) and 
fragmented by repeated passage through a syringe needle until the major part of the 
D N A  was between 2 and 9 kb. The fragments were end-filled using T4 polymerase 
and internal E c o  RI sites protected by methylation with E c o  RI methylase before 
addition of E c o  RI linkers and digestion with E c o  RI restriction enzyme. The D N A  
was then size fractionated on a 0.8% agarose gel, collecting fractions between 2.3 and 
9 kb. Fragmented D N A  was ligated with lambda gtll arms and i n  v i t r o  packaged, 
in two sets, using a Gigapack kit (Vector Cloning Systems), yielding libraries.
Both the libraries were screened by the monoclonal antibody C M A  134.1 for 
the 19 kDa protein antigen and one positive clone which reacted specifically with 
C M A 1 3 4 . 1  was plaque purified. Subcloning of the insert was done in p U C 1 8  as 
described by Collins e t  a l . (1990) and figure 2 shows the structure of different 
recombinant subclones.
T o  confirm the nature of the expression product, lysogens were produced by 
infecting E .  c o l i Y1089 and testing for the inability to form colonies at 42°C. Initial 
attempts to form lysogens using the phage:bacterium input ratio of 10:1 were 
unsuccessful and thus this input ratio was increased to approximately 100:1 (Moss, 
1987). One hundred and fifty colonies were selected and replica plated. One set was 
incubated overnight at 30°C and the other was at 42°C. T w o  colonies failed to grow 
at 42°C and these were picked up from the plate which was incubated at 30°C.
RESULTS AND DISCUSSION:
109
F igu re  2: S tru c tu re  o f recom binan t clones o f  19 kD a an tigen  gene 
a) C lone M B8.1.1 from  phage library
IC E  IC
b) pU S30
Pst IC
P st
J 1
P st
J 1
E N  Pvu S
Agtn
E N  Pvu S Pvu
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c) pUS31
P st IC
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Key: E  - E co R l, IC - K pn  I, N  - N de I, S - Sst I, E  - E co R l  s ta r  activity
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These two lysogens were again checked for their inability to grow at 42°C. Crude 
protein extracts from these two lysogens were prepared as described in section 3.2.3. 
To check the inducibility of the expression, crude protein extracts of IPT G  (final 
concentration 10 m M )  induced and non-induced lysogens were prepared. Along with 
these, extracts of E .  c o l i Y1089 were prepared and electrophoresed on SDS- 
Polyacrylamide gel. The proteins were Western blotted on nylon membrane, non­
specific sites were blocked by B S A  and primary monoclonal antibody C M A  134.1 was 
used ( l O p l of 10"4 dilution) for detecting induced and non-induced 19KDa protein 
antigen. Figure 3 shows the Western blot of induced and non-induced lysogens along 
with crude protein extract of E .  c o l i Y1089 as a negative control. The presence of 
19 kDa band confirmed the expression of the mycobacterial gene in E .  c o l i . These 
results also showed that the expression was inducible, indicating that the cloned gene 
was transcribed from the l a c  promoter in the recombinant lambda gtll lysogens 
although with a significant level of constitutive expression. The 22 kDa band in all 
the tracks including Y1089 is a non-specific reaction due to the E .  c o l i biotin carrier 
protein which has a monomer size of 22 kDa (Fall &  Vagelos, 1972; Collins e t  a l ,
1987).
The orientation of the gene was established by the inducibility of the gtll 
lysogen as shown in figure 3 and confirmed by Northern blot analysis using single 
stranded D N A  probes. R N A  was extracted from a clone carrying pUS32 clone 
(Fig.2) and E .  c o l i JM109 using two different methods, as described in section 2.20.4 
and 2.20.5. Hot phenol method gave better yield of R N A  than the RNAzol method. 
However, D N A  contamination was seen in R N A  isolated by either method. To
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Figure 3: Western blot of induced and non-induced lysogens of E .  c o l i with m A b  
C M A 1 3 4 . 1
Lane 1: Molecular weight marker
2: Lysogen no. 42 - IPTG induced 
3: Lysogen no. 49 - IPTG induced 
4: Lysogen no. 42 - non-induced 
5: Lysogen no. 49 - non-induced 
6: E .  c o l i Y1089
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remove D N A  from R N A  samples RNase free DNase I (Pharmacia) was used and 
optimum concentration and time was standardised. Fifteen units of enzyme for 10 
minutes at 37 °C was found to remove D N A  completely and showed no detectable 
RNase activity. Following DNase treatment R N A  samples were electrophoresed in 
formaldehyde gel in three different sets. First set was used for staining, destaining 
and photography (Fig. 4). The second and third set was Northern blotted and probed 
with two different single stranded probes. The single stranded probes were prepared 
as given in section 2.23.2.2. Figure 5b and 5c show the orientations of the two 
single stranded probes with respect to the l a c  promoter in the clone pUS32. The two 
single stranded probes were hybridised with two sets of Northern blots and filters 
were washed and exposed to X-ray film.
Figure 4b shows the autoradiograph of two Northern blots. Probe P2 showed an 
intense signal at approximately M W  of 800 bp. The high M W  bands may indicate 
the slight contamination of D N A  in the R N A  samples even after DNase treatment. 
If DNase treatment is carried out for a longer time or with more enzyme then RNase 
activity was detected by gel electrophoresis showing staining of R N A  samples in the 
form of longer smear as compared to untreated samples. Probe S A 4  did not give a 
strong hybridization signal which confirmed the orientation of the insert. The size 
of a transcript was approximately 800 bp which would allow scope for a considerable 
leader region indicating that transcription may be occurring from a promoter within 
the vector. The sequence of pUS32, which does not contain l a c  promoter was 
examined for possible E .  c o l i promoters and the only candidate was the region, 
upstream from the origin of replication, where primer R N A  was initiated.
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Figure 4: a) 1.5% agarose - formaldehyde 
gel photograph showing R N A  from
Lane 1: E .  c o l i carrying pUS32 
2: E .  c o l i JM101
b) Autoradiographs of Northern 
blots: i) Probe - S A 4  S S D N A  
ii) Probe - P2 S S D N A  
Lanes 3,5 - E .  c o l i R N A  
Lanes 4,6 - R N A  from E .  c o l i  
carrying pUS32.
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Figure 5: a) Sequencing strategy for 19 kDa antigen gene
Smal Smal
j_______ | 100 bp
, P ro m o te r G en eo rien ta tio n
5    3 ’
b) S ingle stranded  p robe  from  P2 D N A :
3’ «    5’
c) S ingle stranded  p robe from  SA4 DNA:
5’ * 3’
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For D N A  sequence determination, various M 1 3  subclones were prepared by 
Collins, M.E. and Wall, S. The 900 bp Nde I-Pst I fragment of pUS32 was end- 
filled and blunt end ligated with S m a  I cut M13mpl8. Initial sequencing of these 
clones was done using Universal primer which showed an internal Stu I site, which 
was used to clone a K p n  I-Stu I fragment in M13mpl9. Figure 5a shows, the 
sequencing strategy used to obtain the complete sequence of the fragment and figure 
6 shows the complete sequence of the 841 bp fragment.
From the sequence analysis only one open reading frame of required size, 
extending from position 21 to 581 (Fig. 6), was identified as a probable coding region 
by the positional base preference procedure of Staden (1984). Although there is no 
A U G  start codon within this ORF, there is a G U G  codon at position 102 and a 
putative ribosome-binding site ( A A A G G A G )  lying six bases upstream. G U G  
sequences have been reported as start codons in several other mycobacterial genes 
(almost 5 0 %  genes sequenced so far) (Dale &  Patki, 1990). This could be correlated 
to the high G + C  content of mycobacteria. The translation product initiated from this 
position consists of 159 amino acids, with a calculated molecular mass of 15115 Da. 
This is significantly less than the observed size of 22 kDa in M .  b o v i s  and 19-20 kDa 
for the recombinant E .  c o l i product, which could be due to different post-translational 
modifications and/or anomalous behaviour of the protein on SDS-Polyacrylamide gels.
The base composition of this sequence is typical of mycobacteria, and the 
codon usage (Table 13) also shows the high degree of codon bias normally seen in 
these organisms. If an analysis of all published mycobacterial sequences is done then 
this could well fit in to the studies done by Muto and Osawa (1987) on G + C  content
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GAATTTTCCGCCGCACCTAGACCTCGGGCCCTGCTAACGCGCATACTGCCGAAGCGGTCC 
10 20 30 40 50 60
V K R G L T V 
TCAATGCCGATGGACCGCTACGACAGGCAAAGGAGCACAGGGTGAAGCGTGGACTGACGG 
70 80 — *  100 110 120
A V A G A A I L V A G L S G C S S N K S  
TCGCGGTAGCCGGAGCCGCCATTCTGGTCGCAGGTCTTTCCGGATGTTCAAGCAACAAGT 
130 140 150 160 170 180
T T G S G E T T T A A G T T A S P G A A  
CGACTACAGGAAGCGGTGAGACCACGACCGCGGCAGGCACGACGGCAAGCCCCGGCGCCG 
190 200 210 220 230 240
S G P K V V I D G K D Q N V T G S V V C  
CCTCCGGGCCGAAGGTCGTCATCGACGGTAAGGACCAGAACGTCACCGGCTCCGTGGTGT 
250 260 270 280 290 300
T T A A G N V N I A I G G A A T G I A A  
GCACAACCGCGGCCGGCAATGTCAACATCGCGATCGGCGGGGCGGCGACCGGCATTGCCG 
310 320 330 340 350 360
V L T D G N P P E V K S V G L G N V N G  
CCGTGCTCACCGACGGCAACCCTCCGGAGGTGAAGTCCGTTGGGCTCGGTAACGTCAACG 
370 380 390 400 410 420
V T L G Y T S G T G Q G N A S A T K D G  
GCGTCACGCTGGGATACACGTCGGGCACCGGACAGGGTAACGCCTCGGCAACCAAGGACG 
430 440 450 460 470 480
S H Y K I T G T A T G V D M A N P M S P  
GCAGCCACTACAAGATCACTGGGACCGCTACCGGGGTCGACATGGCCAACCCGATGTCAC 
490 500 510 520 530 540
V N K S F E I E V T C S *  
CGGTGAACAAGTCGTTCGAAATCGAGGTGACCTGTTCCTAACCTAAAGCGTGTCGATGCG 
550 560 570 580 590 600
GGCTGTGAACAGCGCGTCGGAGCCGGGCAGTCAGGCCTAGCGCGGCGACGATTCGAGCGG 
610 620 630 640 650 660
 > <-------
TTGCCATCCGTCAAGTGGCAACCCGACCGCAAACTCGGTATATCCGGGTGAGCTACTCAC 
670 680 690 700 710 720
GGTGATCGTTCCGTTGTTCGGCCTTGACCACAGCGGAGACGATCGCCAGGCCGAGCCCGG 
730 740 750 760 770 780
TGCTACCGCTTGGCCGGGACCGTGACGTATCGCCGCGGGCAACCGCTCGAAAACCTCGGA 
790 800 810 820 830 840
C*
Figure 6 : Nucleotide sequence of the M .  b o v i s  19 kDa 
antigen gene. The underlined sequence is the presumptive 
ribosome-binding site and the arrows indicate a potential 
stem-loop structure. The deduced amino acid sequence is 
shown in one-letter code.
1 1 7
Table 13: Codon usage of the M. bovis 19 kDa antigen gene
F TTT 0. S TCT 0. Y TAT 0 . C TGT 2 .
F TTC 1. S TCC 5. Y TAC 2 . C TGC 1 .
L TTA 0. S TCA 2 . * TAA 1 . * TGA 0 .
L TTG 0. S TCG 4. * TAG 0 . W TGG 0 .
L CTT 1. P CCT 1. H CAT 0 . R CGT 1 .
L CTC 2 . P CCC 1. H CAC 1 . R CGC 0 .
L CTA 0. P CCA 0. Q CAA 0 . R CGA 0 .
L CTG 3 . P CCG 4. Q CAG 2 . R CGG 0 .
I ATT 2 . T ACT 2. N AAT 1 . S AGT 0 .
I ATC 5. T ACC 11. N AAC 9. S AGO 4 .
I ATA 0. T ACA 2 . K AAA 0 . R AGA 0 .
M ATG 2 . T ACG 6 . K AAG 8 . R AGG 0 .
V GTT 1. A GCT 1. D GAT 0 . G GGT 5.
V GTC 9. A GCC 10. D GAC 5. G GGC 1 0 .
V GTA 1. A GCA 4. E GAA 1 . G GGA 6 .
V GTG 7. A GCG 6 . E GAG 3 . G GGG 5.
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of microorganisms and evolution. Detailed analysis of this sequence for structural 
motifs revealed one possibly significant hairpin loop structure formed by an 8 base 
inverted repeat starting at position 659 (Fig. 6). This is about 80 bases beyond the 
putative stop codon, and could be involved in transcriptional termination. The 
inverted repeat is not accompanied by a following run of U  residues; the high G + C  
content of mycobacteria may encourage the preferential use of terminators resembling 
those rho-dependent terminators of E. coli that do not have a sequence of U  residues.
The sequence of the 19 kDa antigen gene was analysed and searches of 
Genbank, E M B L  and N B R F  databanks were carried out by means of the U W G C G  
package and Wordsearch program (Wilbur and Lipman, 1983; Devereux e ta l., 1984) 
and the N A Q  program from the Protein Information Resource. The sequence did not 
show homology with any other sequence/s except to that of the 19 kDa antigen 
sequence from M. tuberculosis published by Ashbridge et al. (1989). D N A  homology 
shows complete identity between M. bovis and M. tuberculosis 19KDa antigen. Other 
studies have also shown a high degree of homology between these organisms (Wayne, 
1984, Grosskinsky, 1989) and between M. tuberculosis and M. bovis B C G  (Shinnick, 
1987; Thole et al., 1987; Baird et al., 1989; Shinnick et al., 1989; Yamaguchi et al.,
1988), this study provides further support for the view that M. bovis and M. bovis 
B C G  can be used for the initial molecular studies.
4) C L O N I N G  A N D  S E Q U E N C I N G  O F  T H E  D I H Y D R O F O L A T E  R E D U C T A S E  
( D H F R )  G E N E  F R O M  M Y C O B A C T E R IU M  T U B E R C U L O S IS
\
The aim of the work described in this chapter is to clone and express the 
D H F R  gene from M. tuberculosis. Folic acid biosynthesis is one of the important 
steps involved in the metabolism of any living organism. Para-aminosalicylic acid 
(PAS) and dapsone (Diaminodiphenylsulfone or DDS) are supposed to be the 
inhibitors of the pteroic acid synthetase of M. tuberculosis and M. leprae respectively 
(Seydel et a l., 1988). The question is if a further increase in activity can be achieved 
by using another inhibitor in the folic acid biosynthetic pathway. D H F R  is a suitable 
candidate enzyme for the development of new drugs. Once the gene is cloned and 
expressed in E. coli it will be easier to purify the enzyme on a large scale and study 
its enzymatic and biochemical properties. Also nucleic acid and amino acid sequence 
will throw light on other properties of the enzyme. It will be possible to predict 
amino acids involved in the active site of the enzyme by performing X-ray 
crystallographic and site-directed mutagenetic studies. This will be of great help in 
designing new compounds which will inhibit D H F R  from mycobacteria more 
effectively and will help in better chemotherapy.
4.1) INTRODUCTION:
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4.2.1) Isolation of M. bovis B C G  D N A :
M. bovis B C G  D N A  was isolated from 100 ml culture as described in section
2.20.1. The concentration and purity of D N A  was checked spectropho to metrically 
and by agarose gel electrophoresis. This D N A  was subsequently used for restriction 
endonuclease digestion with various restriction endonucleases, for Southern blot 
hybridisation using different radiolabelled D N A  probes such as clone pAGlOl D N A  
(pUC18 carrying 1.1 kbp D H F R  fragment of E. coli) (Howell et al., 1988), P C R  
product and for P C R  as a target DNA.
4.2.2) Polymerase chain reaction (PCR): %
The typical polymerase chain reaction was set up in a sterile air cabinet as 
follows:
4.2) MATERIALS AND METHODS:
P C R  mix
primers (250ng//xl)
Taq polymerase (0.625U) 
M.bovis B C G  D N A  (2ng) 
distilled water
40 pi 
2+2 p i
2 pi 
1 p i
3 p i
(i) P C R  mix:
dNTP’s (1.25 m M  each) 
10 X  Taq reaction buffer 
distilled water
5 pi 
37 pi
8 pi
(ii) 10 X  Taq reaction buffer:
KC1
Tris.HCl (pH 8.3) 
MgCl2 
gelatin (w/v) 
Tween 20
500 m M  
100 m M  
15 m M  
0 . 1 % 
0.05%
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The tube was centrifuged for 5 seconds, greased lightly at the bottom and 
placed in the heating block. A  programme was selected depending on the annealing 
temperature and reaction was started.
Programme 1:
Denaturation 94°C - 0.30 min
Denaturation 94°C - 0.30 min
Annealing 68°C - 0.15 min
Synthesis 72°C - 2.00 min
30 cycles
Annealing 68°C - 0.15 min
Synthesis 72°C - 5.00 min
In addition to 68°C, the following annealing temperatures were used for the 
reactions: 37°C, 42°C, 45 °C, 52°C, 58°C, 65 °C and 68°C. After completion of the 
reaction, samples were removed from the heating block, mixed with gel loading dye 
and loaded on a 1.5% or 2% agarose gel and electrophoresed, stained and 
photographed. The specific D N A  band of interest was excised from the gel and D N A  
was eluted using Geneclean kit.
4.2.3) Screening of EMBL4-M. tuberculosis library:
The titre of the EMBL4-M. tuberculosis library which was prepared by 
Zainuddin (1988) was determined. The library was plated on two large bio-assay 
plates using E. coli LE392 as a host strain for screening. Resulting clones were 
plaque blotted on Hybond-N nylon membrane and used for plaque blot hybridization 
(section 2.23.1), using P C R amplified, gene cleaned D N A  as a radiolabelled probe. 
Radiolabelling, hybridization and washing of filters were performed according to
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section 2.23. The first screening resulted in few strong signals on the X-ray film. 
However, it was difficult to pick up the corresponding plaques from the bio-assay 
plates, since the plaques were too close to each other. To obtain pure phage clones, 
these positive clones were picked and again plated on smaller plates at lower 
densities. This resulted in isolated plaques which were again blotted and used for 
plaque blot hybridization. This is often known as a second round of screening. The 
third round of screening resulted in pure phage clones showing hybridization with the 
radiolabelled P C R  derived D N A  probe. Phage D N A ’s were isolated from four 
positive clones by two different methods as given in section 2.20.6 and digested with 
different restriction endonucleases to construct a restriction map.
4.2.4) Subcloning in plasmid pUC19:
Clone 31 D N A  was digested with restriction endonuclease Bam HI, 
electrophoresed through 1% agarose gel and 6.0 kbp and 7.8 kbp fragments were 
purified from the agarose gel using Geneclean kit (2.22).
pUC19 plasmid D N A  was isolated using a cleared lysate method (2.20.3) and further 
purified using CsCl-ethidium bromide gradient ultracentrifugation. Ligation of 6 kbp 
Bam HI fragment with Bam HI digested pUC19 was carried out as described in 
section 2.18. Following the transformation using E. coli DH 5a cells (2.19.3.1), six 
transformants were selected, grown in LB broth containing ampicillin (final 
concentration of 50 pg/ml) and plasmid D N A  were extracted using alkaline lysis 
method (2.20.2). All six clones were confirmed as containing a 6 kbp insert by 
restriction enzyme digestion with Bam HI and electrophoresis on a 1 %  agarose gel. 
A  restriction map of one such clone pUS102 was constructed using six different
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restriction endonucleases. Further subcloning of smaller fragments was done in 
pUC18 and pUC19 to obtain following recombinant clones:
i) Clone pUS141 - contains a 4kbp Eco RI-Bam HI fragment in pUC18, ii) 
Clone pUSI53 - contains a 2.7 kbp Bam HI-Kpn I fragment in pUC18 and iii) Clone 
pUS155 - contains a 2.7 kbp Bam HI-Kpn I fragment in pUC19, to study the 
expression of the putative D H F R  gene.
4.2.5) Isolation of R N A  from E. coli carrying plasmid clones:
Total R N A  extraction was performed from different E. coli cells carrying 
plasmid clones namely pUS102, pUS141, pUS153, pUS155 and pUC18 by two 
different methods as described in section 2.20.4 and 2.20.5. In the second set of 
R N A  extraction all these cultures were grown in presence of the inducer IPTG. R N A  
was electrophoresed in formaldehyde agarose gels (in denaturing conditions) and 
Northern blotted using Hybond-N nylon membrane. The Northern blot was 
prehybridized and then hybridized with purified 6 kbp insert D N A  from clone 
pUS 102 radiolabelled with [o:-32p]dCTP using multiprime D N A  labelling kit (section 
2.23).
4.2.6) Isolation of crude protein extracts and inclusion bodies:
Crude protein extracts and inclusion bodies from E. coli cells containing 
various plasmid clones were prepared according to section 2.25. Plasmid clones 
include (i) pUS102, (ii) pUS141, (iii) pUS153, (iv) pUS155 and pUC18, pUC19 as 
negative controls. All these clones were grown in LB broth containing ampicillin 
(final concentration of 50 jug/ml). Crude protein extracts from E. coli JM109 cells 
was also prepared as additional negative control. The second set of all these clones
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was grown in presence of 10 m M  IPTG as an inducer and then used for isolation of 
crude protein extract and inclusion bodies.
4.2.7) Complementation of E. coli (2>thv:kan cells:
E. coli strain JD418 (DHFR gene deleted, Howell et al., 1988) was used to 
study the complementation with plasmid pUS102. Plasmid pAGlOl (pUC18 
containing 1.1 kbp D H F R  fragment from E. coli) was extracted using small scale 
plasmid extraction procedure (section 2.20.2) and used as a positive control in the 
complementation experiment. E. coli JD418 competent cells were prepared for 
transformation by growing cells in 2 X  T Y  medium (section 2.19.2) and 
transformation was carried out using Bio-rad Electroporator as described in section 
2.19.3.2. Transformed cells were plated on different media as discussed in section 
4.3.8.
4.2.8) Crude protein extract preparation for IEF gels and activity assay by sonication: 
E. coli DH5a and E. coli DH 5a containing pUC18, pUS102 and pUS141 cells
were grown in 10 ml LB broths containing 50 pg/ml ampicillin (except for DH5a 
cells) overnight at 37°C in a rotary shaker at a speed of 200 rpm. These cultures 
were used to inoculate 500 ml LB broths containing 50 pg/ml ampicillin (except for 
DH5ce cells) and grown overnight at 37°C shaking at a speed 200 rpm. Cells were 
harvested by centrifuging at 4000 rpm at 4°C for 20 minutes in Beckman J A M  rotor. 
Supernatants were decanted and pellets were resuspended thoroughly in 10 ml of ice 
cold Buffer A  (Tris.HCl pH7.2 - 50 mM , KC1 50 mM, B-mercaptoethanol 10 mM, 
E D T A  pH 8.0 - 1 mM). These suspensions were sonicated at medium power of 3 
amplitude and at 12 microns. Three pulses of 30 seconds each were given at the
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interval of 1 minute. Proper care was taken to maintain the suspensions on ice all the 
time and probe was cooled before and at all intervals. Sonicated extracts were then 
centrifuged at 15000 rpm for 60 minutes at 4°C to remove cell debris. Supernantants 
were collected and stored at -70 °C for further use.
Preformed IEF Phast gels of broad pH range (pH 3-9) from Pharmacia were 
used in the Phast-gel system to separate proteins from sonicated extracts. The typical 
programme used consists of cooling the bed, pre-focussing of gel before sample 
application, application of sample proteins via sample applicator and focusing of the 
applied proteins.
Programme 1:
Sep. 1.1 - 2000 V  2.5 m A  3.5 W  at 15°C for 75 Vhr
Sep. 1.2 - 200 V  2.5 m A  3.5 W  at 15°C for 15 Vhr
Sep. 1.3 - 2000 V  2.5 m A  3.5 W  at 15°C for 410 Vhr
Usually two gels were used for iso-electric-focusing. One gel was used for 
protein staining and the other gel was used for activity assay for DHFR. Protein 
staining of the gel was done using P A G E  blue 83 stain. Gel was destained overnight ' 
using destaining solution (45% methanol, 10% acetic acid). For activity assay the 
method described by Tennhammer-Ekman, and Skold, (1979) was used. Solution I 
(10 ml of 0.2 M  potassium phosphate buffer, pH 6.9; 1.2 m M  N A D P H  and 0.8 m M  
D H F  {Dihydrofolate} prepared in water) was added to the IEF gel and incubated at 
37°C for 5 minute. To this 60 p\ of 0.1 M  M T T  was added and incubated at 37°C 
for 45 minute in the dark. Following the incubation the gel was washed with 0.2 M  
potassium phosphate buffer (pH 6.9), dried with hair dryer and observed for blue
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band.
The sequence at the ends of the clone pUS102 was determined using plasmid 
sequencing method (section 2.24). The internal sequence was determined by 
subcloning 4 kbp Bam HI-Eco Rl fragment of clone pUS102 into M13mpl8 and 
M13mpl9 bacteriophage vectors as described in section 2.24. The internal primers 
were synthesized on oligonucleotide synthesizer and used for the sequencing. The 
sequence data were assembled and analyzed using Staden-plus software (Amersham).
4.2.9) Sequence determination of the insert:
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4.3.1) Isolation of M. bovis B C G  D N A :
M. bovis B C G  D N A  was isolated by the procedure described by Zainuddin 
and Dale (1989). From 100 ml of B C G  culture 200 pg of total D N A  was obtained. 
This D N A  was free of R N A  and protein, as shown by the optical density readings. 
Ten p\ D N A  was diluted to 500 pi with distilled water and % absorbance was 
measured at four different wavelengths.
O.D. readings of M. bovis B C G  D N A  (dilution factor of 50)
4.3) RESULTS AND DISCUSSION:
Five pg of M. bovis B C G  D N A  was digested with following restriction 
endonucleases - (i) Bam HI, (ii) Hind III, (iii) Kpn I, (iv) Pst I, (v) Pvu II and (vi) 
Sma I. Restriction enzymes were chosen on the basis of high G  and C base pairs in 
the sites with the exception of Hind III. These digested D N A  samples were 
electrophoresed through a 1% agarose gel and Southern transferred. A  larger 
average size by digestion with Hind III can be explained on the basis of recognition 
site for the enzyme Hind III (AAGCTT) contains only two G C  pairs. All other 
enzymes used have recognition sites which contain at least four G/C pairs.
Wavelength in nm % Absorbance
310
280
260
230
0.005
0.056
0.092
0.013
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For isolation of the dihydrofolate reductase gene from the EMBL4-M. 
tuberculosis library using D H F R  gene probe from E. coli, it was necessary to check 
the hybridization of the probe to the total DNA. M. bovis B C G  D N A  was used to 
check this gene homology, since (i) the isolation of M. tuberculosis D N A  is difficult 
and dangerous and (ii) M. tuberculosis and M. bovis B C G  are closely related at the 
genetic level.
M. bovis B C G  Southern blot was hybridized with radiolabelled pAGlOl D N A
probe. This gene probe contains a 1.1 kbp D H F R  fragment of E. coli. The
autoradiograph did not show any signal even after exposure for one week at
thCs
-70°C. From this experiment it can be concluded that the use of a D N A  probe which 
does not have high G + C  content is not suitable for Southern blot hybridization and 
for screening mycobacterial gene libraries, which have high G + C  content, at even 
low stringent conditions.
The second well known and widely used approach to derive a suitable gene 
probe is from the amino acid sequence of the gene product. From the amino acid 
sequence of a particular protein, one can derive a probable nucleotide sequence which 
can be used as a gene probe to identify a particular gene by screening genomic library 
or hybridization with Southern blot of total and digested DNA.
Isolation and purification of enzymes from M. tuberculosis is very difficult 
because of their slow growth rate and difficulty in extracting enzymes due to the 
nature of the cell envelope. It is difficult therefore to obtain amino acid sequence, 
which imposes a limitation in the use of the oligonucleotides as a probe. Although
4.3.2) Use of DHFR gene probes:
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D H F R  from Mycobacterium phlei and Mycobacterium, smegmatis have been purified 
and characterised (Al-Rubeai and Dale, 1986; Sirawaraporn et a l., 1991), the 
attempts for amino acid sequencing were unsuccessful and the D H F R  gene from 
mycobacteria or organisms related to mycobacteria (Corynebacteria, Streptomyces) 
has not been cloned. Hence there is no suitable gene probe available for screening 
of the gene library of M. tuberculosis for the D H F R  gene.
4.3.3) P C R  generated gene probes:
Saild et al. (1985) have devised a simple technique for specific D N A  
amplification, known as polymerase chain reaction (PCR). Repeated rounds of 
amplification can lead to 106 copies of a specific D N A  fragment being produced from 
a single molecule. This technique had been used for cloning of specific genes using 
selected sets of primers (Edman, et al., 1989a; Edman, et al., 1989b; Engel and 
Ganem, 1990; Vliegenthart, e ta l., 1990).
4.3.3.1) Design of primers for P C R :
There were four bacterial D H F R  genes sequenced completely (Andrews et a l., 
1985; Gleisner et al., 1974; Iwakura et al., 1988; Smith and Calvo, 1980). Table 14 
shows the homology comparison among these four sequences at amino acid level. 
Two marked regions show considerable homology among amino acid sequence. Also 
aspartate 27 of E. coli (Villafranca et a l., 1983) and of Lactobacillus casei (Jimenez 
et al., 1989) D H F R  is involved in folate binding and hence located in the active site 
of the enzyme. This aspartate 27 is highly conserved and probably plays the same 
role in the D H F R  from B. subtilis and S. faecium. Site directed mutagenesis on 
aspartate 27 of E. coli showed that the enzyme was inactivated if Asp 27 was
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Table 14: HOMOLOGY COMPARISON OF DHFR SEQUENCES
1 ) E coli M I S L I A A L A V D R V I G M E N A M
2 ) S faecium M F I S M W A Q D K N G L I G K D G L L
3) L • casei M T A F L w A Q D R D G L I G K D G H L
4) E subtilis M I S F I F A M D A N R L I G K D N D L
1 ) P W N L P A D L A w F K R N — T L D — K — P — _ V I M G R H T
2 ) P W R L P N D M R - F F R E H T M D - I< - I - L V - M G R K T
3) P w H L P D D L H Y F R A Q - T V - G K - I M V V - - G R R T
4) P w H L P N D L A Y F I< K I — T S — G H S I — — — I M G R K T
1 ) W E S I G - — - R P L P G R K N I I L S S Q P G T D R V T W V
2 ) Y E G M G I< L S L P Y - - R H I I V L T T Q K D F K L K N A E
3) Y E S F P K - - R P L P E R T N V V L T H Q E D Y Q A Q G A V
4) F E S I G — — — R P L P N R K N I V V T S A P D S E F Q G C T
1 ) — — K S V — D E A I A A C G N V P E I — — _ _ M V I _ G G G R
2 ) V L H S I - D E L L A Y A I< D I P E D I Y V S - - _ - G G S R
3) V V H D V - A A V F A Y A K Q H P D Q E L - - - V I A G G A Q
4) V V S S L K D V L D I C S G — — P E E C F — — — V I - G G A Q
1 ) V Y E Q F L — - P K A Q K L Y L T H I D A Q V E G D T H _ F P
2 ) I F - Q A L L - P E T K I I W R T L I D A E F E G D T F - I G
3) I F T A F K D D V D T L - L V - T R L A G S F E G D T K M I P
4) L Y T _ D L F — P Y A D R L Y M T K I H H E F E G D R H - F P
1 ) D Y E P D D W E S V F S E F H D A D A QN S H S Y C F G I L
2 ) E I D F T S F E L V E E H E G I V N QE N QY P - H R F QK W
3) L N W - D D F T K V S S R T V E - D T - N P A L T H T Y E V W
4) E F D E S N W I< L V S S E QG T K D E K N P Y D - Y E F L M Y
1 ) E R R *
2 ) QK M S K V V *
3) QK K A *
4) E I< K N S S K V G G F *
K e y :  a m i n o  a c i d s  i n  b o l d  a r e  u s e d  t o  d e r i v e  p r i m e r s  f o r  P C R .
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replaced by asparagine (Villafranca et al., 1983). Therefore two primers (A and B) 
were designed to correspond to this part of the amino acid sequence.
The selection of other two primers (Primer C and D) were based on the fact 
that Glycine-Glycine residues were important in maintaining the 3-dimensional 
structure of the enzyme (Jimenez et al., 1989). Also this pair is highly conserved in 
all the four D H F R  sequences. This justifies the selection of primer C and D  in the 
range of Glycine-Glycine residues. For P C R following combinations of Primers were 
used: (i) A  and C, (ii) A  and D, (iii) B and C, (iv) B and D  (Figure 7).
The complementary strands of primer C and D  were synthesized and used for PCR.
Since the G + C  content of mycobacteria is different (Baess and Mansa, 1978; 
Baess,1984) from other microorganisms, the relative frequencies of codons used for 
amino acids in mycobacteria differ considerably as compared to the codons used in 
other bacteria. At the time of design of primers 18 different genes from mycobacteria 
had been sequenced completely. Table 15 shows the names of the genes sequenced 
and the species from which they were cloned and the appendix 1 shows the 
mycobacterial codon usage in these 18 genes (Dale and Patki, 1990). The nucleotide 
sequence for four primers was derived using the codon usage table shown in appendix
1. However, since some of the amino acids are not conserved, codons for more than 
one amino acid have been used at several positions. Another precaution was taken 
to maintain less degeneracy at the 3’ ends of the primers. Figure 7 shows the amino 
acid and nucleotide sequence of the four primers. The complementary strand of 
Primer C and D  were used for the synthesis of primers on oligonucleotide 
synthesizer, since the synthesis of D N A  occurs from 5’->3’ direction.
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Figure 7: The nucleotide sequence of the four degenerate primers used for PCR
Primer A:
Aminoacid: P W  N/H L P A  D L A/H W  F
Nucleotidef'cCO TGC *AC CC° G C °  G A ^  £T °  ° A A TGGTTC 3
Primer B:
Aminoacid: P W  N/H/R L P A/N/D D L/M
Nucleotide: 5GGCTCGAG CC? TGG ?  ?  C ^  T ?  CC? ? A  C G A ? A T 3’G  G  G  JL G  G  A G  ^  1 G
Primer C:
Amino acid: V I  G G A Q I/L/M Y/F T
3’
N ucleo tide:5 GTN AT GGN GGN GC ° CAG A  T °  T A C AC °
T C C C T C
Primer D:
Aminoacid: V I  G G A/G Q/R
G 3,
Nucleotide:5,GTN AT J GGN GGN G ? C  C ?  ?T G t  A  G
(N represents any one of the four nucleotide)
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TABLE 15: SEQUENCED MYCOBACTERIAL GENES (Dale & Patki, 1989)
M . t u b e r c u l o s i s :  
Databanlc code identity mnemonic reference
MSGTCWPA 65kD antigen TB 65k Shinnick 1987
MTDNAJ
(hsp60, g r o E L )  
d n a J  analogue TB dnaJ Lathigra et a l . ,  1988
MSGANT19 19-22kD antigen TB 19-22K Ashbridge et a l . ,  1989
MSG10KAG 10-12kD antigen TB 10-12K Baird et a l . ,  1989
MTBCGA
(g r o E S )
10-12kD antigen TB 10-12K Shinnick et a l . ,  1989
M3 004 6
(g r o E S )
38kD antigen TB 38K Andersen and Hansen, 1989
M27016
( p s t S  analogue) 
3 2kD antigen TB 32K Borremans e t  a l . ,  1989
M . b o v i s :
X15803 19—22kD antigen MB 19-22K Collins et a l . ,  1990
BCG:
MSGBCG 64kD antigen BCG 64K Thole et a l ., 1987
MSGBCGA
(hsp60, g r o E L )  
alpha antigen BCG alpha Matsuo et a l . , 1988
MBMPB57
(30/3lkD) 
10-12kD antigen BCG 10-12K Yamaguchi et a l . ,  1988
—
(MPB57)
18kD antigen BCG MPB70 Terasaka et a l ., 1989
— 2 3kD antigen BCG MPB64 Yamaguchi et a l ., 1989
M.  l e p r a e :
MSGANTM 65kD antigen ML65k Mehra e t  a l . ,  1986
MSGANT18K
(hsp60, g r o E L )  
18kD antigen ML18K Booth et a l ., 1988
MLEPSOD 28kD antigen (a) SOD Thangaraj et a l ., 1989
MSG28KDAG
(superoxide dismutase) 
28kD antigen (b) IRG Cherayil & Young 1988
—
(hypothetical iron transport protein)
36kD antigen ML3 6K Thole et a l ., 1990
The list contains only those genes where complete published sequences 
are available, and where a protein product is known, or there is 
substantial evidence for such a product.
Codes starting MSG are GenBank locus numbers; those starting MT, MB, 
ML are from EMBL. Other codes are accession numbers.
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The reactions were set up as described in section 4.2.2. The distance between 
the two marked boxes in table 14 in the four D H F R  sequences is 96 amino acids 
which corresponds to 288 nucleotides. When the combination of primer A  and C was 
used for P C R with total M. bovis B C G  DNA, the band was seen in the range of 280- 
300 base pairs only when the annealing temperature was 37 °C (Figure 8). Because 
of the high degeneracy of the primers no band was seen at the annealing temperatures 
of 42°C, 45°C, 52°C, 58°C, 65°C and 68°C. On the other hand after first P C R  at 
the annealing temperature of 37°C, the band was excised from the agarose gel, 
purified using "Geneclean kit" and used for a second amplification, a strong band was 
observed even at annealing temperature of 68°C. This indicates that the primers were 
not a perfect match. All other combinations of primers failed to give any PC R 
amplified product.
The D N A  product after secondary PC R amplification was purified from an 
agarose gel and used subsequently as a radiolabelled probe for screening Southern 
blot of M. bovis B C G  D N A  and for screening M. tuberculosis genomic library.
4.3.4) Screening of the Southern blot of M. bovis B C G  and EMBL4-M. tuberculosis 
library using PC R product D N A  as a gene probe:
The Southern blot of M. bovis B C G  D N A  was prepared as described in section
4.3.1. The filter was prehybridized for 2 hours to avoid any nonspecific binding of 
the probe and hybridized with radiolabelled PC R amplified D N A  probe. Figure 9a 
shows the gel photograph of undigested and digested B C G  D N A  and figure 9b shows
4.3.3.2) PCR using M. bovis BCG DNA:
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Figure 8: 1.4% agarose gel photograph showing PCR product in the range of 280-300 
bp.
Lane 1: </>X 174/ Hae III D N A  - M W  marker
Lane 2: PCR reaction mix (loaded dircetly after reaction)
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Figure 9A: 1 %  agarose gel containing undigested and digested B C G  D N A  
Lane 1: B C G  undigseted D N A  “
2: B C G  / Bam HI 
3: B C G  / Hind III 
4: B C G  / Kpn I
5: Lambda / Hind III - M W  marker 
6: B C G  / Pst I '
7: B C G  / Pvu II 
8: B C G  / Smal 
9: B C G  / HindlH
Figure 9B: An autoradiograph of the Southern blot of the gel from 9A.
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the autoradiograph of the Southern blot of the gel. The specific hybridization signals 
confirms that the P C R  amplified D N A  is from M. bovis B C G  and is not because of 
any other non-specific D N A  amplification by contamination and hence suitable for 
screening the library.
EMBL4-M. tuberculosis library prepared by Zainuddin (1988) was used for 
screening. Approximately 13000 clones were screened using P C R amplified D N A  
as a radiolabelled probe. Forty five clones were picked up from the first screening 
and were resuspended in 100 pi of S M  buffer and stored at 4°C. Twenty clones were 
used for secondary screening from which fourteen clones were found to be positive. 
In the third screening round, to get pure clones, four clones (clone no. 6, 28, 31 and 
34) were used. Figure 10 shows the autoradiograph of the plaque lifts of the clone 
6 and 31. 280 bp PC R amplified D N A  was radiolabelled and used as the probe.
However, D H F R  is a single copy gene and many clones were not expected in 
the first screening. Since the library used for screening was an amplified library (at 
least 3 times) and originally D N A  used for cloning was partially digested to get the 
average insert size of 12-15 kbp, the number of clones obtained for single copy gene 
is relevent. According to theoretical calculations one can expect one positive per 500- 
1000 clones having average insert size of 15 kbp, at 95 %  probability. Following the 
secondary screening (14 positive clones out of 20), it can be concluded that 30 clones 
were positive from 45, which were picked up in the first screening. This fits with 
the theoretical data and in this case one clone is positive per 433 clones.
After amplification of these four clones, phage D N A  was isolated using liquid 
lysate and plate lysate methods. Yield from liquid lysate method was more and D N A
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samples were digested with different restriction enzymes for Southern blotting. Four 
D N A  samples from clone no. 6, 28, 31 and 34 were digested with Bam HI, Eco Rl, 
Bam HI +  Eco Rl, Sma I and Kpn I and electrophoresed through 1 %  agarose gel. 
From the gel photograph, it can be said that, since all these four D N A  samples gave 
a similar digestion pattern, all four clones were derived from a single parental clone 
via amplification. These digested D N A  samples were southern transferred and probed 
with radiolabelled PC R amplified DNA. Figure 11 shows the autoradiograph of one 
gel containing clones 6 and 31 D N A  digested with different enzymes. In all these 
clones there was a single Bam HI site, cutting the 14.8 kbp insert into 2 fragments 
viz 7.8 kbp and 6.0 kbp. Out of these two fragments only the 6.0 kbp fragment 
hybridized with the PC R D N A  probe. Hence this fragment was subcloned into 
pUC19 plasmid vector for further study.
4.3.5) Subcloning in pUC vectors:
Subcloning of 6.0 kbp fragment was done as described in section 4.2.4. Six 
clones were selected from number of transformants, plasmid D N A  were extracted 
using alkaline lysis method. The restriction map of one clone pUS102 was prepared 
using eight restriction enzymes and further subcloning of the insert was done 
according to the fragments which showed hybridization to the radiolabelled PC R 
D N A  probe. Figure 12 A  shows the restriction map of clone pUS102 and subclones 
derived from pUS102 along with their orientations with respect to lac Z in the 
plasmid vector pUC18 and pUC19. All these subclones namely (i) pUS102, (ii) 
pUS141, (iii) pUS 153 and (iv) pUS155 were again confirmed to hybridize with 
radiolabelled PC R generated D N A  probe. This confirmation was done by isolating
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Figure 10: An autoradiograph of plaque blot hybridization of clone no. 6 and 31.
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Figure 11: An autoradiograph of the Southern blot of digested D N A  from clone 6 and 
31 and probed with 280 bp PCR amplified radiolabelled D N A
1: Clone 6 undigested D N A  
2: Clone 6 / Bam HI 
3: Clone 6 / Eco RI 
4: Clone 6 / Bam HI +  Eco RI 
5: Clone 6 / Sma I 
6: Clone 6 / Kpn I 
7: Lambda / Hind III
8: Clone 31 undigested D N A
9: Clone 31 / Bam HI
10: Clone 31 / Eco RI
11: Clone 31 / Bam HI +  Eco RI
12: Clone 31 / Sma I
13: Clone 31 / Kpn I
14: Lambda / Hind III
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Figure 12 A: Restriction map of pUS102 and structure of recombinant clones
1) pUS102:
B Pv X  Pv K  Ps E E B
i 1 1  i i  i i i
pUC18 pUC18
t 1
Ps Pv I.
Jac Z
-i
2) pUS141:
B K E
lac Z -- ► pUC19
3)pUS153:
B K
pUC18 *---- lac Z
4)pUS155:
B IC
lac Z --- * pUC19
Key: B - Bam HI, E - Eco Rl, K - Kpn I, Ps - Pst I, Pv - Pvu II, X - Xho I
Figure 12 B) Sequencing strategy of 4 kb Bam HI-Eco Rl fragment of pUS102:
-----------------------------------► M13mpl8clone
 „  ►---- Eco RI
4 kbp Bam HI-Eco Rl fragment of pUS102 
BamHI    .____^----
•-------------------------------  M13mpl9 clone
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plasmid D N A  from the above clones, digesting them with appropriate restriction 
enzyme/s and performing Southern blot hybridization using the above probe.
4.3.6) Isolation of R N A  from subclones:
To observe the expression of the gene product in E. coli it was essential to 
start at the transcriptional level. Previous studies had shown that mycobacterial genes 
can be expressed in E. coli either with their own promoters or with the aid of E. coli 
promoters, lac Z promoter in case of p U C  plasmid vectors. From E. coli containing 
plasmid pUC18 and plasmid subclones namely pUS102, pUS141, pUS153 and 
pUS155 R N A  was extracted by two different methods (section 2.20.4 &  2.20.5). 
D N A  contamination was seen in both the methods and hence an extra step of DNase 
treatment was included in the method. DNase (RNase free) from Pharmacia was 
found satisfactory and no detectable RNase activity was seen. The time and 
concentration of DNase was standardized. The second set of R N A  extraction was 
performed from the above cultures grown in presence of the inducer IPTG to check 
if there was any induction by the inducer IPTG. Figure 13 A  shows the R N A  
electrophoresed in denaturing formaldehyde gel which was used for Northern blotting. 
Northern blotting was done as described in section 3.2.4 and the blot was 
prehybridized in prehybridization solution prepared for Northern blots. Six kbp Bam 
HI fragment was isolated by digesting pUS102, electrophoresed through 1% agarose 
gel and purified using "Geneclean kit" and used as a radiolabelled probe. Figure 13 
B shows the autoradiograph of the northern blot. R N A  isolated from clone pUS141 
(containing 4 kbp Bam HI-Eco Rl fragment from pUS102 in pUC19) and clone 
pUS 155 (carries 2.7 kbp Bam HI-Kpn I fragment from pUS102 in pUC18) showed
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Figure 13A: 1.5% agarose - formaldehyde gel photograph showing R N A  samples 
from E. coli carrying different clones 
1: pUS102 - IPTG 
2: pUS102 +  IPTG 
3: pUS141 - IPTG 
4: pUS141 + IPTG 
5: M W  marker 
6: pUC18 - IPTG 
7: pUS155 - IPTG 
8: pUS155 + IPTG 
9: pUS153 - IPTG 
10: pUS153 +  IPTG 
11: pUC18 +  IPTG
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Figure 13B: An autoradiograph of the Northern blot of the gel shown in 13A.
Radiolabelled probe used was 6 kbp Bam HI fragment of clone pUS102.
1: pUS 102 - IPTG 
2: pUS 102 + IPTG 
3: pUS141 - IPTG 
4: pUS141 + IPTG 
5: M W  marker 
6: pUC18 - IPTG 
7: pUS155 - IPTG 
8: pUS155 + IPTG 
9: pUS153 - IPTG 
10: pUS153 +  IPTG 
11: pUC18 + IPTG
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hybridization with 6 kbp radiolabelled probe in both uninduced and induced R N A  
samples. In both cases hybridization signals were at similar positions («1.3 kb and 
*0.8 kb). Since these two clones are in the same orientations it suggests that 
transcription is dependent on the lac Z promoter of pU C plasmid. Absence of 
hybridization signals in E. coli and E. coli carrying pUC18 R N A  confirmed that the 
signal is not due to the contamination of pUC18 D N A  or products of pUC18. If the 
transcription is occurring from lac Z promoter then it should show more hybridization 
in IPTG induced samples. However, there is no distinct difference between induced 
and uninduced R N A  samples, which may be because of the uneven amounts of R N A  
loaded on the gel.
Subsequently the same Northern blot, after removal of the probe, was 
reprobed with radiolabelled P C R  generated D N A  probe and it showed the 
hybridization signal at the similar position to that of the first X-ray film.
4.3.7) Expression of protein in the E. coli carrying clones:
Northern blot analysis confirmed the expression of gene at the transcriptional 
level. To check the expression at translational level crude protein extracts were 
prepared (section 2.25) and SDS-PAGE gels were used at different concentrations to 
attempt to detect the presence of an extra band in protein extracts from clones as 
compared to protein extracts from E. coli carrying pUC18 and pUC19 only. Figure 
14 shows the result obtained in a 12% SDS-PAGE gel; no extra bands can be seen 
in the protein extracts from clones.
Sometimes if foreign protein is expressed in the host, then it is stored in 
inclusion bodies. Crude protein extract preparations usually fail to show proteins
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1 3 5 7 9 11 13 15 17 kDa
Figure 14: 12% SDS-Polyacrylamide gel photograph showing crude protein extracts 
from different clones
1: E. coli JM 101 - IPTG 
2: E. coli JM 101 +  IPTG 
3: E. coli carrying pUC18 - IPTG 
4: E. coli carrying pUC18 + IPTG 
5: E. coli carrying pUC19 - IPTG 
6: E. coli carrying pUC19 +  IPTG 
7: E. coli carrying pUS102 - IPTG 
8: E. coli carrying pUS102 +  IPTG 
9: M W  marker
10: E. coli carrying pUS140 (0.8 kbp fragment of pUS102) - IPTG
11: E. coli carrying pUS140 (0.8 kbp fragment of pUS102) +  IPTG
12: E. coli carrying pUS141 - IPTG
13: E. coli carrying pUS141 +  IPTG
14: E. coli carrying pUS153 - IPTG
15: E. coli carrying pUS153 +  IPTG
16: E. coli carrying pUS155 - IPTG
17: E. coli carrying pUS155 +  IPTG
18: M W  marker
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Figure 15: 12% SDS-Polyacrylamide gel photograph showing proteins solubilized 
from inclusion bodies 
1: M W  marker 
2: E. coli carrying pUS102 
3: E. coli carrying pUS141 
4: E. coli carrying pUS155 
5: E. coli carrying pUS153 
6: E. coli carrying pUC18 
7: M W  marker
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from inclusion bodies. To check this possibility inclusion bodies were isolated 
separately (section 2.25) and then solubilised and proteins were analyzed on SDS- 
P A G E  gels. Surprisingly proteins from inclusion bodies of clone pUS141 and 
pUS 155 showed an intense band of the size of «15 - 18 kDa which was not present 
in pUC18. This experiment confirmed the expression of protein at translational level.
4.3.8) Complementation analysis:
E. coli strain JD418 was confirmed as D H F R  gene deleted by southern blot 
hybridization using 1.1 kbp fragment from clone pAGlOl as a probe. Also this strain 
failed to grow on minimal medium unless transformed with plasmid pAGlOl. E. coli 
strain JD418 was grown in rich liquid medium (2 X  T Y  Broth) and competent cells 
were prepared as given in section 2.19.2. Transformations were performed using 
electroporator and transformants were plated on a series of media to check 
complementation. Transformants obtained from pAGlOl grew on minimal medium 
containing ampicillin and on LB agar containing ampicillin. Table 16 shows the 
transformants grown on different media and positive and negative controls. Plasmids 
pUS102, pUS141, pUS153 and pUS155 failed to complements, coli strain JD418. 
This could be because of the inefficient translation or the translated product may not 
be in active form. Also, if the translated product is not modified by post-translational 
processes it may not form active enzyme and could result in the failure of the 
complementation. Hence to check the activity of the product activity assay must be 
performed. ^
Transformants were not induced before plating because of previous data (Fig. 13B) 
showing that induction is not required for transcription. The failure to detect 
complementation may of course be due to the gene not being DHFR.
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Table 16: Transformants plated on different media
Media B.co/ij
pUS102
D 418 tran 
pUS141
sformed usi 
pUS153
ng plasmid 
pUS155 pAG 101
R co li JD417
M M  + Amp - - - - + +
M M  + Amp + 
Thy - - - - + +
M M  + Amp + 
Thy + A, M, P, G + + + + + +
LA + Amp + + + + + +
LA + Amp + 
T, A, M, P, G + + + + + +
Key: M M  - Minimal medium 
Amp-Ampicillin 
Kan - Kanamycin 
Thy or T - Thymine 
A - Adenine 
G - Glycine 
M-Methionine 
P- Pantothenate
+ for growth 
- for no growth
(for the concentrations please refer to table 10)
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To confirm the activity, enzyme assays were done by performing isoelectric 
focusing and doing zymography on focused gels (Tennhammer-Ekman and Skold, 
1979). Crude protein extracts were prepared by sonication (section 4.2.8) and IEF 
was performed using phast-gel system from Pharmacia. Broad range IEF gels (pH 
3-9) were used and samples were loaded at 3 different positions: (i) near cathode (ii) 
near anode and (iii) in the centre. Prefocusing and focusing was done according to 
the manufacturers instructions. Two gels were usually used for isoelectric focusing 
and subsequently one was used for protein staining and the other was used for activity 
assay. There was a blue band seen in all four tracks (JM109, JM109 containing 
pUC18, clone pUS102 and clone pUS141) which may correspond to the D H F R  from 
E. coli which was showing activity, since mycobacterial D H F R  is known to liave 
different pi as compared to E. coli (Al-Rubeai and Dale, 1986). When the activity 
assay was performed in presence of 10 pM trimethoprim no band was detected 
confirming that the original reaction was specific and not due to nonspecific binding. 
The failure to detect the extra band in clones may indicate the absence of active 
protein.
Also, if protein is present as insoluble inclusion bodies, which are not 
disrupted by conditions used for sonication, the IEF may fail to detect the active 
protein.
The failure to detect the activity may of course be due to the gene not being DHFR.
4.3.9) Activity assay on IEF gels:
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The 4 kbp sequence of the clone pUS102 was determined by performing 
subcloning in M13mpl8 and M13mpl9 bacteriophage vectors using dideoxy 
procedure. Figure 12 B shows the sequencing strategy and primer positions used for 
sequencing. Figure 16 shows the complete sequence of 4 kbp from clone pUS102. 
The sequence has 65.1 % G + C  content as expected for mycobacterial DNA. Detailed 
analysis of the sequence revealed two specific regions (807-840bp and llll~1137bp) 
which showed homology with the primer A  and primer C respectively used for PC R 
amplification of M. bovis B C G  DNA. Figure 17 compares homology among primers 
and the actual sequence. The R N Y  analysis of Staden programme predicts a protein 
of 213 amino acids having G U G  as a start codon. The deduced amino acid sequence 
is shown in the figure 16 using single letter amino acid code. The sequence also 
show the typical Shine-Dalgarno sequence ( A TG AG G - 681-686 bp in fig. 16) 4 bases 
upstream to the presumptive start point. The G + C  content (59.5%) of the coding 
region was slightly less than that of the whole fragment. The calculated molecular 
weight of this putative dihydrofolate reductase gene is 21214 and it showed typical 
codon bias (Table 17) as observed in other sequenced mycobacterial genes. The 
nucleic acid data bank and protein data banks (NBRF Nucleic acid and Protein data 
bank release no. 24, Swissprot protein bank released on July 29, 1991) were searched 
for the homology but no significant homology was detected.
The deduced amino acid sequence was used for the comparison of four 
published D H F R  sequences. The analysis was done using Clustal analysis 
programme and table 18 shows the homology seen with four D H F R  genes. There is
4.3.10) Sequence determination and analysis:
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AAGCTTGCATGCCTGCAGGTCGACTCTAGAGGATCCGGTG 
1 20 40
TCGTTGCAGAGTGCGGTGGGGTTTAGCGCCTTAGGTAGCGAGCATGCGGCGATCGCGGGG
60 80 1 0 0
CGAAGGGGTCGAGGAGCTGGGTCGTTCCGGGGTCGCTGTGGGTGAGTCTGGGATCGGTTA
120 140 160
TGCCGCCGGTGATGCGGTGGCGGCGGCGACGTATCTGGTTTCGGGTGGGTCGTTGTGACG
180 2 0 0 2 2 0
GCGCCGGTGTGGTTGGCGTCGCGCCGGAGGTGCATTCGGCGCTGCTAAGTGCTGGTCCGG
240 260 280
GGCCGGGTTCGTTGCAGGCGGCCGCGGCGGGGTGGAGCGCGTTAACGCGAGTACGCCGCT
300 320 340
GTGGCCAAGAGTTGAGGCGTGGTGGTGGCCGCGGTGGGGGCCGGGGTGTGGCAGGGTCCC
360 380 400
AGTGCTGAGTTGTTTGTGGCCGCCTATGTGCCGTATGTGGCGTGGTTGGTGCAGGCCAGT
420 440 460
GCGGATAGCGCGGCGGCGGCCGGTGAGCATGAGGCCGCGGCGGCTGGCTATGTTTGTGCG
480 500 520
TTGGCGGAGATGCCGACGTTGCCGGAGTTGGCGGCCAACCACCTCACGCATGCGGTGTTG
540 560 580
GTGGCGACGAATTTCTTTGGGATCAACACGATCCCGATCGCGCTCAACGAGGCCGACTAT
  620
<----- > V G A A
GTGCGGATGTGGGTCCAGGCGGCCACCGTGATGAGCGCCTATGAGGCGTGGTGGGTGCCG
660 680 700
L V A T P H T G P A P V I V K P G A N E
CGCTGGTGGCCACACCACACACCGGCCCGGCACCGGTCATCGTCAAACCCGGCGCCAATG
720 740 760
A S N A V A A A T I T P F P W H E I V Q
AAGCCAGCAACGCCGTGGCCGCCGCAACCATAACCCCATTCCCATGGCACGAAATTGTAC
780 800 820
F L E E T F A A Y D Q Y L S A L L S E L
AGTTTTTAGAAGAAACGTTCGCAGCATATGACCAGTATCTGTCCGCTTTGCTTTCCGAAC
840 860 880
P A V A W V W F Q L F V D I L G F N I  I 
TCCCTGCGGTGGCTTGGGTTTGGTTCCAGCTCTTTGTGGATATCCTGGGTTTCAACATTA
900 920 940
G F I I T L A S N A Q L L T E F A I N A
TTGGGTTCATTATTACGTTGGCATCCAATGCTCAACTATTGACAGAGTTCGCTATCAATG
960 980 1000
S Y V A V G L L Y A I A G V I D I V V E
CTTCTTATGTTGCGGTCGGATTATTGTATGCCATTGCGGGCGTTATAGACATAGTTGTCG
1020 1040 1060
W V I G N L F G V A S P F G G A V V G G
AGTGGGTTATTGGGAATCTGTTTGGTGTTGCTTCCCCTTTTGGGGGGGCCGTTGTTGGGG
1080 1 1 0 0 1 1 2 0
V G R C C G S G C S W V G R G G G I G R
GCGTTGGCCGCTGCTGTGGTTCCGGGTGTAGCTGGGTTGGCCGGGGTGGCGGGATTGGCC
1140 1160 1180
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A W R A V
1 2 0 0 1 2 2 0
V
GCTCTGCCGGCGGTGGGTGCGGCTGCTGGCGCGCCGGCGGCTTGGTGGGCAGTGTGGCGC
1240
V G V V A V V G A R
CGGTGTCGGGTGGTGTGGTGTCGCCGCAGGCCGTTGGTGTCGGCGGTGGAGCCGGCTCCC
1260 1280 1300
E H V G V G A G F *
GCGAGCACGTCGGTGTCGGTGCTGGCTTCTGATCGGGGTGCTGGGGCGTTGGGGTTTGTT
1320
1380
1440
1500
1560
1620
1680
1740
1800
1860
1920
1980
2040
2 1 0 0
2160
2 2 2 0
2280
2340
2400
2460
2520
2580
2640
2700
2760
1340
1400
1460
1520
1580
1640
1700
1760
1820
1880
1940
2 0 0 0
2060
2 1 2 0
2180
2240
2300
2360
2420
2480
2540
2600
2660
2720
2780
1360
GGGACGGCTGGCAAGGAGTCGGTTGGGCAGCCGGCGGGGTTGACGGTGTTGGCCGATGAG
1420
TTTGGTGATGGTGCGCCGGTGCCGATGCTGCCGGGCAGCTGGGGGACCGGATTTGGTCGG
1480
TGTGGCCGGTGATGGGGGTTGGTGTCAGTTTGACGATCTGACGGCCGTGAACTCGACCAA
1540
ATTTTCGATCGAAAGAGTGTCTAAAAATCATTGCCCGGAATATTTGAAAGGGATTCGTGG
1600
TGTCGCAGAGTATGTACAGCTACCCGGCGATGACGGCCAATGTCGGAGACATGGCCGGTT
1660
ATACGGGCACGACGCAGAGCTTGGGGGCCGATATCGCCAGTGAGCGCACCGGCCGTCGCG
1720
TGCTTGCCAAGGTGATCTCGGGATGAGTCATCAGGACTGGCAGGCCCAGTGGAATCAGGC
1780
CATGGAGGCTCTCGCGCGGGCCTACCGTCGGTGCCGGCGAGCACTACGCCAGATCGGGGT
1840
GCTGGAAAGGCCGGTACGATTCGTCAGACTGCGGAACGATTAGGGTGGGGTCGTTCCGGG
1900
GTCGGTGGCTGGACCCGCGCCATGGCTGAGGCCGCCGACGCCGGAGACTAAACGCGCGTG
1960
GTGGAAATGTCAGCACCAATGTCGCTCGCGCCAGAACGCACAACTGACCACGTTGACATC
2 0 2 0
CGTCCTGGCATCCTGAACGCGGGCTCGAGGTGCTAACCCGGCACGTTGGCGGCGATGTTC
2080
GTCATCACGATGTCGGAGACCGATTCCGGGAAGCCGCAGAAGGTCACTTCCAACAGGGCC
2140
GCCGATAGGACCCGGTAGTCGCGACCGCAATCGCCGGCCCGGATGTGTAGGGAATTGCCG
2 2 0 0
CCGGCGGTCCACCTACTGACGAACAGCCAGCTGCCGGACTTGCCGCGGCAGTCGTGGACG
2260
GTGACCGCCAGGGTGTCGAAGGCACGCCGGGCGGTGCCGGCATCCCGATAGGCGGCGGCC
2320
GCCTCGGAGATCAGACTGCCATCTGGCCGGTCCTGGAAGGTGGTCTTGTGAAACGCTTCG
2380
ATCTCAGAGCCAAAGACTGCCGTCTCGGCATAGATGAACCGGCATTCTCGTGGTATGGGT
2440
TGGGCGAAATCGTCGACGTCGACGGGATACGTCGTGTCCATCGTGGGGATGATCGTCAGG
2500
TCATCGCCGGAGCCGGTGATTGCTTGCATCCGTGACTGATCCAACAGGATCGTAGCGACG
2560
TCAAGCATGCCTGTCGGTCACCGCCAAAAGTCGCCGAAGCCGTGCCGCCCACCACCCGGG
2620
GTGCACGCCGCAATCAGTAGTGTCGCGCCACATAACAGCAGCGGCCGCGTCAATCCCACC
2680
ATCTGCCACCCTTCTGCTTCGAAGGTACCCGGGCGAACCTGCAGCAGACACCCCTGGCGG
2740
CCAGCCGACGATGTGAGGTCGAATACGGTTGCCGGGTGAGTGTTTTCGCAACGGCCACCG
2800
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GGATCGGATCGTGGCCGGGCACCGCCGCGCGAGAGGCCGCGCAGGTCGTGGTCGGGAGTT
2820 2840 2860
GGCGGGCGCATTGGCCTATCTCACCGAGCTGCGCCAGGGGCGTCGGCGCCGACATGCTGG
2880 2900 2920
GGCGAGCCGGCGGACTGCTGGTCGACGTGGCGATTGACACCGTGCCTCGTGGCTACGCAT
2940
3000
3060
3120
3180
3240
3300
3360
3420
3480
3540
3600
3660
3720
3780
3840
3900
2960 2980
CGCTGCTCGACCCGGCGCGGTGACACGGCGGGCCGCCGAGCCTCCTCGACGAGGATATGG
3020 3040
ATGCCTTAGAAGAGGCCTGGGAGACCGCGGGCCTGCGTGGCTGTGGGCGGGCGGTGAAGG
3080 3100
TGCAGGCGCCCGGGCCAGTCACATTGGTCGCGGGGTTGGAGCTGGCCAACGGTCACCGGG
3140 3160
CGATCACCGACCCCGGAGCCGTGCGTGACCTGGCCGCCTCGCTGGCCGAAGGCGTTGCCC
3200 3220
ATCGCGCGGCTGGCGCGTCGACTTGACACACCGGTGGTGGTGCAGTTCGACGAGCCGTCG
3260 3280
TTGCCGGCGGCGTTGGGCGGCCGGCTGACCGGGGTGACCGCGTTGAGCCCGGTTGCCCCG
3320 3340
CTCGACGAGACGGTGGCCGAAGCGCTGCTCGACACTTGCATCGCGGCTGTCGACGCGGAC
3380 3400
GTAGCGCTACACAGCTGCAGTCCGGATTTGCCGTGGGATCTGCTGCAGCGCAGCAGAATT
3440 3460
AGTGCGGTATCGGTGGATGCGAGCACACTGCAGGCTGCGGATTTGGATGCTGTCGCGGCA
3500 3520
TTTGTCGAGTCGGGCCGAACCGTCGTGCTGGGCCTGGTCCCGGTGACCGCCCCGGAGCGA
3560 3580
GCACCTTCGATGAAGAGGTGCCTGCTGCGGCGGTCGCGGTCACCGATCGGCTCGGCGTTC
3620 3640
CTCGCTCGGCTACGCGATCGACTCGGCGTCAGCCCGGCGTGTGGTCTGGCCAATGCGACG
3680 3700
GGGCAGTGGGGCCCACCGCGGTCGGGCTTGCCCGTGATGGCGCTGAGGGCGTTCGCGCGG
3740 3760
GACCCAGAGGCCATCTGAGGGAAGAGCCCCCTCGGCTAGCCTGCCAGAGTGAGCTCCCCA
3800 3820
GACGCCGATCAGACCGCTCCCGAGGTGTTGCGGCAGTGGCAGGCACTGGCCGAGGAGTGC
3860 3880
GTGAGCACCAGTTCCGTTATTACGTGCGGGACGCGCCGATCATCAGCGACGGCGGAATTC
3920 3940
Figure 16: Nucleotide sequence of the putative Dihydrofolate 
reductase gene from M . t u b e r c u l o s i s . The underlined sequence 
indicate potential promoter region and the arrows indicate the 
presumptive ribosome-binding site. The decuced amino acid 
sequence is shown in one-letter code.
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Table 17: Codon usage table of the putative dihydrofolate reductase 
gene of M. t u b e r c u l o s i s
F TTT 4 . S TCT 2. Y TAT 4. C TGT 2 .
F TTC 7. S TCC 6 . Y TAC 0 . C TGC 3 .
L TTA 2. S TCA 0 . * TAA 0 . * TGA 1 .
L TTG 5. S TCG 2 . * TAG 0 . W TGG 6 .
L CTT 1. P CCT 2. H CAT 0 . R CGT 0 .
L CTC 2. P CCC 1. H CAC 3 . R CGC 4.
L CTA 1. P CCA 3. Q CAA 1 . R CGA 0 .
L CTG 4. P CCG 4. Q CAG 4 . R CGG 1 .
I ATT 8 . T ACT 0. N AAT 4. S AGT 1 .
I ATC 3. T ACC 3. N AAC 2 . S AGC 2 .
I ATA 3. T ACA 2 . K AAA 1 . R AGA 0 .
M ATG 0 . T ACG 2. K AAG 0 . R AGG 0 .
V GTT 11. A GCT 7. D GAT 1 . G GGT 12 .
V GTC 7. A GCC 13. D GAC 2 . G GGC 16.
V GTA 1. A GCA 5. E GAA 5 . G GGA 2 .
V GTG 10. A GCG 5. E GAG 3 . G GGG 8 .
Figure 17: Homology comparison of the primers with the sequence 
Primer A:
Amino acid: P W  N/H L P A  D L A/H W  F
Nucleotide:5,CCG TGG £  AC IjT c CCC G C C G A T T T C C A C T G G T T c 3
Sequence: CAC GAA TTG T A C  AGT TTT TTA GAA GAA ACGTTC 
from fig. 16 (807 - 840 bp)
Primer C:
Amino acid: V I G G A  Q I/L/M y/F T
5’ C 3Nucleotide:5GTN AT GGN GGN G C °  CAG A  t ° T A C AC °
T C C C T C
Sequence: GTT GTT GGG GGC GTT GGC CGC TGC TGT 
from fig. 16 (llll-1137bp)
j indicates match between the primer and the sequence 
(N represents any one of the four nucleotide)
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fT a b le  1 8 : The am ino  a c i d  c o m p a r is o n  o f  f o u r  d i h y d r o f o l a t e  
r e d u c t a s e s  w i th  t h e  p u t a t i v e  DHFR fro m  M. tuberculosis, u s i n g  
C l u s t a l  a n a l y s i s  p ro g ram m e.
BSDI MI S F IF  AMD ANR-LIGKDND   — LPWH- - —  LPNDLAYFKKITSGH
LCDI MTAFLWAQDRDG-------LIGKDGH-------------------------- LPWH-------- LPDDLHYFRAQTVGK
ECD I  MISLIAALAVDR-VIGMENA  -------------------------MPWN--------- LPADLAGFKRNTLNK
SFDI MFISMWAQDKNG-------LIGKDGL---------------------------LPWR-------- LPNDMRFFREHTMDK
MTDI VGAALVATPHTGPAPVIVKPGANEASNAVAAATITPFPWHEIVQFLEETFAAYDQYLSAL
BSDI S------------------------ IIMGRKTFESIG-R-PLPNRKNIWTSAPDSEFQGCTWSSLKDVLD
LCDI I ------------------------MWGRRTYESFP-KRPLPERTNWLTHQEDYQAQGAVVVHDVAAVFA
ECDI P ------------------------VIMGRHTWESIG-R-PLPGRKNIILSSQPGTD-DRVTWVKSVDEAIA
SFDI I ------------------------ LVMGK-TYEGMG-KLSLPYRHIIVLTTQKDFKLKNAEVLHSIDELLA
MTDI LSELPAVAWVWFQLFVDILGFNIIGFIITLASNAQLLTEFAINASYVAVGLLYAIAGVID
• • ^ • *
BSDI ICSGPEE— CFVI GGAQLYTDLFP-YADRLYMTKIHH-EFEGDRHFPEFDESNW-K
LCDI YAKQHPDQELVIA GGAQIFTAFKD-DVDTLLVTRLAG- S FEGDTKMIPLNWDDF-T
ECDI ACGDVPE— IMVI GGGRVYEQFLP-KAQKLYLTHIDA-EVEGDTHFPDYEPDDW-E
SFDI YAKDIPE-DIYVS GGSRIFQALLP-ETKIIWRTLIDA-EFEGDTFIGEIDFTSF-E
MTDI IWEWVIGNLFGVASPFGGAWGGVGRCCGSGCSWVGRGGGIGRSAGGGCGCWRAGGLVG• • • •  ^ • « • o •• • •  * • ® • • • •  O « « • •  • o
BSDI LV S S EQGTKDEKNPYDYEFLMYEKKNS SKVGGF
LCDI KVSSRT- VEDTNPALTHTYEVWQKK— A---------
ECDI SVFSEFHDADAQNSHSYCFQILERR---------------
SFDI LVE EH EGIVNQENQYPHRFQKWQKM— SKVV—
MTDI SVAPVSGGVVSPQAVGVGGGAGSREHVG-VGAGF
* : : : . :
Key : BSDI -  B . subtilis  d i h y r o f o l a t e  r e d u c t a s e  
LCDI -  L . caesi  i h y d r o f o l a t e  r e d u c t a s e  
ECDI -  E. coli d i h y d r o f o l a t e  r e d u c t a s e  
SFDI -  S. faecium  d i h y d r o f o l a t e  r e d u c t a s e  
MTDI -  M . tuberculosis  p u t a t i v e  d i h y d r o f o l a t e  r e d u c t a s e
* = m a tc h  a c r o s s  a l l  s e q s .
. = c o n s e r v a t i v e  s u b s t i t u t i o n s
: = i d e n t i c a l  o r  c o n s e r v a t i v e  am ino  a c i d  i n  m ore  t h a n  t h r e e
s e q u e n c e s  i n c l u d i n g  MTDI.
The underline regions show where primer A  and C are thought to bind and the 
overline regions show where they were designed for.
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a degree of homology through out the amino acid sequences, however, very few 
amino acids are identical through out the five sequences. The primer sequences used 
for the polymerase chain reaction however do not align correctly. From this analysis 
it can be said that there is no evidence that this gene is D H F R  and further 
experiments are required to identify it.
i
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5) I S O L A T I O N  A N D  C H A R A C T E R I Z A T I O N  O F  T H E  T H Y M I D Y L A T E  
S Y N T H A S E  G E N E  F R O M  M Y C O B A C T E R IU M  T U B E R C U L O S IS
Thymidylate synthase (TS) and dihydrofolate reductase (DHFR) play a central 
role in D N A  synthesis in both prokaryotic and eukaryotic organisms (Myoda and 
Funanage, 1985; Ivanetich and Santi, 1990). Thus, it would seem advantageous for 
cells to regulate coordinately the expression of these two enzymes. This is very well 
demonstrated in three protozoan species. In Leishmania major, Plasmodium 
falciparum and Crithidia fasciculata TS and D H F R  are on the same polypeptide 
(Grumont et al., 1988; Bzik et al., 1987; Ferone and Roland, 1980). In the 
bifunctional protein, the TS domain is on the carboxyl terminus and D H F R  is on the 
amino terminus (Ivanetich and Santi, 1990). In many other eukaryotic organisms, 
however, separate genes (TS and DHFR) exist which encode dihydrofolate reductase 
and thymidylate synthase respectively. Several groups (Myoda and Funanage, 1985; 
Allen et a l., 1983) have shown that a functional interaction exists between the D H F R  
and TS encoded by these genes. This interaction involves the formation of a 
multienzyme complex containing DHFR, TS and at least four other enzymes also 
involved in D N A  replication (Jazwinski and Edelman, 1984; Chui et al., 1982; 
Tomich et al., 1974).
The frd  and td genes, which encode bacteriophage T4 D H F R  and TS, 
respectively, have been shown to overlap by 4 bp (Purohit and Mathews, 1984). 
Although these genes are cotranscribed early in viral infection (Mileham et a l., 1980), 
the activity of TS and possibly D H F R  is dependent on their association into a 
multienzyme complex (Allen et al., 1983; Tomich et al., 1974). Thus, in both 
prokaryotic and eukaryotic cells D H F R  and TS seem to be functionally
5.1) INTRODUCTION:
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Myoda et a l., (1984) has shown that the thy B and D H F R  genes are linked 
closely on the B. subtilis chromosome. Additionally, both genes have been co-cloned 
on a 4.5 kb Bgl II fragment of B. subtilis chromosomal D N A  carried on plasmid 
pERl. They have also shown that each of the T M P r mutations are linked closely (90- 
99 % cotransformation) to the thy B gene. Later on they demonstrated that a single 
mutation is responsible for the elevated dihydrofolate reductase and thymidylate 
synthase activities, indicating D H F R  and thy B are coregulated in B. subtilis. Other 
groups (Albrecht et al., 1966; Crusberg et al., 1970; Freisheim et a l , 1972) also 
have observed that the TS activity is elevated in drug-resistant mutants of either L. 
casei or Streptococcus faecium that overproduce DHFR.
To investigate the possible linkage and co-regulation of TS-DHFR in M. 
tuberculosis, the flanking regions of the putative D H F R  gene (2 kb from either side) 
were sequenced and analyzed for highly conserved TS protein sequence. 
Unfortunately no significant protein homologies were detected, when searches were 
made on protein and nucleic acid data banks, though TS is a highly conserved 
protein. Since this enzyme catalyses the reductive methylation of d U M P  to d T M P  
with the concomitant conversion of 5,10-methylene-tetrahydyrofolate to 7,8- 
dihydrofolic acid and it is the sole de novo source of d T M P  synthesis, it is an 
attractive target for the development of chemotherapeutic agents. Therefore, it was 
decided to clone and characterize the gene for the thymidylate synthase enzyme from 
Mycobacterium tuberculosis. Because of an unavailability of a suitable D N A  probe 
for the library screening and limitations for using oligonucleotide probes, it was
interdependent.
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decided to generate a panel of synthetic degenerate primers from highly conserved 
domains of TS for P C R  and use amplified D N A  as a probe to screen the EMBL4-M. 
tuberculosis library. A  comparison of TS from bacteriophage T4 TS to human TS 
shows strildng similarities at amino acid level. There are six highly conserved 
domains in the whole TS sequence as shown in table 19. Four of these domains were 
used to generate a panel of degenerate primers for PCR. Edman et al., (1989b) have 
isolated the thymidylate synthase gene from Pneumocystis carinii using this approach 
successfully, after the failure of initial attempts to isolate the TS gene from library 
using a variety of heterologous hybridization probes. Hence no attempts were made 
to isolate the TS gene from M. tuberculosis library using heterologous hybridization 
probes. v
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5.2) MATERIALS A N D  M E T H O D S :
All the methods used in this chapter are described in either chapter 2 or 
chapter 4.
5.3) RESULTS A N D  DISCUSSION:
5.3.1) Design of primers for P C R :
Thymidylate synthases isolated from a variety of organisms have many similar 
properties at the functional level (Santi and Danenberg, 1984). The similarities 
between the various synthases are becoming more apparent as more amino acid 
sequences, most derived from D N A  sequencing, become available. The Diagon 
comparison menu, from Staden-plus software (Amersham), between the amino acid 
sequences of the thymidylate synthases from E. coli and L. casei or between any two 
sequences of the thymidylate synthases from any two organisms showed good 
homology. Taylor et al. (1987) have compared the amino acid sequence of the 
thymidylate synthase from ten different organisms ranging from bacteriophage T4 to 
human TS. Table 19 shows a comparison of the amino acid sequence of the 
thymidylate synthase from these organisms. Sequences have been aligned to maximize 
the homologies. Overall comparison indicated four different amino acid domains 
suitable for making degenerate primers for the use in PC R with total genomic D N A  
from M. bovis B C G  as a target. Primer 1 and primer 3 are located in the folate 
binding site while primer 4 is located in the fdUMP site. The external two primers 
were designed with restriction enzyme sites at the 5’ ends, suitable for cloning of the 
P C R amplified DNA. The pair of internal degenerate primers was designed for the 
nested PCR. The mycobacterial codon usage table prepared from all published
164
mycobacterial genes was used in designing primer sequences (see appendix 1 for 
mycobacterial codon usage). Figure 18 shows the sequence of four degenerate 
primers. The complementary strand of Primer 2 and 4 was used for the PCR. The 
primers were synthesized on the Applied Biosystems oligonucleotide synthesizer and 
recovered from columns as per manufacturer’s instructions.
5.3.2) P C R using M. bovis B C G  D N A :
Polymerase chain reactions were performed using a Hybaid Intelligent Heating Block. 
Reaction mixtures (50 pi) were prepared as described in section 4.2.2., except using 
different sets of primers. Different pairs of primers were used for P C R amplification 
at different annealing temperatures as follows:
i) Primer 1 and Primer 2,
ii) Primer 3 and Primer 4
iii) Primer 1 and Primer 4 and
iv) Primer 3 and Primer 2.
The annealing temperatures were used for the reactions were: 37°C, 40°C, 
45°C, 52°C, 55°C and 60°C. As the primers are highly degenerate, initial PC R 
reactions were performed at lower annealing temperatures. As a result of the lower 
annealing temperature a nonspecific D N A  amplification occurred, although some 
bands were quite strong in intensity, however, not of appropriate size. All four 
combinations of primers failed to give D N A  amplification at the annealing 
temperatures of 52°C. An annealing temperature of 45°C resulted in specific D N A  
amplification of approximately 300 bp, using the primer pair of 1 and 4. The 
distance between these two primers i.e. primer 1 and 4, in E. coli is 310 bp and
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Figure 18: The nucleotide sequence of the four degenerate primers used for PCR
Primer 1:
Amino acid: p L LA2 T T IC
Nucleotide:5GGAATTCC C C N  TT^ A C ^  a c q  a a
Primer 2:
Amino acid: Y Q R S V/A D
Nucleotide: 5T A  ^  C A A  C G N T C N G ^ N  G A C  G G A A T T C C 3' 1 G I
Primer 3:
Amino acid: E L  L W  F L
Nucleotide:5G A G  £ T ^  £ T ^  T G G  T T ^ S t 3’1 G 1 G T T
Primer 4:
Amino acid: M  A L P P C H
Nucleotide: A T G  G C N  C C N  C C N  T G C  CA31 G
(N represents any one of the four nucleotides)
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Figure 19: 1.5% agarose gel photograph showing PCR amplified D N A  at 45°C and 
55°C.
2: PCR performed at 45 °C annealing temperature using primer 1 and 4 and 
B C G  D N A  as a target.
3: M W  marker
4: PCR performed at 55°C annealing temperature using primer 3 and 4 and 
310 bp D N A  (purified from agarose gel after first PCR) as a target.
1 and 5: Negative controls at 45°C and 55°C.
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figure 19 shows the band at 310 bp in lane 2, which was loaded with the P C R  
mixtures with primer 1 and 4. Also this pair of primer failed to give D N A  
amplification of E. coli DNA. This is because of the primer specification according 
to the mycobacterial codon usage. Again other primer combinations failed to give 
any D N A  amplification. The amplification of specific D N A  of the size of 
approximately 310 bp using primer 1 and 4 was sufficiently significant to consider as 
highly specific amplification according to the primers.
The 310 bp P C R  amplified D N A  product was purified using Geneclean kit and 
subsequently used for further amplification and for nested PCR. The 310 bp D N A  
product, when used as a target, constantly gave D N A  amplification at higher 
annealing temperatures namely at 45°C, 50°C, 55°C and 60°C. Also when this 310 
bp D N A  is used for nested PCR, using primer 3 and 4 gave D N A  amplification of 
*270 bp, which is the exact distance between primer 3 and primer 4 of E. coli at 
annealing temperatures up to 55°C (Fig. 19). However, when 270 bp amplified D N A  
was purified using Geneclean kit and used as a target gave D N A  amplification at 
higher annealing temperature of 60°C. This indicated that the 310 bp P C R  amplified 
D N A  internally contained the sequence for primer 3, which is true as seen from table 
19. Based on the published sequence data of TS genes, the above results were 
promising and I therefore decided to clone and sequence the PC R amplified DNA.
5.3.3) Cloning and sequencing of the PC R amplified D N A :
The 270 bp PC R amplified D N A  was subsequently used for ligation, after 
filling the ends and phosphorylating the 5’ ends, with Sma I digested pUC18 vector 
D N A  which was dephophorylated to avoid self ligation. The transformation was done
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using high efficiency E. coli DH 5a competent cells, however the efficiency was very 
poor. The exact efficiency was difficult to calculate since the accurate amount of 
D N A  used for ligation was not known. Five white colonies were picked, re­
inoculated and grown overnight. Small scale plasmid D N A  extraction was done from 
overnight grown cultures and the plasmid D N A  were checked for the presence of 
insert DNA. These five plasmid D N A  were double digested with restriction 
enzymes, which are located on either side of Sma I site and electrophoresed on a 
0.8% agarose gel. Due to the very small size of insert it was not seen in digested 
samples. However, undigested D N A  samples when compared with uncut pUC18 
plasmid D N A  show very little but definite difference in molecular weight on the 
stained agarose gel. To confirm the insertion of 270 bp DNA, this gel was Southern 
transferred and membrane was probed with 270 bp PC R amplified radiolabelled D N A  
probe. Subsequent to hybridization, washing and autoradiography two clones showed 
hybridization (pUS157 and pUS158) which were further used for sequencing and as 
the probe.
For sequencing of double stranded DNA, plasmids were isolated (section
2.20.2) and sequencing was carried out as described earlier (2.24). The complete 
sequence of the P C R  product was determined, which was not fully reliable (data not 
shown) and the ends of the sequence obtained from the sequencing correspond to the 
primer sequence 1, 3 and 4 which were used for PC R amplification. Primer 4 
sequence showed the best match in which five out of seven amino acids showed 
complete identity. This confirmed the specific amplification of DNA. The sequence 
is high in G + C  content (63% G + C  content) and to check the D N A  amplified is from
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5.3.4) Screening of the Southern blot of M. bovis B C G :
The Southern blot of M. bovis B C G  digested D N A  was prepared and 
hybridized with radiolabelled Eco RI digested pUS157 DNA. The autoradiograph 
obtained from this gel shows specific hybridization signals, which confirmed that PC R 
amplified D N A  hybridises to specific fragment of M. bovis B C G  D N A  and could be 
used for screening of M. tuberculosis genomic D N A  library.
5.3.4.1) Screening of EMBL4-M. tuberculosis genomic library:
EMBL4-M. tuberculosis genomic D N A  library prepared by Zainuddin (1989) 
was used for screening. Approximately 12000 clones were plated on two large bio­
assay plates and plaques were blotted according to Benton and Davis (1977, section
2.23.1.3) and used for screening with radiolabelled pUS157 D N A  probe. The first 
round of screening resulted in ten possibly positive clones showing hybridization 
signals on the X-ray film. Since the clones were not isolated on the bio-assay plate, 
the ten regions, corresponding to the regions on the X-ray film, were picked and 
resuspended in 100 p i of S M  buffer overnight and plated again for blotting and 
hybridization. The second round of screening resulted in eight positive clones, 
although most of them were not pure. Two filters, 1 and 6 show no hybridization at 
all. From the remaining eight filters, six individual well isolated plaques showing 
strong hybridization signals were picked for final screening. The third round of 
screening resulted in 100% hybridization of plaques, showing the purity of the clones 
(Fig. 20).
M. bovis BCG following experiment was performed.
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Figure 20: An autoradiograph of plaque blot hybridization
Final screening of clone 3.1 and 3.2. Probe used was radiolabelled 270 bp PCR 
amplified DNA.
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These six clones were amplified and phage D N A  was isolated using liquid 
lysate method (section 2.20.6). The D N A  samples were digested with Bam HI, 
electrophoresed on 1% agarose gel and stained with 2 pg/ml ethidium bromide. All 
six clones showed a similar restriction pattern and are probably re-isolates of the same 
clone, hence only one clone, namely 3.1, was used for further analysis. The clone 
3.1 contained —11 kbp insert with one internal Bam HI site. Figure 21a and 21b 
show the agarose gel photograph and the autoradiograph of clone 3.1 D N A  digested 
with Bam HI, Eco Rl, Bam HI+Eco Rl, Sal I, Sma I and Kpn I and hybridized with 
radiolabelled pUS157 D N A  and figure 22a shows the restriction map of the clone 3.1 
phage DNA. This clone contain number of Sail, Sma I and Kpn I restriction sites 
and hence restriction map with respect to these sites was not prepared. According 
to an agarose gel photograph and hybridization data (fig. 21a and 21b) one fragment 
from each digest of Bam HI, Sal I, Sma I and Kpnl was chosen for subcloning into 
pU C plasmid vectors. Figure 21 also show digested B C G  D N A  samples and 
hybridized with the radiolabelled pUS157 DNA. From the autoradiograph it can be 
seen clearly that 4 specific fragments from 4 B C G  D N A  digests show hybridization 
to the probe. These fragments are (i) 7.7 kbp Bam HI fragment, (ii) 2.2 kbp Sal I 
fragment, (iii) 3.4 lcbp Sma I fragment and (iv) 4.3 kbp Kpn I fragment, which 
exactly correspond to the hybridization signals from the corresponding lanes of the 
clone 3.1 D N A  digests. This data confirms that the Clone 3.1 contain the 
corresponding fragments from the B C G  DNA.
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Figure 21 A: 0.8% agarose gel photograph of clone 3.1 and M. bovis B C G  digested 
DNA.
1: Lambda D N A  / Hind III - M W  marker
2: Clone 3.1 D N A  / Bam HI
3: Clone 3.1 D N A  / Eco RI
4: Clone 3.1 D N A  / Bam HI +  Eco RI
5: Clone 3.1 D N A  / Sal I
6: Clone 3.1 D N A  / Smai
7: Clone 3.1 D N A  / Kpn I
8: B C G  / Bam HI
9: B C G  / Sal I
10: B C G  / Sma II
11: B C G  / Kpn I
Figure 2IB: An autoradiograph of the southern blot of the gel shown in figure 21 A. 
Probe used was radiolabelled 270 bp P C R  amplified D N A
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Fig 22 : Structure of different recombinant clones of the putative 
thymidylate synthase gene
a) Phage clone 3.1:
B B
I 1 1 Kbp
B
7.7 kbp 3.4 kbp
Left arm Right arrm
b) pUS159:7.7 kbp Bam HI fragment of phage clone 3.1 cloned 
inpUC19
B B
pUC19
c) pUS160:3.4 kbp Sma I fragment of phage clone 3.1 cloned 
inpUC19 S S
pUC19
d) pUS161:2.2 kbp Sal I fragment of phage clone 3.1 ccloned 
mpUC19 SalI San
pUC19
e) Sequencing strategy of 2.2 kbp Sal I fragment cloned 
inM13mpl9 1 Kbp
Sail Sail
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5.3.5) Subcloning in p U C  vectors:
Subcloning of 7.7 kb Bam HI fragment, 3.4 kb Sma I fragment and 2.2 kb Sal 
I fragment of the clone 3.1 phage D N A  which showed hybridization to the 
radiolabelled pUS157 D N A  was done into pUC19 vector. Three white transformants 
from each transformation were selected, plasmid D N A  were extracted using small 
scale alkaline lysis method (2.20.2) and confirmed to have proper size inserts in each 
clone. All these subclones showed hybridization with pUS157 D N A  as a 
radiolabelled probe. The clone (i) pUS159 contains 7.7 kb Bam HI insert, (ii) 
pUS160 contains 3.4 kb Sma I insert and (iii) pUS161 contains 2.2 kb Sal I insert of 
Clone 3.1 phage D N A  (Fig. 22, a-d). These subclones were further used for 
complementation studies. The exact location and of Sal I, Sma I and Kpn I fragment 
on 7.7 kbp Bam HI fragment was not determined. Also the orientations of the inserts 
with respect to lac promoter in pUC19 was not determined.
5.3.6) Complementation of E. coli TS~ cells:
JD 317 strain of E. coli (Personal collection of Dr. J.W. Dale) was unable to 
grow on minimal medium unless supplemented with thymine. The competent cells 
from this strain were prepared and used for transformation. If the TS is expressed 
from any of the above three clones, when introduced into TS deleted E. coli cells will 
complement the TS minus genotype and the transformed cells will be able to grow 
on minimal medium. However none of the transformants were able to grow on 
minimal medium containing ampicillin. This may be the result of applying sudden 
pressure on the transformants, hence subsequently the transformants were initially 
grown on LB agar plates containing ampicillin and then replicated on minimal
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medium. Random selection of 50 transformants from each plasmid were done and 
replica plated on minimal medium +  ampicillin, minimal medium +  thymine 4- 
ampicillin and incubated overnight. All the transformants grew on medium containing 
thymine but failed to grow on minimal medium without thymine. This indicated that 
either mycobacterial TS failed to complement E . c o l i TS or the enzyme was not 
expressed or if expressed was not functional. This may be because of lack of post- 
translational modifications (see discussion chap. 6) of mycobacterial enzymes in E .  
c o l i hosts, although there are many reports of expression of mycobacterial proteins 
in E . c o l i . Another explanation for the failure in complementation could be the lack 
of multienzyme complex. Previous reports suggests that the activity of thymidylate 
synthase and possibly dihydrofolate reductase is dependent on their association into 
a multienzyme complex and in both prokaryotic and eukaryotic cells, TS and D H F R  
seem to be functionally interdependent. Neuhard e t  a l . (1978) had shown that there 
are two thymidylate synthases in B . s u b t i l is . These two enzymes are coded by two 
separate genes th y  A  and th y  B, which are unlinked genes on the B . s u b t i lis  
chromosome. They had also shown that the two genes codes for two separate 
thymidylate synthases having different enzymatic properties, although the 
physiological function of the two TSases is not known. The possibility of the second 
TS having a function during differentiation is postulated (Neuhard e t  a l., 1978), but 
not yet proved. According to Wilson e t  a l . (1966) mutations are required in both th y  
A  and th y  B  for thymine auxotrophy. All this data may be relevant to the 
mycobacterial TS and may possibly explain the failure of complementation of TS 
minus E . c o l i cells.
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The 2.2 kb insert from pUS161 was subcloned in M 1 3 m p l 9  bacteriophage 
vector and four clones were randomly selected and sequenced using dideoxy method. 
The clones were obtained in both orientations: three clones in one orientation and the 
fourth clone in the opposite orientation. Synthetic oligonucleotide primers were 
synthesised and used for sequencing. Figure 22e shows the sequencing strategy and 
figure 23 shows the complete sequence of 2.2 kb Sal I insert of clone pUS161. The 
sequence is 63.7% in G + C  content. Detailed analysis of sequence using Staden-plus 
software revealed one long open reading frame from 1 to 1371 nucleotides and 
Sheperds R N Y  analysis predicts possibility of D N A  coding region. Search of protein 
databanks with these 456 amino acids failed to show any significant homology with 
known protein sequences. The P C R  product D N A  sequence obtained from 
sequencing of plasmid pUS157 and pUS158 was compared with this sequence and it 
showed considerable identity from nucleotide number 140 to 400 in figure 23. 
Primer 4 sequence matches with good homology from base 385 to 405. Primer 3 
sequence does not show good matches with bases « 2 7 0  upstream to the primer 4 
region and primer 1 matches well at bases 23 to 41. It shows perfect match of 6 
nucleotides at the 3 ’ end of the primer.
The detailed analysis of the sequence showed a possible Shine-Dalgarno 
sequence (83-89 in fig.23) five bases upstream to the possible start codon A T G .  
Figure 23 also shows the deduced amino acid sequence (426 amino acids) of in single 
letter code which has the molecular weight of 45480. Table 20 shows the codon 
usage of the putative thymidylate synthase gene from M . tu b e r c u lo s is . This coding
5.3.7) Sequence determination of pUS161:
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T T T C G A G G G C T C G G G A C A T T T C C C G T T T C A C G A C G A C C C T G C G C G C T T C A T C G A C A T C G T
440 460 480
R T L H G H T E P A E Y D Q A A L R C A
C G A A C G C T T C A T G G A C A C A C T G A G C C C G C C G A A T A C G A C C A G G C C G C G C T G C G C T G T G C T
500 520 540
S P G W R R T T V T G S A D T R V A V L
T C G C C G G G G T G G C G G C G A A C A A C C G T C A C C G G C T C G G C A G A C A C C C G T G T T G C A G T A C T G
560 580 600
N A I G S N E R S A T L I T T G S V R A
A A C G C C A T C G G G T C C A A C G A A C G C A G C G C T A C C C T G A T C A C C A C C G G G T C T G T T A G G G C T
620 640 660
L P Q V V Q S G H G I E V S V L R V F T
C T T C C C C A G G T C G T A C A G T C G G G C C A T G G C A T T G A G G T T T C G G T G T T G C G G G T T T T C A C C
680 700 720
D S D G N F G N P L G V I N A S K V E H
G A T T C A G A C G G G A A T T T C G G T A A T C C G C T G G G G G T G A T C A A C G C C A G C A A G G T C G A A C A C
740 760 780
R D R Q Q L A A Q S G Y S E T I F V D L
C G C G A C A G G C A G C A G C T G G C A G C C C A A T C G G G C T A C A G C G A A A C C A T A T T C G T C G A T C T T
800 820 840
P S P G S T T A H A T I H T P R T E I P
C C C A G C C C C G G C T C A A C C A C C G C A C A C G C C A C C A T C C A T A C T C C C C G C A C C G A A A T T C C G
860 880 900
F A G H P T V G A S W W L R E R G T P I
T T C G C C G G A C A C C C G A C C G T G G G A G C G T C C T G G T G G C T G C G C G A G A G G G G G A C G C C A A T T
920 940 960
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N T L Q V P A G I V Q V S Y H G D L T A
A A C A C G C T G C A G G T G C C G G C C G G C A T C G T C C A G G T G A G C T A C C A C G G T G A T C T C A C C G C C
980 1000 1020
I S A R S E W A P E F A I H D L D S L D  
A T C A G C G C C C G C T C G G A A T G G G C A C C C G A G T T C G C C A T C C A C G A C C T G G A T T C A C T T G A T  
1030 1040 1050 1060 1070 1080
A L A A A D P A D F P D D I A H Y L W T
G C G C T T G C C G C C G C C G A C C C C G C C G A C T T T C C G G A C G A C A T C G C G C A C T A C C T C T G G A C C
1100 1120 1140
W T D R S A G S L R A R M F A A N L G V
T G G A C C G A C C G C T C C G C T G G C T C G C T G C G C G C C C G C A T G T T T G C C G C C A A C T T G G G C G T C
1160 1180 1200
T E D E A T G A A A I R I T D Y L S R D
A C C G A A G A C G A A G C G A C C G G T G C C G C G G C C A T C C G G A T T A C C G A T T A C C T C A G C C G T G A C
1220 1240 1260
L T I T Q G K G S L I H T T W S P E G W
C T C A C C A T C A C C C A G G G C A A A G G A T C G T T G A T C C A C A C C A C C T G G A G T C C C G A G G G C T G G
1280 1300 1320
V R V A G R V V S D G V A Q L D *
G T T C G G G T A G C C G G C C G A G T T G T C A G C G A C G G T G T G G C A C A A C T C G A C T G A C G T A G A G C T
1340 1360 1380
C A G C G C T G C C G A T G C A A C A C G G C G G C A A G G T G A T C C T G C A G G G G T T G C C C G A C C G C G C G C
1400 1420 1440
A T C T G C A A C G A G T A C G A A A G C T C G T C G C C G T C G A T G C G G T A G G A A C G G T C A A G G G C G G T C
1460 1480 1500
A C C T C T T T T G C G G T C G G G G C C A A T C C G A T C G A C C C A T C C G C G C G T G T G G A C A A T T C G A G T
1520 1540 1560
T C G A T G A C G T C A C C G G T C A C C G A A T A G G T T C C A A C C T C A A T T T C G G T G A T G C C G C T T G G A
1580 1600 1620
T G G G C G A G A A C G A G T T C A A C G C A G C C C G G T C G G C A A A C G C G G A G A T A C C C C G T C T C G G A A
1640 1660 1680
T G C A G C G G C T T C C C G T C A C G T A C C G C C C T G G T C T G C T G T G T G T A G C T C A G A A A C G G T T T A
1700 1720 1740
C C C A C A T G G G C G A A T A C G A C T T C C T C G A G G T A T T C G A A C G G C C G G A T G G T G G G G T A C T T G
1760 1780 1800
C G C C A C G C G A C C C G C C C A A C G C C C A G G A G G G G T G A C A G C G C T G C A G G G C A G G G G C C A G A T
1820 1840 1860
C T C G G G T C A T C G C C G C T T G C G G G G G A C A G G C A T G C G G G A A G C C T A G C G C C G C G A G A T C G G
1880 1900 1920
T C A G C T G T G G G C T G A T A G G T T G C G G T G C G C G A A G C G C C T C A A T C T C G C G C G C G A A A T C G T
1940 1960 1980
C C G C G G A A G A A A A C G A C C G G T A G A C C G A C G C G A A C C G T A G G T A G G C C A C C T C G T C A A G C T
2000 2020 2040
C G C G C A A C G G G C C C A G G A T A G C C A G G C C G A C A T C G T G A C T C G G A A T C T C C G G C G A C C C C G
2060 2080 2100
C G G C A C G C A C C G A A T C C T C G A C T T G C T G A G C C A G C A G G T T C A A C G C A T C G T C G T C G A C
2120 2140 2158
F ig u r e  2 3 : N u c le o t id e  s e q u e n ce  o f  t h e  p u t a t i v e  t h y m id y la t e  
s y n th a s e  gene  f ro m  M. tuberculosis. The a r ro w s  i n d ic a t e  
(8 3 -8 9 )  t h e  p r e s u m p t iv e  r ib o s o m e - b in d in g  s i t e .  The d e d u ce d  
am in o  a c id  s e q u e n ce  i s  shown i n  o n e - l e t t e r  c o d e .
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T a b le  20 : Codon u sa g e  t a b le  o f  t h e  p u t a t i v e  t h y m id y la t e  
s y n th a s e  gene  f ro m  M. tuberculosis
F TTT 5 . S TCT 1 . Y TAT 0 . C TGT 2 .
F TTC 6 . S TCC 4 . Y TAC 6 . C TGC 3 .
L TTA 0 . S TCA 5 . * TAA 0 . * TGA 1.
L TTG 5 . S TCG 9 . * TAG 0 . W TGG 13 .
L CTT 8 . P CCT 2 . H CAT 7 . R CGT 4 .
L CTC 7 . P CCC 1 2 . H CAC 11 . R CGC 9 .
L CTA 1 . P CCA 4 . Q CAA 5 . R CGA 9 .
L CTG 13 . P CC G 9 . Q CAG 1 1 . R CGG 9 .
I ATT 6 . T ACT 3 . N AAT 2 . S AGT 1 .
I ATC 16 . T ACC 2 5 . N AAC 5 . S AGC 8 .
I ATA 1 . T ACA 3 . K AAA 1 . R AGA 2 .
M ATG 3 . T ACG 3 . K AAG 2 . R AGG 3 .
V GTT 8 . A GCT 7 . D GAT 9 . G GGT 5 .
V GTC 9 . A GCC 2 7 . D GAC 1 5 . G GGC 1 7 .
V GTA 4 . A GCA 9 . E GAA 9 . G GGA 6 .
V GTG 1 0 . A GCG 9 . E GAG 5 . G GGG 12 .
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T a b le  2 1 : The am in o  a c id  c o m p a r is o n  o f  f i v e  t h y m id y la te  
s y n th a s e  g e n e s  w i t h  p u t a t i v e  TS fro m  M. tuberculosis, 
u s in g  c l u s t a l  a n a ly s is  p ro g ra m m e .
B S T S  M ---------------------------- ”K Q  Y K D F C R H V L E H G E K K G D R T G T G T I S T F G Y  - Q M R F N
E C T S  M ---------------------- — — - - K Q Y L E L M Q K V L D E G T Q K N D R T G T G T L S I F G H - Q M R F N
H S T S  M S T --------H T E E Q H G E H —  Q Y L S Q V Q H I L N Y G S F K N D R T G T G T L S I F G T - Q S R F S
L C T S  M C R --------W N G K G A E Q T M L E Q P Y L D L A K K V L D E G H F K P D R T H T G T Y S I F G H - Q M R F D
S CTS M T M --------D G K N K E - E E  Q Y L D L C K R I I D E G E F R P D R T G T G T L S L F A P P Q L R F S
M T T S  M A L L R L P L V L P A V Q I A G R I V G Q G H R Y H Q L G A R P A Q C A A H F G R P A R A D G F C G - V R P L R Q W W
B S T S  L R E G - F P M L T T K K L H F K S I A H E L L W ----- F L K G D T N V R Y L Q E N G V R I W N E W A D E N ------
E C T S  L Q D G - F P L V T T K R C H L R S I I H E L L W ----- F L Q G D T N I A Y L H E N N V T I W D E W A D E N ------
H S T S  L - E N E F P L L T T K R V F W R G V V E E L L W — — - F I R G S T D S K E L S A A G V H I W D ------- -----
L C T S  L S K G - F P L L T T K K V P F G L I K S E L L W ----- F L H G D T N I R F L L Q H R N H I W D E W A F E K W V K S
S C T S  L R D D T F P L L T T K K V F T R G I I L E L L W ------F L A G D T D  A N L L S  EQCjVKI W D --------------
M T T S  T G G G R W S P C W T D A I S T E A I P V Q I I W G T K D W L P V R H A H M A L P P S G L A I G D F R G L G T F P V S  
: . . .  * . :  * . . . *  * . * * * *
B S T S ---------------------------------------------------------------- G E L G P V Y G S Q W R S
E C T S ---------------------------------------------------------------- G D L G P V Y G K Q W R A
H S T S ---------- - A N G S R S - - -----------F L D K L G - F Y D R — *--------- D E G D L G P V Y G F Q W R H
L C T S  D E Y H G P D M T D F G H R S Q K D P - E F A A V Y H E E M A K F D D R V L H D D A F A A K Y G D L G L V Y G S Q W R A
S C T S ------------G N G S R E ------------- Y L D K M G - F K D R --- - ------- K V G D L G P V Y G F Q W R H
M T T S  R R P C A L H R H R R T L H G H T E P A E Y D Q A A L R C A S P G W R R T T V T G S A D T R V A V L N A I G S N E R S A
B S T S  W ---------------- R G A D G E T I D - Q I S R L I E D I K T N P N S R R L I V S A W N V G E I D K M A L P P C H
E C T S  W ---------------- P T P D G R H I D - Q I T T V L N Q L K N D P D S R R I I V S A W N V G E L D K M A L A P C H
H S T S  F ----- G A E Y K G V G R D Y K G E G V D - Q L K Q L I D T I K T N P T D R R M L M C A W N V S D I P K M V L P P C H
L C T S  W ---------------- H T S K G D T I D - Q L G D V I E Q I K T H P Y S R R L I V S A W N P E D V P T M A L P P C H
S C T S  F ----- G A K Y K T C D D D Y T G Q G I D - Q L K Q V I H K L K T N P Y D R R I I M S A W N P A D F D K M A L P P C H
M T T S  T L I T T G S V R A L P Q V V Q S G H G I E V S V L R V F T D S D G N F G N P L G V I N A S K V E H R D R Q Q L A A Q S  
* .* * .  * .  .. .. * .*.. *: :*..
B S T S  C L F Q - F Y V ------   S D G K L S C Q -----------------------L Y Q R S A D V - F L G V P F N I A
E C T S  A F F Q - F Y V ------------ A D G K L S C Q ------------------— L Y Q R S C D V - F L G L P F N I A
H S T S  V L S Q - F Y V C ------------ D G K L S C Q -------   - L Y Q R S A D M - G L G V P F N I A
L C T S  T L Y Q - F Y V  ------- N D G K L S L Q ------------    L Y Q R S A D I - F L G V P F N I A
S C T S  I F S Q - F Y V S F P K E G E G S G K P R L S C L   ------   L Y Q R S C D M - G L G V P F N I A
M T T S  G Y S E T I F V D L P S P G S T T A H A T I H T P R T E I P F A G H P T V G A S W W L R E R G T P I N T L Q V P A G I V
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BSTS SYALLTM IIAH VTG LE-PG EF-IH TFG -- -DVHIYQNHIEQ-VNLQLERDVRPLP
ECTS SYALLVHMMAQQCDLE-VGDF-VWTGG-----------------DTHLYSNHMDQ-THLQLSREPRPLP
HSTS SYSLLTCM IAHVTNLV-LG EF-IHTIG — --------— DAHIYVDHIDA-LKMQLTRTPRPFP
LCTS SYALLTHLVAHECGLE-VGEF-IHTFG - — -DAHLYVNHLDQ-IKEQLSRTPRPAP
SCTS SYALLTRMIAKVVDME-PGEF-IHTLG--------  — ----DAHVYKDHIDA-LKEQITRNPRPFP
MTTS QVSYHGDLTAISARSEWAPEFAIHDLDSLDALAAADPADFPDDIAHYLWTWTDRSAGSLR 
. * * *  * * .  . *  . * . * .  *
BSTS QLRFARKVDS------------------------ IF N F A F E D F IIE D ----------- --------YDPHPHIKGAVSV— -
ECTS K L IIK R K P E S ------------------------ IFDYRFEDFEIEG-------------------YDPHPGIKAPVAI------
HSTS TLRFARNVSC------------------------ ID D FKAD D IILEN -------------------YNPHPIIKMHMAV------
LCTS TLQLNPDKHD------------------------ IFDFDMKDIKLLN— ---------------YDPYPAIKAPVAV------
SCTS KLKIKRDVKD------------------------IDDFKLTDFEIED-------------------YNPHPRIQMKMSV------
MTTS ARMFAANLGVTEDEATGAAAIRITDYLSRDLTITQGKGSLIHTTWSPEGWVRVAGRVVSD 
. *  . *  * .  * .  *  . . *  . . : *
B S T S ------------
E C T S ------------
H S T S ------------
L C T S ------------
S C T S ------------
MTTS GVAQLD
K ey : BSDI -  B. subtilis t h y m id y la t e  s y n th a s e  
ECTS -  E. coli t h y m id y la t e  s y n th a s e  
HSTS -  Herpesvirus saimiri t h y m id y la t e  s y n th a s e  
LCTS -  L. casei t h y m id y la t e  s y n th a s e  
SCTS -  S. crrevisiae t h y m id y la t e  s y n th a s e  
MTTS -  M. tuberculosis t h y m id y la t e  s y n th a s e  
*  — m a tc h  a c ro s s  3 o r  m ore  in c lu d in g  MTTS 
. -  c o n s e r v a t iv e  s u b s t i t u t i o n
: = i d e n t i c a l  o r  c o n s e r v a t iv e  s u b s t i t u t i o n  w i t h  
r e s p e c t  t o  MTTS
The underline regions show where primer 3 and 4 are thought to bind and the 
overline regions show where they were designed for.
182
Complementary strand sequence of the sequence shown in figure 23
2158 2129 2099
GTC GAC GAC GAT GCG TTG AAC CTG CTG GCT CAG CAA GTC GAG GAT TCG GTG CGT GCC GCG
Val Asp Asp Asp Ala Leu Asn Leu Leu Ala Gin Gin Val Glu Asp Ser Val Arg Ala Ala
2069 2039
GGG TCG CCG GAG ATT CCG AGT CAC GAT GTC GGC CTG GCT ATC CTG GGC CCG TTG CGC GAG
Gly Ser Pro Glu lie Pro Ser His Asp Val Gly Leu Ala lie Leu Gly Pro Leu Arg Glu
* * - * * * - - - *
2009 1979
CTT GAC GAG GTG GCC TAC CTA CGG TTC GCG TCG GTC TAC CGG TGG TTT TCT TCC GCG GAC
Leu Asp Glu Val Ala Tyr Leu Arg Phe Ala Ser Val Tyr Arg Trp Phe Ser Ser Ala Asp
- * * * * * - * * * * * * * *
1949 1919
GAT TTC GCG CGC GAG ATT GAG GCG CTT CGC GCA CCG CAA CCT ATC AGC CCA CAG CTG ACC
Asp Phe
k
Ala Arg Glu
'k
lie Glu Ala Leu
*
Arg Ala Pro Gin Pro lie Ser Pro Gin Leu Thr
1889 1859
GAT CTC GCG GCG CTA GGC TTC CCG CAT GCC TGT CCC CCG CAA GCG GCG ATG ACC CGA GAT
Asp Leu Ala Ala Leu Gly Phe Pro His Ala Cys Pro Pro Gin Ala Ala Met Thr Arg Asp
1829 1799
CTG GCC CCT GCC CTG CAG CGC TGT CAC CCC TCC TGG GCG TTG GGC GGG TCG CGT GGC GCA
Leu Ala Pro Ala Leu Gin Arg Cys His Pro Ser Trp Ala Leu Gly Gly Ser Arg Gly Ala
1769 1739
AGT ACC CCA CCA TCC GGC CGT TCG AAT ACC TCG AGG AAG TCG TAT TCG CCC ATG TGG GTA
Ser Thr Pro Pro Ser Gly Arg Ser Asn Thr Ser Arg Lys Ser Tyr Ser Pro Met Trp Val
AAC CGT TTC TGA
Asn Arg Phe End
B . s u b t i l i s dnaB gene
30 60
GAA TTC AGC AGA GAA AAA ATG CTG CGC GGC CTC ATA AAA GCA TGT GAA AAA AGG CCT GTT
Glu Phe Ser Arg Glu Lys Met Leu Arg Gly Leu lie Lys Ala Cys Glu Lys Arg Pro Val
90 120
TCA CTC AAA ACG CTT GAA GAC ATG TGC TTT GAT ATT GAA AAA GAA CTT CGC AAT CAA GGC
Ser Leu Lys Thr Leu Glu Asp Met Cys Phe Asp lie Glu Lys Glu Leu Arg Asn Gin Gly
150 180
TGC TCC GAG GTG AAG AGT GAG CTC GTC GGA GAA ATG GTC ATG GAC CGG CTG GCT AAG ATT
Cys Ser Glu Val Lys Ser Glu Leu Val Gly Glu Met Val Met Asp Arg Leu Ala Lys lie
* * - * * * - - - * -
210 240
GAC GAA GTC GCA TAT GTG CGG TTC GCG TCC GTC TAT CGG CAG TTT AAA GAT ATA AAC GTC
Asp Glu Val Ala Tyr Val Arg Phe Ala Ser Val Tyr Arg Gin Phe Lys Asp lie Asn Val
* * * * * - * * * * * * * *
270 300
TTT ATC GAT GAA TTA AAA GAC TTA ATA AAG AAA GAG CGT TAA
Phe lie Asp Glu Leu Lys Asp Leu H e Lys Lys Glu Arg End
* * _ *
Figure 24: Homology comparison of unidentified ORF from complementary 
strand of putative thymidylate synthase with unknown ORF next to d n a B  
gene of B . s u b t i l i s . * represents identical amino acid and - represents 
conservative substitution.
\
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reading region of 426 amino acids was analyzed for the amino acid comparison with 
five thymidylate synthase sequences and table 21 shows the result obtained using the 
clustal analysis programme. F rom the table it can be concluded that putative 
thymidylate synthase gene from M . tu b e r c u lo s is  shows some homology with the 
five other sequences at amino acid level. However, the programme failed to align 
the primer regions to the amino acids from which the primer sequences were 
designed. This may indicate the possibility of continuous open reading frame beyond 
the upstream region of the sequenced clone. Thus further experiments like 
complementation, expression of the gene and detection of the activity of the enzyme 
are necessary to investigate the identity this gene.
Though the data bank (Swissprot protein data bank released on July29, 1991) 
search failed to show any homology with thymidylate synthase sequences, a stretch 
of amino acids from complementary strand downstream from the putative T S  gene 
showed a strong homology with an unknown open reading frame next to dna B  gene 
of B . s u b t i lis  (Hoshino e t  a l . , 1987) (figure 24). The significance of the homology 
is not known.
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6) GENERAL DISCUSSION
During the initial stages of study of the molecular biology of mycobacteria, 
it was very difficult to consider the expression of mycobacterial genes in E . c o l i .  
This was partly due to the belief that organisms such as mycobacteria with high G  +  C  
content in their D N A  must use radically different transcriptional and translational 
control systems from those in E . c o l i; it would therefore be impossible to get decent 
levels of expression in E . c o l i . This view was to some extent substantiated, for 
example, by the failure of mycobacterial cosmid libraries to complement any of a 
range of auxotrophic defects in an E . c o l i host strain (Clark-Curtiss e t  a l ,  1985; 
Jacobs e t  a l . , 1986b), although complementation of a citrate synthase mutation was 
demonstrated using an expression vector (Jacobs e t  a l ,  1986a). However, work by 
Thole e t  a l . , (1985) and Moss (1987) had shown that mycobacterial antigens are 
expressed weakly in E . c o l i and can be detected using the technique of Western 
blotting.
6.1) 19 kDa antigen of M .  b o v i s :
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The complete sequence of the gene for 19 kDa antigen from M . b o v is  
presented in Chapter 3 is exactly identical to the corresponding gene from M .  
tu b e r c u lo s is  (Ashbridge e t  a l . , 1989), which reveals the close relatedness of the two 
organisms (Imaeda, 1985). Since this gene is very specific to M . b o v is ,  M .  
tu b e r c u lo s is  and M . b o v is  B C G ,  with the exception of the two strains of M . k a n s a s ii 
(Collins e t  a l . , 1990), the P C R  technology can be used for the detection of bovine 
and human tuberculosis. Using this sequence information, various attempts are being 
made to develop simple detection system for bovine tuberculosis using fluorescent 
labelled primers for the P C R  (Woolford and Dale, Personal communication).
The sequence information has also been used to compare various aspects of 
the gene with use of computer programmes. The sequence did show a typical Shine- 
Dalgarno sequence as shown in figure 6. The lack of a typical promoter consensus 
sequence may be because of the short 5 ’ flanking D N A  present in the clone. 
Biochemical properties and sequence analysis suggest that it may be a secreted antigen 
and it may represent a class of lipoprotein, possibly involved in transport of nutrients 
through the mycobacterial cell wall (Young e t  a l . , 1990).
A n  additional feature of the 19 kDa antigen is the nature of antigenicity. This 
relatively small protein is found to be highly antigenic. The production of 
recombinant mycobacterial proteins which are antigenic in nature may lead to 
immunization of mice and to investigate the effect on the growth of mycobacteria 
since according to Colston (1990), a "trial and error" approach to study a protective
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immune response using cloned antigens is the only practical approach available at 
present. Since this protein can be expressed in E . c o l i , purified protein can be 
obtained for determination of antigenic epitope by peptide mapping. This information 
will be useful to understand the structure, function and regulation of the 19 kDa 
protein antigen of M . b o v is  and M . tu b e r c u lo s is .
6.2) D H F R  and TS gene from M . tu b e r c u lo s is :
The folate antagonists are an important class of therapeutic compounds, as 
evidenced by their use as antiinfective, antineoplastic, and antiinflammatory drugs. 
Thus far, all of the clinically useful drugs of this class have been inhibitors of 
dihydrofolate reductase (DHFR), a key enzyme in the synthesis of thymidylate, and 
therefore D N A .  The putative dihydrofolate reductase and thymidylate synthase genes 
cloned and sequenced from M y c o b a c te r iu m  tu b e r c u lo s is  showed detectable homology 
with the published sequences of both the genes at the amino acid level. Homologies 
at the nucleic acid level are usually difficult to detect if the organisms have high 
G + C  content, which is the case for M y c o b c a te r iu m  tu b e r c u lo s is . However, the 
homologies of both the genes at the amino acid level are not high enough to confirm 
the identity of the genes. In the case of dihydrofolate reductase 
bacterial resistance is mostly through the transfer of plasmid-encoded resistant enzyme 
and so far all enzymes coded by bacterial plasmids show great variation at D N A  and 
protein level (Amyes e t  a l . , 1989; Broad and Smith, 1982). Thus the putative 
dihydrofolate reductase gene from M y c o b a c te r iu m  tu b e r c u lo s is  was checked for D N A  
and amino acid homologies with all published plasmid-encoded enzymes, which did 
not reveal any significant homologies.
Both the genes failed to complement E . c o l i mutants. The failure m a y  be the 
result of different possibilities. One of them is the lack of postranslational 
modifications of the translated protein. The other possibility is the absence of the 
complex of the proteins. As shown in many cases, for the expression of 
dihydrofolate reductase and thymidylate synthase, a complex of at least five proteins 
is required and the expression of these enzymes is linked to the effective combination 
of all the proteins (Chui e t  a l., 1982; Jazwinski and Edelman, 1984). Hence for the 
confirmation of these genes, cloning in mycobacterial mutants itself seems to be one 
of the alternative. Although rapid success has been achieved over the last few years 
in the cloning of genes encoding protein antigens from pathogenic mycobacteria in 
E . c o l i , direct attempts to clone mycobacterial genes coding for proteins with known 
enzyme activities have met with only limited success (Clark-Curtiss e t  a l . , 1985; 
Jacobs e t  a l . , 1986b; Husson e t  a l . , 1990; Garbe e t  a l . , 1990). However, 
it must be considered possible that the genes described in this thesis do not 
correspond to D H F R  and T S  genes.
6.3) Mycobacterial gene expression and regulation:
The sequence information obtained from all the three genes studied during this 
work adds to the initial indirect confirmation of data of mycobacterial gene expression 
and regulation. Although in most cases direct confirmation of the regulatory 
processes is lacking in mycobacteria, sufficient information is now available, through 
gene cloning and sequencing, to infer that most of the systems will be found to be 
essentially similar to those operating in other bacteria.
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Mycobacterial gene expression at the transcriptional level does not seem to 
differ fundamentally from other microorganisms. Promoter probe studies confirmed 
that some mycobacterial promoters are recognised by E . c o l i transcriptional 
machinery very efficiently. A n  earlier comparative study done by Kieser e t  a l .  
(1986) showed that mycobacterial D N A  in E . c o l i and in S tre p to m y c e s  liv id a n s  can 
act as promoters, though more efficiently in S . liv id a n s . The computer analysis of 
all the published mycobacterial genes also showed that most of the mycobacterial 
genes contain typical consensus sequence for -10 and -35 promoter region (Dale and 
Patki, 1990). L a m b  and Colston (1986) also showed that M . le p r a e  D N A  can be 
expressed in Streptomyces. However, these studies do not prove that the fragment 
cloned in a promoter probe vector or the promoter region identified by computer 
analysis, actually has promoter activity in mycobacteria. Further studies by SI 
analysis, in mycobacteria and in E . c o l i and direct R N A  polymerase binding studies 
are necessary to confirm the nature of transcriptional control in mycobacteria.
The translational control in mycobacteria also does not seem to differ 
significantly from other organisms. The Shine-Dalgarno sequence which is required 
for the attachment of ribosomes on the m R N A  show a typical consensus sequence 4-7 
bases upstream to a start codon. In most of the sequences of mycobacterial genes 
sequenced so far, the Shine-Dalgarno consensus sequence does exists with minor base 
changes. (Dale and Patki, 1989). The important feature of the start codon which 
should be noted is the use of G U G  as a start codon in mycobacteria as frequently as 
A U G .  These start codons are identified on the basis of promoter region and Shine- 
Dalgarno sequence, by computer analysis and hence may not be the actual start
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codons in the mycobacterial system. While the number of sequences recorded is still 
too small to make any firm predictions, the use of G U G  as a start codon would be 
consistent with the higher G + C  content in mycobacteria.
All the mycobacterial genes sequenced so far, show a relatively high degree 
of codon bias, which is reflected in a predominance of those codons with G  or C  at 
position 3. W e  have shown that the codon bias is much more pronounced for M .  
t u b e r c u lo s is  than for M . le p r a e , which is consistent with the lower G + C  content of 
the D N A  of the latter. For example, of the six available serine codons, three "G/C" 
codons U C C ,  U C G ,  A G C  account for 88%  of the serine residues in M . tu b e r c u lo s is  
genes, while in M . le p r a e  the distribution of serine codons is comparatively even 
apart from the low level of A G U  codons (Dale and Patki, 1990). It has been shown 
in unicellular organisms that a strong connection exists between protein expressivity 
and the degree of codon bias, which, in the extreme case, leads to the so-called major 
codon bias (Gouy and Gautier, 1982; Grosjean and Fiers, 1982; Sorensen e t  a l . ,  
1989). The other functional parameters such as the rates of translation, protein 
expression levels and cellular growth rates can be studied as more information on 
mycobacterial sequences become available. The preferential codon bias, relatively 
small number of ribosomal R N A  genes (Bercovier e t  a l . , 1986) and the performance 
of the translational system along with other factors may reflect the slower growth rate 
of M . tu b e r c u lo s is  and M . le p r a e . However, if the above assumptions are correct, 
the fast growing mycobacteria contradicts the assumptions and hence may not be valid 
completely.
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The codon bias in the microorganisms can be related to evolution, though 
there is no direct evidence for this. W e  may assume that the very earliest peptides 
were composed of the amino acids most abundant at that time. From the primitive 
biosphere studies it has been shown that glycine, valine, aspartic acid, glutamic acid 
and alanine were the most abundant amino acids (Anderson and Kurland, 1990). The 
point to be noted is, all these amino acids are coded by G + C  rich codons. As at 
present sufficient data is not accumulated from mycobacterial genes, it is premature 
to make any conclusions from this type of information.
One of the other prominent features observed of all the mycobacterial genes 
sequenced so far, is to show very high "Z-DNA" structures when analyzed through 
computer programmes. It is well known that "Z-DNA" structures are favoured by 
an alternating sequence of purines and pyrimidines, e.g. d(CG)n and prokaryotic D N A  
seems to form Z - D N A  more readily than the eukaryotic D N A  (Rich e t  a l., 1984). 
It is also known that negative supercoiling of the D N A  stabilizes Z - D N A  and D N A  
supercoiling is also regulated by environmentally e.g. by osmotic shock and 
anaerobiosis (Dorman e t  a l., 1990). N o w  the question that arises is whether the 
mycobacterial D N A  is in Z - D N A  form for most of the time or not? It has most of 
the properties that are required for the formation of Z-DNA. If it is not in Z - D N A  
form than there must be additional DNA-gyrase inhibitors present in the cell system 
which will reduce D N A  supercoiling and hence regulate the gene expression in 
mycobacteria. The relationship between D N A  supercoiling and the gene expression 
of stress proteins can be checked easily by performing the following experiment: The 
gene coding the stress protein can be subjected to different stress conditions like
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osmotic shock or temperature shock or anaerobic conditions etc. and then the 
expression of the protein and D N A  supercoiling can be examined. Dorman e t  a l . ,  
(1990) have found a definite relationship between these two in case of virulent gene 
of S h ig e lla  f le x n e r i . Similar attempts were made with the 19 k D a  antigen of M .  
b o v is . The cloned gene in E . c o l i (clone pUS30) was subjected to temperature and 
osmotic shock and protein expression was checked on S D S - P A G E  gel and the D N A  
supercoiling was checked by doing plasmid extraction and running chloroquine gels 
to check plasmid D N A  topoisomers. The results obtained from this experiment were 
not conclusive and hence not included in the thesis. The same 19 kDa cloned gene 
(pUS30 clone) was grown in the presence of novobiocin, a drug which inhibits D N A  
gyrase and checked for the expression of protein and for plasmid topoisomers. Again 
in this experiment no conclusive results were obtained. Since 19 k D a  antigen is not 
known as one of the stress proteins, this experiment will be more useful, if done 
using one of the known mycobacterial stress proteins. The other way of checking the 
Z - D N A  will be to raise monoclonal antibodies against Z - D N A ,  which is known as 
highly immunogenic molecule and then check for the presence of Z - D N A  by doing 
in  s i t u  reactions with mycobacteria.
In conclusion it will be interesting to investigate the probability of Z - D N A
structures in mycobacteria, which may be contributing as one of the factors for slower
(
growth rates of M . tu b e r c u lo s is  and M . le p r a e .
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A p p e n d ix  1 : Codon u s a g e  t a b le  o f  t h e  p u b l is h e d  s e q u e n c e s  
o f  M. tuberculosis and  M. leprae as  l i s t e d  i n  t a b le  15.-
a . a . co d o n n o . t o t % a . a . co d o n n o . t o t %
F TTT 15 12 T ACT 25 8 . 9
F TTC 109 124 8 7 .9 T ACC 161 5 7 .5
T ACA 26 9 . 3
L TTA 3 0 .8 T ACG 67 279 24
L TTG 67 1 9 .1
L CTT 16 4 .5 A GCT 57 12 . 2
L CTC 63 18 A GCC 219 47
L CTA 21 6 A GCA 46 9 . 8
L CTG 180 350 51 A GCG 143 465 3 0 .7
I ATT 37 2 0 .5 * TAA 3 21
I ATC 131 7 2 . 1 * TAG 5 3 5 .7
I ATA 12 180 6 * TGA 6 14 4 2 .8
M ATG 69 69 100 H CAT 9 2 1 .9
H CAC 32 41 78
V GTT 32 10
V GTC 141 4 4 .2 Q CAA 30 26
V GTA 23 7 .2 Q CAG 115 145 79 . 3
V GTG 123 319 3 8 .5
N AAT 25 13 . 4
s TCT 21 8 .6 N AAC 161 186 8 6 .5
s TCC 51 2 0 .9
s TCA 19 7 .8 K AAA 31 1 5 . 9
s TCG 74 3 0 .4 K AAG 163 194 84
s AGT 10 4 .2
s AGC 68 243 2 7 .9
D GAT 46 2 1 .6
p CCT 26 10 D GAC 166 212 78 . 3
p CCC 62 2 4 .2
p CCA 30 1 1 .7 E GAA 51 23 . 7
p CCG 138 256 53 .9 E GAG 164 215 7 6 .2
Y TAT 19 1 8 .2 C TGT 11 30 . 5
Y TAC 85 104 8 1 .7 C TGC 25 36 69 .4
R CGT 31 2 0 .9 w TGG 45 45 100
R CGC 68 4 5 . 9
R CGA 13 8 .7 G GGT 119 2 7 .9
R CGG 29 1 9 .5 G GGC 221 5 1 .8
R AGA 1 0 .6 G GGA 30 7
R AGG 6 148 4 G GGG 56 426 13 . 1
TOTAL CODONS 4004
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